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1
CHAPTER 1

INTRODUCTION

1.1 Summary
Cyclins are a family of highly conserved proteins that activate Cyclin-dependent
kinases (Cdks) to regulate the cell cycle, transcription, and other cellular processes. In
metazoans, the well-characterized cyclins include CycA, CycB, CycD, and CycE, which
play major roles during cell cycle regulation, and CycH, CycT, CycK, and CycC, which
are mainly involved in transcriptional regulation. Several additional proteins with the
characteristic domain of the cyclin family remain poorly or completely uncharacterized.
In Drosophila one of these is encoded by a gene named CG14939, which I recently
renamed Cyclin Y (CycY). CycY is a highly conserved protein that has not been
functionally characterized in Drosophila, or any other model organism. Only minimal
information is available for the human ortholog, CCNY. In this project, I used a reverse
genetics approach to characterize the function of Drosophila CycY. I set out to generate
and characterize loss-of-function mutants to determine the role of CycY during
development. I generated a deletion of the CycY gene (CycY) using a technique in
which a P-element transposon is mobilized to create an imprecise excision. This
deletion, E8, removed the entire CycY transcript along with non-coding portions of the
adjacent genes. I provided multiple lines of evidence showing that CycY is the only
gene influenced in E8 and hence renamed this deletion as an allele of CycY, CycYE8. I
also generated transgenic flies that can express dsRNA targeting CycY in specific
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tissues. The combination of the phenotypic characterization of the CycY null mutant and
tissue-specific CycY knockdown provided initial clues about CycY function in
Drosophila. I demonstrated that CycY plays important functions during multiple
developmental stages, from embryogenesis to adult viability. The major mutant
phenotypes of the zygotic null were visualized during metamorphosis. I also identified
the binding partner of CycY, Eip63E (also known as Cdk14), a Cdk induced by
ecdysone. Finally I established a connection between CycY and the Brm chromatinremodeling complex in regulating gene expression. In this chapter, I will introduce
background information about cell cycle regulation, CycY, Eip63E and their human
orthologs, ecdysone signaling, and Brm complex functions.

1.2 Cell cycle regulation, cyclin-dependant kinases, and cyclins
A number of potentially fatal human diseases like cancer involve cell cycle
defects (Hunter and Pines, 1991). Cell cycle control is regulated by an evolutionarily
conserved family of serine/threonine protein kinases called cyclin-dependent kinases
(Cdks) and their regulatory subunits, the cyclins (Edgar and Lehner, 1996; Morgan,
1995). Critical cell cycle events are both positively and negatively regulated by specific
Cdks, whose activities oscillate throughout the cell cycle. Cdk activities are controlled by
several different mechanisms, including binding of the positively activating cyclin
subunits, inhibition by Cdk inhibitor proteins, phosphorylation by Cdk activating kinases
(CAKs)

or

inhibitory

kinases,

and

dephosphorylation

by

cell-cycle

regulated

phosphatases (Petersen et al., 1999).
In the human genome, there are 21 genes encoding Cdks and 5 genes encoding
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distantly related proteins known as Cdk-like kinases (CdkLs). These have recently been
renamed Cdk1-20 and CdkL1-5 on the basis of similarities in sequence and function,
although cyclin partners have not yet been identified for a few of them (Malumbres et
al., 2009). Cdks regulate cell cycle progression (Cdk1-4, Cdk6), transcription (Cdk7-10),
differentiation (Cdk5), and other cellular processes as well. The activation of a Cdk
relies on the binding of a cyclin and on the phosphorylation of specific Cdk residues. For
example, Cdk1 by itself is inactive due to a distortion of the ATP-binding site and
blockage of the substrate binding by the “T-loop”. The binding of CycB to the highly
conserved PSTAIRE helix of the upper kinase lobe causes a conformational change
that allows phosphorylation of the tip of the “T-loop” by a Cdk activating kinase (CAK)
which is itself a Cdk. This results in movement of the “T-loop” to a group of positively
charged amino acids to open the active site. Cyclin binding also activates
phosphorylation of the inhibitory site, which holds the Cdk still in an inactive state.
Removal of the inhibitory phosphate by the Cdc25 phosphatase finally triggers the
activation of Cdk1 (De Bondt et al., 1993; Millar and Russell, 1992). In the absence of a
cyclin, the Cdk is inactive regardless of its phosphorylation state. Thus, cyclins are
critical regulators of Cdk.
The founding members of the cyclin family, cyclins A and B, were first discovered
as proteins that oscillated throughout the cell cycle, peaking in late G2 and M phase
(Evans et al., 1983). These proteins were later shown to be required to activate Cdk1,
(also known as Cdc2), which is required for entry into M phase in most eukaryotes
(Morgan, 1997). At the N terminus of these mitotic cyclins, there is a 9-amino acid
destruction motif (RXALG[D/N/E/V]IXN) (D box), which targets the protein for ubiquitin-
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dependent degradation by the 26S proteasome during mitosis (Hunt, 1991b).
Ubiquitination is mediated by an E3 ubiquitin ligase known as anaphase promoting
complex (APC), which has several key targets during mitosis (King et al., 1996). For
example, securin, the inhibitor of separase, needs to be degraded at the onset of
anaphase to promote sister chromatid separation (Nasmyth, 2002; Nasmyth et al.,
2000).
Other cyclins with sequence similarity to cyclins A and B were subsequently
identified and shown to be required at other points during the cell cycle (see Table 1-1)
(Murray, 2004). The best characterized of these in metazoans include D-type cyclins,
which partner with Cdk4 to control G1 phase events, and E-type cyclins, which partner
with Cdk2 to control the transition from G1 to S phase. Many of the cellular signals that
control entry into S phase function by promoting the stability or degradation of CycD or
CycE. D-type cyclins are synthesized in response to growth factor stimulation and
persist as long as the stimulation still exists. The protein levels do not show strong
oscillation during cell cycle but only form a weak peak near G1-S. Upon serum
starvation, they are rapidly degraded (Sherr, 1994). The half-life of these proteins is only
about 30 minutes (Hunter and Pines, 1994). The levels of CycE, on the other hand,
oscillate with the cell cycle, peaking in late G1. These G1 cyclins do not contain the Nterminal destruction signals found in mitotic cyclins but do contain PEST sequences
(enriched for the amino acids Pro, Glu, Ser, Thr) at the C-terminus, which have been
suggested to target proteins for rapid degradation (Lew et al., 1991). It was later shown
that binding of Cdk2 protected free CycE from degradation by the ubiquitin-proteasome
pathway. Phosphorylation of CycE by its cognate Cdk promotes its recognition by

Table 1-1. The regulation of cyclin protein levels during the cell cycle
Oscillation?

Destruction
signal

Ubiquitin
ligase

References

CycA

Starts to accumulate during S phase and
diminishes at mitosis.

destruction box

APC

(Evans et al., 1983; Hunt, 1991a;
Hunt, 1991b)

CycB

Synthesized during late S and G2 and degraded
at the transition to anaphase.

destruction box

APC

(Evans et al., 1983; Hunt, 1991a;
Hunt, 1991b)

CycC

No

No

No

(Loyer et al., 2005)

CycD

Synthesized in response to growth factor
stimulation. Forms a weak peak near G1-S.

PEST

unknown

(Hunter and Pines, 1994; Sherr,
1994)

CycE

Peaks at G1/S

PEST

SCF

(Clurman et al., 1996; Koepp et al.,
2001; Lanker et al., 1996)

unknown

SCF?b

(Tetzlaff et al., 2004)

No

No

(Shimizu et al., 1998)

CycF
CycG

Starts to accumulate during S phase, peaks in
late G2, and declines sharply as cells enter
mitosis.
Expression induced at G2/M under stress
condition.
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Cyclina (Drosophila
/human)

CycH

No

No

No

(Loyer et al., 2005)

CycJ

Not degraded during mitosis.

No

No

(Althoff et al., 2009)

CycK

No

No

No

(Loyer et al., 2005)

CG16903/CycL

No. Expression induced upon extracellular
signal stimulation.

No

No

(Loyer et al., 2005)

CycT

No

No

No

(Loyer et al., 2005)

CycY

Peaks at G2/M.

unknown

unknown

(Davidson et al., 2009)

Koko/FAM58

unknown

unknown

unknown

not available

a

A generic name for both Drosophila and human cyclins is used in most cases, whereas a species-specific name is used when the gene is not
characterized and named as a cyclin in that species. The definition of such proteins as specific cyclins is based on sequence analysis. Drosophila
does not have CycF.
b
CycF is an F-box protein that is part of an SCF complex; therefore, it has been predicted to aid in self degradation.
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the protein degradation machinery. The Ser within the PEST sequence is at least one of
the phosphorylation sites, which is consistent with the assumption that PEST is part of
the destruction signals for G1 cyclins (Clurman et al., 1996; Lanker et al., 1996). This
phosphorylation-mediated degradation mechanism provides a self-limiting control of
protein level. The ubiquitin ligase responsible for CycE ubiquitination is SCF, which is
composed of Skp1, Cul1 (Cdc53), Rbx1, and an F-box containing protein (Koepp et al.,
2001).
Several other members of the cyclin family do not show cell-cycle-dependent
degradation or synthesis and some have been shown to play roles in cellular processes
that are not directly related to cell cycle regulation (Table 1-2). One group of cyclins, for
example, regulates transcription by activating Cdks that can phosphorylate the carboxyterminal tail of the large subunit of RNA polymerase II (Loyer et al., 2005). Several
additional members of the cyclin family remain uncharacterized or poorly characterized.
The defining feature of the cyclin family is a homologous region of about 100
amino acids called the cyclin box (Hunt, 1991b), which includes the domain responsible
for interaction with a Cdk. Detailed studies on specific Cdk/cyclin complexes have
shown that the cyclin box domain is essential and sufficient for interaction with and
activation of the Cdk partner (Morgan, 1996). Thus, while specific Cdk partners have not
yet been identified for every cyclin, the presence of a cyclin box suggests that all cyclins
play the role of activating one or more Cdks. In addition to activating kinase activity, the
cyclins may also influence the substrate specificity or determine the subcellular
localization of the active complex (Miller and Cross, 2001). Although there are certain
specific functions for some cyclins, gene redundancy is also common in the cyclin

7
Table 1-2. Summary of cyclins, Cdk partners, and the major functions of the
cyclin/Cdk complex
Cyclina
(Drosophila /human)

Cdk partners

Cellular functions

CycA

Cdk1, Cdk2

CycA/Cdk2 complex is implicated in the control of DNA replication
whereas CycA/Cdk1 complex is involved in mitosis by
phosphorylating Cdh1 to prevent CycB degradation by APC/Cdh1
(Yam et al., 2002). The S phase role for CycA in Drosophila has
also been reported, while in Drosophila, CycA only interacts with
Cdk1 (Sprenger et al., 1997).

CycB

Cdk1

CycB/Cdk1 complex is the M phase promoting factor (MPF) in all
eukaryotes (Draetta et al., 1989).

CycC

Cdk3, Cdk8

CycC/Cdk3 complex phosphorylates pRB to promote G0-arrested
cells to reenter the cell cycle (Ren and Rollins, 2004). CycC also
forms a complex with Cdk8 to phosphorylate the C-terminal
domain (CTD) of the largest subunit of RNA polymerase II and the
CycH subunit of the TFIIH to regulate transcription both positively
and negatively (Loyer et al., 2005).

CycD

Cdk4/6

CycD/Cdk4/6
complex
promotes
G1
progression
by
phosphorylating pRB (Sherr, 1994). In Drosophila, this complex
has been shown to promote cellular growth through mRpL12 and
Hif-1 Prolyl Hydroxylase (Hph) (Datar et al., 2000; Frei and Edgar,
2004; Frei et al., 2005; Meyer et al., 2000).

CycE

Cdk2

CycE/Cdk2 complex promotes G1 to S phase transition by
phosphorylating pRB, which then releases E2F to activate
transcription of genes needed for S phase (Dynlacht et al., 1994;
Hinds et al., 1992; Koff et al., 1992).

CycF

no

CycF plays a role in S/G2 that has a subsequent positive impact
on G0 cells to reenter cell cycle or G1 to S phase transition. It
contains an F-box and assembles into an SCF complex in vivo,
suggesting it may function in proteolysis (Tetzlaff et al., 2004). It is
recently identified to mediate the degradation of CP110, a protein
essential for centrosome duplication, and therefore plays a role for
mitosis (D' Angiolella et al., 2010).
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Table 1-2. Summary of cyclins, Cdk partners, and the major functions of the
cyclin/Cdk complex (continued)
Cyclina
(Drosophila /human)

Cdk partners

Cellular functions

CycG

Cdk5 (non-Cdk
interactors:
GAK and
PP2A)

CycG associates with Cdk5 and CycG-associated kinase
(GAK) (Kanaoka et al., 1997). CycG also associates with
PP2A phosphatase to dephosphorylate Mdm2 and hence
promotes the degradation of p53 (Okamoto et al., 1996;
Okamoto et al., 2002).

CycH

Cdk7/Mat1

CycH/Cdk7/Mat1 complex can function as Cdk activating
kinase (CAK) to phosphorylate CycA/B/Cdk1, CycE/Cdk2, and
CycD/Cdk4/6. This complex also phosphorylates the CTD of
the largest subunit of RNA polymerase II to promote
transcriptional elongation as a component of the general
transcription factor IIH (TFIIH) (Loyer et al., 2005).

CycJ

Cdk1, Cdk2

CycJ/Cdk2 complex plays a role in the rapid nuclear division
cycles of early Drosophila embryogenesis (Kolonin and Finley,
2000) and plays a role in oogenesis (G. Atikukke and R.
Finley, unpublished). It has also been reported that CycJ
forms a complex with Cdk1 (Althoff et al., 2009).

CycK

Cdk9

CycK/Cdk9 complex phosphorylates CTD of the largest
subunit of RNA polymerase II to promote transcriptional
elongation (Loyer et al., 2005).

CG16903/CycL

Cdk11

CycL/Cdk11 complex is involved in pre-mRNA splicing (Loyer
et al., 2005).

CycT

Cdk9

CycT/Cdk9 complex phosphorylates CTD of the largest
subunit of RNA polymerase II to promote transcriptional
elongation (Loyer et al., 2005).

CycY

Cdk14

This work.

Koko/FAM58

Cdc2rkb

Koko may be required for germline stem cell maintenance
(Baker and Kernan, 2007). In human, mutation in FAM58A
causes x-linked “STAR syndrome”, while the molecular
function is unknown (Unger et al., 2008).

a

A generic name for both Drosophila and human cyclins is used in most cases, whereas a speciesspecific name is used when the gene is not characterized and named as a cyclin in that species. The
definition of such proteins as specific cyclins is based on sequence analysis. Drosophila does not have
CycF.
b
D. Liu and R. Finley, unpublished data.
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family. In Drosophila for example, deletion of either CycA, CycB or CycB3 individually
causes no major defects, whereas deletion of both CycB and CycB3, or CycA and
CycB3, results in mitotic defects (Jacobs et al., 1998), suggesting substantial overlap
among the function of these cyclins. In addition to regulating other downstream
substrates, a cyclin can also be the phosphorylation target of its Cdk partner. The
phosphorylation may trigger the proteolytic degradation of the cyclin (Ceccarelli and
Mann, 2001; Clurman et al., 1996; Lanker et al., 1996) or aid in substrate recognition
(Waters et al., 2004).
In summary, a number of proteins in the cyclin family have been identified by
virtue of their conserved cyclin box domain (Tables 1-1 and 1-2). Some of these
proteins oscillate with the cell cycle like the founding members of the family, while
others do not (Table 1-1). Almost all members of the family are thought to partner with
specific Cdks. Some cyclin/Cdk complexes regulate the cell cycle, while others regulate
transcription or unknown processes (Table 1-2).

1.3 CycY
Several members of the cyclin family, including Drosophila CG14939 (CycY),
have not been characterized. In this project, I choose to characterize the biological
functions of CG14939 and recently renamed it Cyclin Y (CycY) (Liu and Finley Jr,
2010). CycY is highly conserved in metazoan species. This conservation extends
throughout the length of the protein, even outside of the cyclin box, and is more
extensive than the conservation of any other type of metazoan cyclin, except for CycC
(Liu and Finley Jr, 2010). This level of conservation suggests an important function, yet
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prior to last year CycY had not been studied in any organism. Aside from genome
sequences, the gene had only been noted in a limited number of functional genomics
experiments and genome-wide association studies. A few of these are worth
mentioning. A large-scale phosphoproteome study in Drosophila embryos identified
several phosphorylated peptides from the CycY protein (Zhai et al., 2008). One of the
phosphorylation sites, S389, is highly conserved and has also been found to be
phosphorylated in human CycY, both in nuclear and cytoplasmic fractions (Beausoleil et
al., 2004; Olsen et al., 2006). The human CycY gene, CCNY, was identified as a
potential susceptibility factor for inflammatory bowel disease (IBD), a complicated
genetic disorder affecting the intestinal mucosa. A single nucleotide polymorphism
(SNP) located in an intron of CCNY was found to be strongly associated with the two
IBD subphenotypes, Crohn’s disease and ulcerative colitis (Franke et al., 2008;
Weersma et al., 2009). Another study found that human CycY is among a number of
proteins that are significantly upregulated in metastatic colorectal cancer cells (Ying-Tao
et al., 2005). While these results are intriguing, functional studies are needed to
determine whether CycY plays any causal role in these diseases.
Recently a handful of independent groups including our own made discoveries
about CycY, each from a different starting point (Davidson et al., 2009; Jiang et al.,
2009; Li et al., 2009; Liu and Finley Jr, 2010). Combined, these studies have identified a
Cdk that is regulated by CycY (Eip63E/PFTK1/Cdk14), found that CycY has a novel
plasma membrane localized isoform, demonstrated that it is essential for Drosophila
development, and identified a potential role for a CycY-associated kinase in Wnt
signaling. These recent findings will be described further in section 1.6 and Chapter 2.
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1.4 Eip63E/Cdk14
An initial clue about CycY function came from the fact that Drosophila CycY was
isolated through a physical interaction with a Cdk named ecdysone-induced protein 63E
(Eip63E) in a high throughput yeast two-hybrid (Y2H) screen (Stanyon et al., 2004). The
Eip63E gene encodes five highly related and apparently functionally redundant protein
isoforms, all of which have homology to cyclin-dependent kinases (Sauer et al., 1996;
Stowers et al., 2000). The proteins are most similar to the poorly characterized
mammalian Cdk called PFTAIRE, so named because of the amino acid sequence in the
conserved helix that binds to cyclins. Although a cyclin partner for Eip63E had not been
identified, rescue experiments using mutant variants of the protein have suggested that
its activity depends on cyclin binding (Stowers et al., 2000). In those experiments
mutation of a conserved glycine adjacent to the PFTAIRE (G243), which in other Cdks
is required for cyclin binding, abolished the ability of an Eip63E transgene to rescue null
mutant embryos to adulthood. Similarly, mutation of a conserved isoleucine (I249),
which is also required for cyclin binding in other Cdks, diminished the ability of Eip63E
to promote development. A directed yeast two-hybrid screen by Rascle et al., identified
two potential regulators of Eip63E, PIF-1B and PIF-2 (PIF stands for PFTAIRE
Interacting Factor), but neither of these proteins has any similarity to cyclins. Both PIF1B and PIF-2 are cysteine-rich proteins, interacting with the same non-conserved Nterminal histidine-rich domain of Eip63E. It has been proposed that the function of the
binding of PIF to the long N-terminal extension of Eip63E, which may inhibit its kinase
activity, is to counter the inhibitory effect (Rascle et al., 2003). Subsequent identification
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of the Eip63E-CycY interaction in the high throughput yeast two-hybrid screen is not
surprising given that Y2H screens are rarely saturating (Schwartz et al., 2009).
Furthermore, because Y2H screens can result in false positives, further characterization
was needed to show that Eip63E and CycY are functional partners.
The name of Eip63E derives from the fact that one of the three transcription units
of the Eip63E gene is induced in response to pulses of the steroid hormone 20hydroxyecdysone (hereafter referred to as ecdysone) (Stowers et al., 2000). Ecdysone
triggers crucial developmental transitions, including metamorphosis, as described
further below. Phenotypic characterization of Eip63E loss-of-function mutants has
shown that it has essential roles in several developmental processes (Stowers et al.,
2000). The majority of zygotic null mutants die during larval development, while only a
small percentage survive to pupation. The mutants that survive take 2-3 days longer
than their heterozygous siblings to pupariate and are generally smaller than wild type
pupae. These phenotypes point to a role for Eip63E in larval development and
metamorphosis and further suggest that this Cdk may be involved in growth control.
Mutant eye clones, however, showed no morphological or cell cycle defects, leading
Stowers et al., to conclude that Eip63E does not regulate the cell cycle (Stowers et al.,
2000). Eip63E proteins have also been shown to be important for embryogenesis since
zygotic null embryos from null mothers fail to hatch into first instar larvae. Interestingly,
this maternal effect can be complemented by zygotic expression (Stowers et al., 2000).
These

findings

indicate

that

this

ecdysone-inducible

metamorphosis and other developmental events as well.

gene

is

important

for
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1.5 Ecdysone signaling and metamorphosis
Since Eip63E encodes at least one ecdysone induced isoform, and I have shown
that CycY plays a role in metamorphosis (Chapter 2) (Liu and Finley Jr, 2010), I will now
introduce this important developmental process. Metamorphosis is characterized by
striking developmental changes, including the degradation of obsolete larval tissues by
programmed cell death and the construction of adult tissues and structures by
controlled proliferation, differentiation, and morphogenesis of progenitor cells in the
larvae (Riddiford, 1993). The external structures of the adult, such as the head, wing,
eye, and leg, develop from larval tissues called imaginal discs or from other primordial
cells called histoblasts. The specification of general cell fates (e.g. wing, eye, etc)
happens in the embryo, while more specific cell fates are determined during larval
development. It is during this stage that imaginal disc cells proliferate rapidly and
undergo pattern formation (Cohen, 1993; von Kalm et al., 1995). At metamorphosis,
these cells arrest cell division, start differentiation, and initiate the cell shape changes
that drive the eversion and elongation to form adult structures (Condic et al., 1991). For
example, the wing imaginal disc originates in the embryo within the larval epidermis as
a cluster of ~ 50 cells (Bryant and Simpson, 1984; Garcia-Bellido, 1975). These cells
are mitotically quiescent before the end of the first larval instar, after which they undergo
continuous logarithmic cell proliferation until 24 hr after puparium formation, with an
average 8.5 hr cell doubling time (Gonzalez-Gaitan et al., 1994). At the end of the third
larval instar, most wing blade cells are arrested in G2 phase and wing margin cells are
arrested in G1. These ~ 50,000 wing disc cells are fully grown and patterned to a great
degree. After this point, there is still, however, at least one cell division that must occur
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during pupal development. During the last 4 hr of the pupal time (20-24 h after puparium
formation), there are mitotic events without further DNA synthesis. These cells are
finally arrested at G1/G0 phase where they continue differentiation (Milan et al., 1996).
To achieve the final adult structures, cell shapes need to be changed through the
contraction of abdominal muscles that drive the eversion and elongation of the imaginal
discs (Condic et al., 1991; Fristrom and Fristrom, 1993). For example, failure of the leg
imaginal disc to change shape during prepupal development leads to legs not fully
extended and/or legs elongated in the wrong direction (D'Avino and Thummel, 1998;
Gates and Thummel, 2000). Many factors influence the cell shape changes, such as
muscle contraction, rigidity of the pupal cuticle, and proteolysis (Fekete et al., 1975;
Fortier et al., 2003). Muscle contraction provides an external force. A less rigid pupal
cuticle and the de-attachment of disc cells from the extracellular matrix by protease
hydrolysis provide a suitable external environment. Some genes have been reported to
be involved in these processes, such as zip and sqh, encoding subunits of nonmuscle
myosin II (Edwards and Kiehart, 1996; Young et al., 1993); ds, encoding a member of
the cadherin superfamily (Clark et al., 1995); sb, encoding a serine protease (Appel et
al., 1993); vlc, probably functioning at the septate junction; bl, encoding a RNA binding
protein to regulate transcription or translation (Gates and Thummel, 2000); crol, E74,
BR-C and βFTZ-F1, all of which encode transcription factors induced by ecdysone
hormone (D'Avino and Thummel, 1998; Fletcher and Thummel, 1995b; Fortier et al.,
2003; Kiss et al., 1988).
The steroid hormone ecdysone is the major insect molting hormone that controls
metamorphosis. Ecdysone levels reach six peaks from embryogenesis to pupation
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(Richards, 1981a; Richards, 1981b). At the end of third larval instar, the fourth pulse of
ecdysone signals puparium formation and the onset of metamorphosis, a set of
responses that includes eversion of the imaginal discs to form rudimentary adult
appendages, larval tissue histolysis, and the apolysis of the larval cuticle as it forms the
puparium (Cohen, 1993). About 12 hours after puparium formation, a brief ecdysone
pulse triggers another set of metamorphic responses that includes eversion of the adult
head, proliferation of the imaginal histoblast cells to form the epidermis of the adult
abdomen, and further histolysis of larval tissues (Bate, 1993; Fristrom and Fristrom,
1993; Skaer, 1993). The final ecdysone pulse lasts throughout the pupation stage and
directs differentiation into the adult form. The general mechanism by which ecdysone
regulates important transition events during the Drosophila life cycle, especially the
larval to pupal transition, has been widely studied. The hormone first binds to a receptor
consisting of a heterodimer of ecdysone receptor (EcR) and Ultraspiracle (Usp).
Another novel receptor has also been reported (Costantino et al., 2008). The active
complex then binds to DNA to induce early or primary response genes, a process that
does not require protein synthesis. The protein products from these early genes in turn
induce activation of the late genes (secondary response genes). The well characterized
primary response genes include Broad-Complex (BR-C), E74, and E75, which are all
transcription factors (Burtis et al., 1990; Crowley and Meyerowitz, 1984; DiBello et al.,
1991; Feigl et al., 1989; Fletcher and Thummel, 1995a; Segraves and Hogness, 1990;
Thummel, 1990). Non-transcriptional regulators have also been reported, such as a
calcium binding protein encoded by E63-1, an ABC transporter encoded by E23, and a
lipoprotein binding protein encoded by IMP-E1 (Andres and Thummel, 1995; Hock et al.,
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2000; Natzle et al., 1988; Thummel, 1990). Late genes are initially repressed by the
ecdysone-receptor complex and are later activated by primary response genes.
Traditionally it was assumed that secondary-response genes provide effector functions,
which directly affect the metamorphic response. Several well characterized secondary
response genes support this assumption (Bayer et al., 1996). The Sgs family, for
example, encodes glue proteins that are secreted from the salivary gland to help attach
the pupae to a dry surface, which protects the animals during metamorphosis (Russell
and Ashburner, 1996). L71 genes encode a series of secreted small polypeptides to
provide an antimicrobial defense during metamorphosis (Wright et al., 1996). Other
partially characterized secondary response genes, however, may play regulatory roles,
such as the Cdk Eip63E.

1.6 CycY, Eip63E/PFTK1, and Wg/Wnt signaling
During the past year several independent groups made discoveries about CycY,
each from a different starting point (Davidson et al., 2009; Jiang et al., 2009; Li et al.,
2009; Liu and Finley Jr, 2010). Here I will introduce some of these new findings.
The human ortholog of Eip63E is PFTAIRE kinase 1 or PFTK1, named for the
amino acid sequence in the cyclin-binding domain. The Eip63E/PFTK1 proteins are now
known generically as Cdk14 (Malumbres et al., 2009), though the species-specific
names will be used here to refer to studies in each organism. Similarly, the human
ortholog of Drosophila CycY is CCNY. I will generically call these proteins CycY or use
CCNY to refer to studies in human. Little was known about the function of PFTK1. It is
expressed in many tissues and is particularly highly expressed in brain, testis, and

17
ovary in both mouse and human (Besset et al., 1998; Lazzaro and Julien, 1997; Yang
and Chen, 2001). A number of PFTK1-interacting proteins have been identified by yeast
two-hybrid screens, including CycD3, and more recently CycY (Davidson et al., 2009;
Gao et al., 2006a; Gao et al., 2006b; Giot et al., 2003; Jiang et al., 2009; Liu and Finley
Jr, 2010; Rascle et al., 2003; Shu et al., 2007; Stanyon et al., 2004). My own work
confirmed this interaction for the Drosophila proteins, CycY and Eip63E. Chen and
coworkers confirmed the human PFTK1/CycY interaction by co-AP assays from human
cells and demonstrated that PFTK1 enhances the serine phosphorylation of CycY,
suggesting that CycY may itself be one substrate for the PFTK1/CycY complex.
Davidson and coworkers further identified that both Drosophila CycY/Eip63E complex
and its human ortholog CCNY/PFTK1 phosphorylate the Wnt co-receptor, known as
arrow in Drosophila and LRP6 in humans, and therefore may regulate Wnt signaling
(described further below).
One novel feature of CycY is that it spends at least some of its time tethered to
the plasma membrane. Jiang et al. showed that human CycY with a C-terminal GFP tag
localized to the plasma membrane, a finding confirmed by the Niehrs group (Davidson
et al., 2009; Jiang et al., 2009). This localization was dependent on a conserved Nterminal myristoylation signal. Mutation of the putative myristoylation site, glycine 2, to
alanine abolished membrane localization, as did fusion to N-terminal tags such as GFP
or HA. Jiang et al further showed that forced expression of CycY resulted in
relocalization of GFP-PFTK1 from the cytoplasm to the plasma membrane, indicating
that this cyclin is capable of recruiting the Cdk to the membrane (Jiang et al., 2009).
CycY is the only member of the cyclin family that is known to contain a myristoylation
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signal although two non-cyclin proteins that bind Cdk5, p35 and p39, are both
myristoylated and require this signal to localize Cdk5 to the plasma membrane (Asada
et al., 2008; Humbert et al., 2000; Patrick et al., 1999). The presence of a myristoylation
signal and the localization of CycY to the plasma membrane make it likely that CycY
functions at least in part by localizing Cdk activity to the plasma membrane to direct
phosphorylation of membrane-associated substrates, such as the Wnt co-receptor
LRP6/Arrow (Davidson et al., 2009). In cultured cells, myristoylation defective CCNY
mutants showed decreased physical interaction with LRP6 and LRP6 S1490
phosphorylation, suggesting the importance of the myristoylation signal and membrane
localization for CCNY function, at least for its putative regulatory role of LRP6 (Davidson
et al., 2009; Jiang et al., 2009). The human CCNY gene and one of its paralogs (CCNYlike 1) each encode two splice isoforms, which differ in the presence or absence of the
N-terminal 54 amino acids containing the N-terminal myristoylation signal. The shorter
splice variant (isoform 2, originally named CycX) of human CycY was cloned and shown
to be mostly nuclear (Li et al., 2009). Thus, it is possible that a form of CycY functions in
the cytoplasm or nucleus to promote phosphorylation of substrates other than LRP6.
In cultured cells, CCNY level oscillates throughout the cell cycle, peaking at
G2/M. The protein also appears to be subject to ubiquitination mediated protein
degradation (Davidson et al., 2009). PFTK1 also peaks at G2/M, coincident with the
maximal LRP6 phosphorylation and Wnt signaling. The induction of Wnt signaling at
G2/M by CCNY/PFTK1 phosphorylation has been proposed to orchestrate a mitotic
program (Davidson et al., 2009). Besides CCNY, PFTK1 has also been shown to be
activated by another cyclin, CCND3, and inhibited by p21Cip1, and to phosphorylate Rb.
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Ectopic expression of PFTK1 in U2OS cells specifically promotes G1 to S transition,
and PFTK1 knockdown in SH-SY5Y cells arrests cells at G1 phase (Shu et al., 2007).
Consistently, in Drosophila S2 cells, Eip63E knockdown led to decreased mitotic index
(Bettencourt-Dias et al., 2004). These cell cycle related phenotypes may be a
synergistic effect from both LRP6 and Rb phosphorylation involving CCNY and CCND3
respectively. It is still unclear why a Cdk that is enriched at G2/M has major cell cycle
related effects during the transition from G1 to S phase. Whether there are other cyclins
or substrates that also contribute to the PFTK1-related cell cycle regulation requires
further investigation.
The Wnt/Wingless (Wg) signaling pathway is conserved during evolution. All the
components in the mammalian Wnt signaling have counterparts in the Drosophila Wg
signaling pathway (Table 1-3). The pathway is required for pattern formation during
embryonic

development, cell

proliferation, differentiation, and other biological

processes. Wnt are secreted signaling molecules involved in multiple signaling
pathways, one of which is the canonical Wnt/β-catenin cascade. In the absence of Wnt,
the transcription factor β-catenin is phosphorylated at serine 45 by CK1, which is
recruited by the scaffold protein Axin. This phosphorylation primes the subsequent
phosphorylation by GSK3, another Axin binding protein, at β-catenin serine 41, 37, and
33. The fully phosphorylated β-catenin is recognized and ubiquitinated by the β-TrCP
E3 ubiquitin–ligase complex, and transferred by the adenomatous polyposis coli (APC)
tumor suppressor gene product, a third Axin binding protein, from the Axin complex to
the 26S proteasome to be degraded. The Dishevelled (Dvl) protein is also capable of
interacting with Axin and inhibiting the Axin-mediated GSK3-dependent phosphorylation
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Table 1-3. Wnt/Wg pathway components
Mouse/Human

Drosophila

Function

Wnt

Wingless (Wg)

Secreted ligand

Frizzled (Fz)

Frizzled (Fz)

Wnt/Wg receptor

LRP5/6

Arrow (Arr)

Wnt/Wg co-receptor

Dishevelled (Dvl)

Dishevelled (Dsh)

Scaffold protein

GSK3

Shaggy/Zeste-white 3 (Sgg)

LRP6/Arr kinase

CK1

Gilgamesh (Gish)

LRP6/Arr kinase

Axin

Axin

Scaffold protein

APC

APC

Scaffold protein, tumor
suppressor

β-catenin (β-cat)

Armadillo (Arm)

Transcription factor

Tcf/Lef

dTcf/Pangolin (Pan)

Transcription factor
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and degradation of β-catenin (Kishida et al., 1999). Upon Wnt stimulation, the single
pass transmembrane Wnt co-receptor LRP6 aggregates and recruits Dvl, GSK3, and
Axin to the cell membrane to assemble a complex called the LRP6 signalosome. In the
signalosome, the intracellular domain of LRP6 is phosphorylated by GSK3 on PPPSP
motif and by CK1γ (a membrane-anchored member of the CK1 family) on other sites
including T1479. This removes the autoinhibitory effect exerted by the LRP6
extracellular domain on itself. These sequential translocation and phosphorylation
events finally release β-catenin from the Axin degradation complex. The free
cytoplasmic β-catenin then translocates to the nucleus and binds Tcf/Lef to regulate the
transcription of Wnt target genes (Verheyen and Gottardi, 2010).
In addition to the ligand-dependent phosphorylation of LRP6 by GSK3 and CK1γ,
it had been noted that the LRP6 receptor also undergoes a ligand-independent
phosphorylation at residue S1490, which may be required for or enhance the
subsequent ligand-dependent phosphorylations (Davidson et al., 2005). To search for
the kinase(s) responsible for ligand-independent S1490 phosphorylation, the group
performed a screen in which they individually knocked down the expression of every
kinase by RNAi in Drosophila S2R+ cells and screened for decreases in both Wnt
signaling and LRP6 S1490 phosphorylation. The investigators identified Eip63E and
were led to its potential partner (CycY) by the previously mentioned yeast two-hybrid
data. Kinase assays using immunopurified Eip63E and CycY showed that in
combination they significantly enhanced phosphorylation of LRP6. Using RNAi
knockdown in Drosophila and human cells they were able to show that both Eip63E and
CycY are required for maximal LRP6 S1490 phosphorylation and for maximal Wnt
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signaling. These results are consistent with a model in which membrane-associated
CycY recruits Cdk14 to the membrane where it phosphorylates LRP6 to help prime
LRP6 for activation by Wnt. Although membrane localization has not yet been
demonstrated for Drosophila CycY, it does have the N-terminal myristoylation signal
and the signal is required for LRP6 S1490 phosphorylation in cultured cells (Davidson et
al., 2009).

1.7 Brm ATP-dependent chromatin-remodeling complex function
CycY has been identified to physically interact with Snr1 in a high throughput
yeast two-hybrid screen (Giot et al., 2003), which prompted us to investigate the
relationship between CycY and Snr1, and to test the possibility that Snr1 is a
downstream target of CycY/Eip63E complex.
Snr1 (SNF5-related 1) is the Drosophila counterpart of yeast SNF5 and human
hSNF5/INI1 (Integrase-interacting protein 1). It is one of the core subunits of the
SWI/SNF ATP-dependent chromatin-remodeling complex, which in Drosophila is known
as the Brahma (Brm) complex (Dingwall et al., 1995). Chromatin is mainly composed of
DNA and histone proteins. In order to fit the relatively long DNA into a small nucleus
while maintaining appropriate access to it, DNA is wound around a histone protein core,
which together forms a highly compact structure. During the processes of DNA
replication, recombination, repair and transcription, the chromatin has to be remodeled
to make DNA accessible. There are four classes of ATP-dependent chromatin
remodelers, SWI/SNF, ISWI, Mi-2, and Ino80, each of which has a unique ATPase and
subunit composition (Mohrmann and Verrijzer, 2005). All of these use the energy from
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ATP hydrolysis to modulate the relative position of DNA and histones. The ATPase in
the SWI/SNF complex is SWI2/SNF2 or Sth1 in yeast, Brm in Drosophila, and hBrm or
Brg1 in human. By modulating chromatin structures, SWI/SNF complex is involved in
both gene activation and suppression. In yeast, about 5-7% of genes are regulated by
SWI/SNF complex activity based on microarray studies in mutants (Monahan et al.,
2008; Sudarsanam et al., 2000)s. In Drosophila, about 2% of the genes are differentially
regulated in Brm complex mutants (Zraly et al., 2006). The genes regulated by the
SWI/SNF complex in metazoans include genes required for cell proliferation and several
components of the Brm complex have been suggested to be tumor suppressors,
including hSNF5, Brg1, and Brm (Reisman et al., 2009). One important mechanism by
which SWI/SNF complex activity is regulated is phosphorylation. For example, Brg1 and
BAF155 both have been found to be phosphorylated by the CycE/Cdk2 complex and
the expression of CycE can overcome the ability of Brg1 to induce growth arrest
(Shanahan et al., 1999).

1.8 Project outline
The goal of the studies described in this dissertation was to characterize the
function of a novel conserved cyclin, CG14939 (CycY) in Drosophila. In Chapter 2, I
describe the generation of a null mutant allele of CycY and show that its phenotype is
similar to that of Eip63E mutants. I show that CycY plays major essential roles during
metamorphosis, especially during pupariation. I also show that maternally provided
CycY is essential for embryogenesis and that this requirement could be partially
rescued by zygotic expression. Finally, I confirm that CycY and Eip63E specifically
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interact and show that the interaction depends on a conserved phosphorylation target
on CycY, Ser389. This part of work has been published recently (Liu and Finley Jr,
2010).
In Chapter 3, I describe the generation of transgenic flies for knocking down the
expression of CycY in specific tissues. By combining data from the conditional
knockdown and the null mutant allele, I show that CycY is required for wing growth and
sustained adult viability. I also show that CycY genetically interacts with two
components of the Brm ATP-dependent chromatin-remodeling complex, Snr1 and Brm,
and that CycY and Snr1 can physically interact. Moreover, the downstream targets of
Brm complex, Eig71Eh and Eig71Ei, are misregulated in CycY mutants. Taken together,
these data suggest that CycY may be involved in gene regulation through modulating
the Brm complex activity.
Data presented in this dissertation have provided initial interesting findings about
essential in vivo requirements for CycY. Perhaps more importantly, the establishment of
the CycY null mutant strain and a variety of transgenic lines opens the door for further
studies. In Chapter 4, I present the results of several additional experiments aimed at a
better understanding of CycY function. In Chapter 5, I summarize the important
conclusions from this study and discuss several interesting questions that it raised. I
also propose future experiments to address some of the questions.
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CHAPTER 2

CYCLIN Y IS A NOVEL CONSERVED CYCLIN ESSENTIAL FOR DEVELOPMENT
IN DROSOPHILA
Part of the work described in this chapter has been published in Genetics 184:
1025-1035, 2010.

2.1 INTRODUCTION
Cyclins are a superfamily of eukaryotic proteins that play a critical role in
activating a group of S/T kinases called cyclin-dependent kinases (Cdks). Well studied
metazoan cyclins have two major biological functions, regulating the cell cycle (CycA,
CycB, CycD, CycE) and transcriptional regulation through RNA pol II (CycH, CycT,
CycK, CycC). CG14939 (CycY) is one of the few poorly or fully uncharacterized cyclins
in Drosophila. Alignment of the amino acid sequences of all cyclins from one species
shows that there are two sequence classes that roughly correspond to the two major
functional categories. CycY, however, does not fit neatly into either one of these two
sequence classes. The sequence alone, therefore, has not provided any clues to
CycY’s cellular functions. One powerful approach to elucidate the in vivo biological
functions of a gene is to create loss-of-function mutants and examine their phenotypes.
Here I set out to do this for CycY.
In Drosophila, a number of in vivo mutagenesis techniques are available,
including gene targeting by homologous recombination (Rong and Golic, 2000; Rong et
al., 2002), creation of a deletion by FRT-mediated recombination (Golic and Golic,
1996; Parks et al., 2004), P-element-mediated imprecise excision (Robertson et al.,
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1988), and conditional knockdown by using Gal4/UAS-RNAi systems (Lee and Carthew,
2003). Gene targeting by homologous recombination is theoretically a great way to
create specific mutations in the gene of interest (Rong and Golic, 2000; Rong et al.,
2002). However, due to uncertain technical issues, reports of successful mutant
generation with this approach have been rare. Insertional mutagenesis using
transposons is a useful gene disruption technique that is now being applied on a
genome-wide basis in Drosophila (Bellen et al., 2004; Thibault et al., 2004), increasing
the likelihood that a locus of interest will have a P-element in it or nearby. However, in
many cases, the insertion itself will not cause any detrimental effect on the function of a
gene. Looking through all available P-element or PiggyBac transposon insertion lines
around the CycY genomic region, I found only one P-element insertion line, d03228,
which is from the Exelixis mutant collection (Thibault et al., 2004). This P-element is
inserted in between the CycY stop codon and the start codon of its neighboring gene
crol. Adult flies bearing this insertion do not show any visible developmental defects,
suggesting that the genes around this insertion site are still functional. However, this is
a good candidate strain to be used for P-element imprecise excision. In this approach,
the P-element is mobilized by transiently expressing transposase. At some frequency
the P-element will be excised imprecisely, resulting in deletion of nearby sequences.
The gene arrangement around the CycY region on the chromosome is very simple.
There is no overlap between neighboring genes and they are not particularly close to
each other. This should enable the creation of a CycY null mutant that has the
neighboring genes intact. Finally, knocking down gene expression with dsRNA is
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becoming a widely used and efficient approach, although the caveat of off-target-effects
always exists. This approach will be discussed further in Chapter 3.
In this chapter, I successfully generated a null mutant of CycY using the
imprecise excision approach. I further show that the null mutant, CycYE8, is homozygous
lethal with most mutant animals arresting during pupal development. The mutant
exhibits delayed larval growth and major developmental defects during metamorphosis,
including impaired gas bubble translocation, head eversion, leg elongation, and adult
tissue growth. Heat shock-induced expression of CycY at different times during
development resulted in variable levels of rescue, the timing of which suggests a key
function for zygotic CycY during the transition from third instar larvae to prepupae. CycY
also plays an essential role during embryogenesis since zygotic null embryos from null
mothers generated with germline clones fail to hatch into first instar larvae. I provide
evidence that the CycY protein (CycY) interacts with Eip63E, a Cyclin-dependent kinase
(Cdk) for which no cyclin partner had previously been identified. Like CycY, the Eip63E
gene has essential functions during embryogenesis, larval development, and
metamorphosis. Our data suggest that CycY and Eip63E form a cyclin/Cdk complex
that is essential for several developmental processes.
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2.2 MATERIALS AND METHODS

2.2.1 Fly stocks
All fly stocks were maintained in vials containing standard cornmeal molasses
medium and raised at 25°C unless otherwise stated. Fly strains used in this study are
listed in Appendix A.

2.2.2 Plasmid cloning for P-element transformation and expression in Drosophila
tissue culture cells
pAS1 (A. Soans, and R.L.F., unpublished) is a modified pUAST (Brand and
Perrimon, 1993) vector encoding a myc-tag followed by 5’ and 3’ recombination tags
(RTs) to facilitate cloning of open reading frames containing the same RTs from yeast
two hybrid vectors (Giot et al., 2003; Stanyon et al., 2004). A map of pAS1 is available
at http://www.proteome.wayne.edu. pAS1-CycY was constructed by subcloning a
fragment of the CycY cDNA beginning with the ATG and ending with the stop codon.
The fragment was generated by PCR from the yeast two-hybrid clone using
oligonucleotides [Forward: 5' TTGACTGTATCGCCGGAATTC (5’RT-F, Finley lab #
891); Reverse: 5' CCGGAATTAGCTTGGCTGCAG (3’RT-R, Finley lab # 892)], which
provided the 5’ and 3’ RTs at either end, respectively. The fragment was subcloned by
gap repair in E.coli (Parrish et al., 2004). The P{CycY} genomic clone was constructed
by sequentially subcloning a 3.6 kb BamHI/NotI fragment and then a 4.0 kb AvrII/EcoRI
fragment, each from BACR05B13 (BACPAC resources center), into pCaSpeR2
(Thummel et al., 1988). The whole insert is 7.3 kb, which includes the entire CycY gene
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and sequences 4,032 bp upstream of the CycY start codon, and 1,970 bp downstream
of the stop codon, and includes none of the coding regions of crol or Pde1c. A Pelement carrying the CycY cDNA expressed from a heat shock promoter, pCaSpeR-hsCycY, was constructed by subcloning the 1.5 kb HpaI/StuI fragment encoding mycCycY from pAS1-CycY into the HpaI/StuI sites of pCaSpeR-hs (Thummel et al., 1988).
P-element mediated transformation was performed as previously described (Rubin and
Spradling, 1982).
pDL4 is a derivative of pUAST-NTAP (Veraksa et al., 2005) containing the NTAP
tag followed by the same 5’ and 3’ RTs found in pAS1. pDL2 is modified from pAS1 by
replacing the myc tag with GST tag. pDL5 is modified from pAS1 and pCeMM-NTAP
(GS) by replacing the myc tag with NTAP (GS) tag (Burckstummer et al., 2006). This
NTAP tag (GS) is composed of two IgG binding domains of Staphylococcus aureus
protein G and a streptavidin-binding peptide, separated by a TEV protease cleavage
site. Coding regions from the ATG to the stop codon of various Cdks, cyclins, and other
proteins were amplified from yeast two-hybrid clones (Stanyon et al., 2004) with primers
that added the 5’ and 3’ RTs and the products were subcloned into pAS1, pDL4, pDL5,
or pDL2 by gap repair in E.coli. Plasmids used or constructed in this study are listed in
Appendix B.

2.2.3 Establish stable transgenic fly strains
All the fly embryo microinjections for P-element-mediated transformation were
performed by Duke University. We received from Duke second or third instar larvae that
developed from microinjected embryos. A few drops of sterile water were added to the
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food surface upon receiving these vials. Each individual G0 male and female was
crossed with w1118 females and males respectively. Red-eyed G1 progeny were crossed
with a double balancer strain, Finley lab # 41 (w*; CyO/Sp; TM3 Ser/Sb). Red-eyed F1
progeny with CyO and TM3 Ser balancer chromosomes were crossed again with the
double balancer strain Finley lab # 41. For each F1 transgenic fly, a stable line was
established by collecting the progeny with CyO and Ser balancer chromosomes and at
least one marker chromosome (Sp or Sb). The genotype of the transgenic flies with
transgene on the second chromosome is w*; CyO/transgene; TM3 Ser/Sb. The
genotype of the transgenic flies with transgene on the third chromosome is w*; CyO/Sp;
TM3 Ser/transgene. Any progeny with four markers, CyO, Sp, Ser, and Sb, suggested
that the transgene in this line was probably located on the X chromosome. In this case,
either a self-cross of the red-eyed progeny with all four markers was done to generate
stable homozygous lines, or a cross with an X chromosome balancer strain Finley lab #
270 (FM7i/Rok2). All transgenic lines generated for this work are listed in Appendix C.

2.2.4 Generation and molecular characterization of a CycY mutant allele
I used P-element imprecise excision to generate CycY mutant alleles. The
starting P element in d03228 is inserted 1,958 bp downstream of the CycY stop codon
and 5,723 bp upstream of the crol start codon (Figure 2-1). The genetic crossing
scheme is shown in Figure 2-2. d03228 virgin females were mated with w*; CyO/Sp; ∆23, Sb/TM6 males, which provided P-transposase. F1 females (w*; d03228/CyO; ∆2-3,
Sb/+) were then mated to w*; CyO/Sp; TM3, Ser/Sb males, and F2 progeny were
screened

for

P-element

excision

by

the

reversion

of

eye

color

to

white
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Figure 2-1. The genomic region of CycY and the flanking genes crol and Pde1c.
Exons of the CycY, crol, and Pde1c transcripts are indicated by boxes. Black boxes
represent coding regions and grey boxes represent untranslated regions. Direction of
transcription and approximate start sites are shown with arrows. Pde1c has five
predicted transcripts that all start from the same position. CycY has one predicted
transcript, and crol has three predicted transcripts (RA, RB, RC) that start from the
same position and one (RD) that starts further upstream as shown. The P-element in
strain d03228 is inserted just upstream of exon 1 of crol transcripts RA-RC, and within
exon 1 (offset box) of crol transcript RD. The two deleted regions in the CycYE8 allele,
which was isolated by imprecise excision of the P-element in strain d03228, are
indicated as ( ∆ ). The deletion removes the entire CycY gene, the first non-coding exon
of crol, and a non-coding portion of the last exon of Pde1c. The genomic fragment used
to create a transgene P{CycY} that complements CycYE8 is also depicted (black bar).
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Figure 2-2. The genetic crossing scheme for performing P-element imprecise
excision to generate CycY null alleles. Red triangles represent the P-element in
strain d03228. “+” represents a wild-type chromosome. ♀, virgin females; ♂, males; ( ),
a deletion; X, cross.
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(Carney et al., 2004). 100 white-eyed flies were collected and further balanced
individually with Finley lab # 41 to make stocks. For each stock, genomic DNA was
extracted from homozygous single adult flies and analyzed by PCR for the presence of
CycY gene regions close to the d03228 insertion site. For those stocks that are
homozygous lethal, I rebalanced each line with CyO, Act5C-GFP balancer strain, which
allows the collection of homozygous larvae (non-GFP) for genomic DNA extraction and
PCR. The primer pairs used to characterize the deletion are listed in Appendix D and
the positions of these primers are schematically showed in Figure 2-3. The sequences
of all primers used in this study are listed in Appendix E.
The excision that removes all CycY coding sequences was named E8 and was
shown here (Figure 2-1) to be a null allele of CycY (CycYE8). To make sure there is not
a second site mutation on the same chromosome as CycYE8, the CycYE8 chromosome
was cleaned up by homologous recombination with d03228 for 7 generations. Since
homozygous d03228 is fully viable and normal, I assume the P-element insertion in this
line did not interfere significantly with gene expression. This makes it a good choice to
be used as a wild type chromosome for homologous recombination to remove any
potential second site mutations generated during mutagenesis and to avoid loss of the
initial deletion while screening recombinants. The initial balanced deletion strain
(E8/CyO) was crossed with the homozygous d03228 strain (red-eyed). I collected nonbalanced orange-eyed female progeny (E8/d03228) and crossed again with the
homozygous d03228 males. I repeated this cross for six more generations. The
E8/d03228 flies from the final cross were collected and balanced with Finley lab # 41 to
make a stock. To determine the precise endpoint of the E8 deletion, genomic DNA was
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Figure 2-3. The positions of all available primers around the genomic region
containing crol, CycY, and Pde1c. Exons of the CycY, crol, and Pde1c transcripts are
indicated by boxes. Black boxes represent coding regions and grey boxes represent
untranslated regions. Direction of transcription, approximate start sites, primer position
and orientation are shown with arrows. The length of the genome is proportionate
except for the region labeled with “/

/”. Primer sequences are listed in Appendix E.
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extracted from heterozygous CycYE8 adults and the region was amplified by PCR using
primers 5’-GGGCCAAGCACAAATACAAACG-3’ (DL94) and 5’-TGGTGAACGGCGAAC
AGAGC-3’ (DL98). The PCR product, which is about 1 kb, was gel purified and
sequenced from both ends. The deletion end points were determined by sequence
alignment with wild type genomic sequence. CycYE8 is missing 6,119 bp of DNA from
734 bp downstream of the Pde1c stop codon to 1,411 bp downstream of the CycY stop
codon, and a second small region of 988 bp from 1,955 bp downstream of the CycY
stop codon to the first non-coding exon of crol transcripts RA-RC or the first intron of
crol transcript RD. This removes the entire CycY transcript along with non-coding
portions of the last exon of Pde1c and the first non-coding exon of crol (Figure 2-1).

2.2.5 Extraction of genomic DNA from single flies
I followed the well established protocol by Ashburner with minor modifications
(Ashburner, 1989). Freeze a single fly in an eppendorf tube at -20°C for a few minutes.
Homogenize in the eppendorf tube with a pellet pestle attached to a pellet pestle
cordless motor from VWR (VWR KT749521-1590 and KT749540-0000) in 50µl of
homogenization buffer (10mM Tris-HCl pH7.5, 60mM NaCl, 10mM EDTA, 0.15mM
Spermine, 0.15mM Spermidine, 5% Sucrose). Add 50µl of lysis buffer (300mM Tris-HCl
pH 9.0, 100mM EDTA, 0.63% SDS, 5% Sucrose) and incubate the tube at 70°C heat
blocker for 15 minutes. After cooling the mixture to room temperature, add 15μl of 8M
KOAc and incubate on ice for 30 minutes. Centrifuge at 13500 rpm at 4°C for 5 minutes.
Transfer the supernatant to a new tube and add two volumes of ethanol to precipitate
DNA. After 5 minutes incubation at room temperature, centrifuge at 13500 rpm for 10
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minutes at room temperature. Discard the supernatant. Air-dry the pellet for about 10
minutes and add 100μl of H2O to dissolve the DNA. Use 1μl of the genomic DNA for
PCR.

2.2.6 Lethal phase analysis
Eggs were collected from w*; CycYE8/CyO, Act5C-GFP flies for 12 hours on apple
juice plates with fresh yeast paste. After another 30 hours, the numbers of unhatched
embryos and hatched first instar larvae were counted. Since homozygous CyO balancer
is lethal during embryogenesis, a roughly 75% hatching rate suggests no embryonic
lethality. 180 w*; CycYE8/CyO, Act5C-GFP and 180 w*; CycYE8 (lacking GFP) first instar
larvae were picked under a fluorescence dissection microscope and transferred into
regular vials. The numbers of wandering third instar larvae, pupae, and adults were
counted once a day for 15 days to score for a delay in puparium formation, progression
through metamorphosis, and adult eclosion. To estimate the delay of puparium
formation more accurately, I followed 180 first instar larvae for each genotype and
calculated the average time to form pupa by counting the number of pupa newly formed
after each 24 hour period and averaging over all individuals and days. Similarly, I
analyzed the following animals: (1) w*; CycYE8/CyO, Act5C-GFP; P{CycY}, (2) w*;
CycYE8; P{CycY}, (3) w*; CycYE8/CyO, Act5C-GFP and Df(2L)Exel6030/CyO, Act5CGFP, (4) w*; CycYE8/Df(2L)Exel6030, (5) w*; CycYE8/CyO, Act5C-GFP; P{CycY} and w*;
Df(2L)Exel6030/CyO, Act5C-GFP; P{CycY}, (6) w*; CycYE8/Df(2L)Exel6030; P{CycY},
(7) w*; Eip63E81/TM3, Ser Act5C-GFP and w*; Eip63EGN50/TM3, Ser Act5C-GFP, (8) w*;
Eip63E81/Eip63EGN50. All flies were incubated at 25ºC except were noted.
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2.2.7 Phenotypic characterization
200 w*; CycYE8/CyO, Act5C-GFP and 200 w*; CycYE8 first instar larvae were
collected (see above), transferred into individual fresh vials and allowed to develop for 9
days. For each genotype, pupae at all developmental stages were collected, weighed,
and imaged. The relative pupal length was measured based on the image size. The
average pupa weight and length were then calculated. To document the pupal
phenotype, pupae at all developmental stages were carefully removed from the wall.
For pharate adults, the pupal case was gently dissected. Images were taken with the
Leica MZ 16FA Stereomicroscope and Leica DFC 490 camera (kindly provided by Dr.
Markus Friedrich). Similarly, I analyzed the following animals: (1) w*; CycYE8/CyO,
Act5C-GFP; P{CycY}, (2) w*; CycYE8; P{CycY}, (3) w*; CycYE8/CyO, Act5C-GFP and
Df(2L)Exel6030/CyO, Act5C-GFP, (4) w*; CycYE8/Df(2L)Exel6030, (5) w*; CycYE8/CyO,
Act5C-GFP; P{CycY} and w*; Df(2L)Exel6030/CyO, Act5C-GFP; P{CycY}, (6) w*;
CycYE8/Df(2L)Exel6030; P{CycY}, (7) w*; Eip63E81/TM3, Ser Act5C-GFP and w*;
Eip63EGN50/TM3, Ser Act5C-GFP, (8) w*; Eip63E81/Eip63EGN50.

2.2.8 Heat shock induction and rescue efficiency
Eggs from a self cross of CycYE8/CyO; hs-CycY/TM3, Ser flies (Finley lab fly
stock # 700) were collected in glass vials with standard cornmeal Drosophila medium
for 24 hours and then heat shocked on each day as indicated in Figure 2-12. For each
heat shock induction, glass vials were incubated in a 37ºC water bath for one hour.
Vials were kept at 25ºC otherwise. The numbers of flies with or without curly wings were
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counted separately. If CycYE8/CyO and CycYE8 flies have equal viability (full rescue), the
number of CycYE8 flies should be half of that of CycYE8/CyO flies. The rescue efficiency
was then determined by the number of CycYE8 adult flies divided by half of the number
of CycYE8/CyO adult flies. The genotype of representative flies was confirmed by singlefly PCR. The primers used to confirm the genotypes were listed in Table 2-1.

2.2.9 Generation of mosaic germline clones with homozygous CycYE8
CycYE8 was recombined with FRT40A as previously described (Xu and Rubin,
1993). The genetic crossing scheme is shown in Figure 2-4. CycYE8 males or virgin
females (Finley lab stock # 692) were crossed with FRT40A flies with opposite sex
(Finley lab stock # 355). Virgin females with straight wings and red eyes from the above
cross were then mated with balancer strain males (Finley lab stock # 41). Individual redeyed males with curly wings from the above cross were mated with CycYE8 virgin
females (Finley lab stock # 692). If none of the progeny had straight wings from the
above cross, it suggested that CycYE8 successfully recombined with FRT40A since
homozygous CycYE8 is lethal (see Results and Discussion). I collected red-eyed adults
with curly wings to make a stock (Finley lab stock # 702).
Germline clones with homozygous CycYE8 were generated based on the wellestablished approach of Chou et al. with minor modification (Chou and Perrimon, 1996).
w*; CycYE8 FRT40A/CyO females were crossed with hs-FLP/Y; ovoD1 FRT40A/CyO
males for 3 days. Eggs were collected for 3 days and aged for 2 more days. Larvae,
which were at either second or third instar stages, were heat shocked at 37ºC in a water
bath for two hours. Females with straight wings (hs-FLP/w*; CycYE8 FRT40A/ovoD1
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Table 2-1. Primers used to confirm the genotypes.
Genotypes

Primer pairs

Product length

CycYE8/CyO; hs-CycY/TM3, Ser

DL94/DL98

1 kb

DL93/DL101

1.15 kb

DL94/DL98

1 kb

DL93/DL101

negative

CycYE8; hs-CycY/TM3, Ser
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Figure 2-4. The crossing scheme for recombining CycYE8 with FRT40A. Red
triangles represent a P-element with the miniwhite gene (38D4) closely linked to the
FRT40A insertion used as a selection marker for FRT40A; Black triangles represent the
FRT40A site; ♀, virgin females; ♂, males; ( Δ ), a deletion; X, cross. Bigger X,
recombination; Oval, centromere.
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FRT40A) from the above cross were then mated to CycYE8/CyO, Act5C-GFP males to
test for a maternal requirement for CycY. GFP positive (CycYE8 FRT40A/CyO, Act5CGFP) and GFP negative (CycYE8 FRT40A/CycYE8) first instar larvae were picked and
development was followed as described above.

2.2.10 Gene expression
Gene expression was assayed by reverse-transcription PCR (RT-PCR) (Figure
2-7) or quantitative real-time PCR (RT-qPCR) (Figure 2-13). Flies at the indicated
developmental stages were collected and total RNA was extracted using the RiboPure®
Kit (Ambion). The RNA samples were then treated with DNase from a DNA-free Kit
(Ambion) to remove contaminating genomic DNA. cDNAs were synthesized with a
Transcriptor First Strand cDNA Synthesis Kit (Roche) according to the manufacturer's
protocol. qPCR reactions were performed using Brilliant® SYBR® Green QPCR Master
Mix (Stratagene) in a 96-well plate. qPCR reactions were carried out in triplicate for
each RNA sample. The primers used in this work are listed in Table 2-2. rp49 was used
as the internal control gene and the mRNA level of CycY was normalized to rp49 levels.

2.2.11 Co-affinity purification (co-AP) assays
Co-AP assays were conducted by expressing pairs of N-terminally myc-tagged
and NTAP-tagged proteins in Drosophila S2R+ cells, purification of the NTAP-tagged
protein, and detection of associated myc-tagged proteins by immunoblotting. Myctagged proteins were expressed from pAS1. NTAP-tagged proteins were expressed
from pDL4, a derivative of pUAST-NTAP (Veraksa et al., 2005) containing the NTAP tag
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Table 2-2. Primers used for RT-PCR and qPCR.
Genes

Primers Finley
lab # (alias)

CycY

crol

Pde1c

β-Tubulin

rp49

a

Sequence

Positiona

Product
length (bp)

722 (DL108)

5’-AGGAGAATGGCACCCAAC

765-782

414

469 (DL17)

5’-TACTCCCGGTGGCAATAG

1161-1178

723 (DL109)

5’-AGCTCGGTGCCATCAGTAG

1440-1458

724 (DL110)

5’-GCGGCATTATTCGTGGACG

1753-1771

728 (DL114)

5’-GTGTGATCGCAACAATACGC

1622-1641

729 (DL115)

5’-TTGCTTTCCTCCGCTTCC

2069-2086

642 (DL12)

5’-GACCATGTCCGGCGTAAC

881-898

643 (DL13)

5’-AGCTCCTGGATGGCAGTG

1301-1318

732 (DL118)

5’-GATATGCTAAGCTGTCGCACAAATGGC

95-121

733 (DL119)

5’-GTGCGCTTGTTCGATCCGTAACCG

189-212

Inclusive nucleotide positions in predicted transcript RA for each gene.

332

465

438

118
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followed by the same 5’ and 3’ RTs found in pAS1. Note that pDL4 was validated for
Gal4-dependent expression of NTAP-tagged proteins in transiently-transfected
Drosophila S2R+ cells, but it cannot be used to make transgenic flies, possibly due to
mutations in the P-element. Coding regions from the ATG to the stop codon of various
Cdks or cyclins were amplified from yeast two-hybrid clones (Stanyon et al., 2004) with
primers that added the 5’ and 3’ RTs and the products were subcloned into pAS1 or
pDL4 by gap repair in E.coli. I used the following protocols adapted from Effectene
user’s manual and Veraksa’s protein purification protocol for transfection, cell lysis, and
co-AP assays (Veraksa et al., 2005).
2.2.11.1 Transfection of cultured Drosophila cells
Day 1 afternoon: Resuspend S2R+ cells in a T75 flask by pipetting and count the
cell numbers. Dilute the cell suspension to 1x106 cells/ml with fresh Schneider’s
Drosophila culture media (Invitrogen) supplemented with 10% FBS and 0.1mg/ml
Gentamicin. Seed 2ml of the above diluted cells in each well of a 6-well plate. Incubate
in the 25°C fly incubator overnight. Day 2 afternoon about the same time: Replace the
old media in the 6-well plate with fresh media and put it back into the incubator until
transfection. For each transfection, mix 10µl of 50ng/µl pAS1-X, 10µl of 50ng/µl pDL4-Y,
and 10µl of 50ng/µl pMT-Gal4 (Klueg et al., 2002). Add 70 µl of buffer EC to make a
total of 100 µl. Add 12µl of enhancer, vortex at the highest speed for 1 second, and
incubate at room temperature for 5 minutes. Add 30 µl of effectene, vortex at the
highest speed for 15 seconds, and incubate at room temperature for 10 minutes. Mix
with 600µl of culture media and add to the top of the cells in a drop-wise way. Put the
plate back into the fly incubator. The reagents mentioned above, including buffer EC,
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enhancer, and effectene, are from the effectene transfection kit (Qiagen). Day 3
morning: Add 220µl of 10mM CuSO4 to each well to induce the expression of Gal4. Day
4 morning: Replace with 1.5ml of fresh media supplemented with 1mM CuSO4 in each
well. Day 6: Resuspend the transfected cells by pipetting up and down several times.
Transfer the cells to a 1.5ml of eppendorf tube and centrifuge at 13500 rpm for 2
minutes at 4°C to spin down the cells. Wash the cell pellet two times with cold PBS.
2.2.11.2 Cell lysis
Add 300 µl of fresh-made lysis buffer [50mM Tris-HCl pH7.4, 180mM NaCl, 5mM
EDTA, 1% NP-40, 10% glycerol, 50mM NaF, 1mM Na3VO4, 1mM PMSF, 1x Protease
inhibitor cocktail (Roche)] to the cell pellet from one well of the 6-well plate. Homogenize
by pipetting up and down several times. Incubate on ice for 45 minutes. Vortex once
every 5 minutes. Centrifuge at 13500 rpm at 4°C for 40 minutes to clarify the cell lysate.
Transfer the supernatant to a new tube.
2.2.11.3 Protein quantification
Quantify the protein concentration using the BioRad protein assay reagent.
Generate a standard curve using a series of BSA dilutions ranging from 0 to 10µg/ml.
Take 4µl of protein lysate and add 796µl of H2O to make a total of 800µl. Mix with 200µl
of BioRad protein assay dye reagent. Incubate at room temperature for 5 minutes and
then measure OD595 to determine the absorbance and convert it to the protein
concentration on the basis of the standard curve. Usually, the protein concentration is
about 1.5-2.5µg/µl.
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2.2.11.4 Western blot to examine the protein expression
Mix the cell lysate with LDS sample loading buffer (Invitrogen) and incubate at
70°C for 10 minutes. Load 15µg of total protein for myc western blot or 2µg for protein A
western blot. Run the SDS-PAGE gel with Invitrogen electrophoresis system at 200V for
30-40 minutes. Transfer the protein to PVDF membrane (Bio-Rad) at 40V for 90
minutes. Block with 1XPBS, 5% milk at room temperature for one hour or 4°C overnight.
Incubate with primary antibody (anti-myc 1:500, Santa Cruz) at room temperature for
one hour or 4°C overnight. Wash with 1XPBS 2 times. Incubate with secondary
antibody [goat anti-mouse HRP conjugated secondary antibody (1:10000, BioRad) or
goat

anti-Protein

A

peroxidase-conjugated

antibody

(1:15000,

Rockland

Immunochemicals)] at room temperature for one hour. Wash with 1XPBS, 0.05%
Tween-20 5 times for 10 minutes each time. Detect proteins with ECL plus reagents
(GE Healthcare Life Sciences).
2.2.11.5 Co-AP
Transfer 40µl of rabbit IgG-conjugated agarose beads (Sigma) slurry (20µl of
settled beads) into an eppendorf tube using big orifice pipet tips. Wash 3 times with lysis
buffer. Mix with 500µg of cell lysate in a total of 1ml of lysis buffer. Incubate at 4°C for
two hours. Wash with lysis buffer 5 times. Add 1XLDS sample buffer to the beads and
heat at 70°C for 10 minutes. Resolve co-purified proteins by SDS-PAGE and detect by
western blotting.

2.2.12 Sequence alignments
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We determined the reciprocal best-match BLAST hits between Drosophila and
human cyclins (Table 2-3). BLAST searches were conducted with each of the
Drosophila cyclins listed below to identify the top matching human cyclins. In cases
where a gene had multiple protein isoforms, the longest isoform that had a cyclin
domain was used. The top matching human proteins were then used in BLAST
searches against the Drosophila melanogaster annotated proteins and the top matching
protein was identified. Reciprocal best-match BLAST hits are listed in Table 2-3. An
example of how reciprocal best-match hits are interpreted is as follows: Human CCND1,
CCND2, and CCND3 are the human proteins most similar to Drosophila CycD, and
Drosophila CycD is the Drosophila protein most similar to human CCND1, CCND2, or
CCND3, according to BLAST. Multiple sequence alignment was performed using
ClustalX version 2 (Larkin et al., 2007; Thompson et al., 2002). Pair-wise percent
identity was determined by dividing the number of identical sites in the alignment by the
length of the alignment, including gaps and unaligned ends. The dendrogram shown in
Figure 2-5 A was constructed using ClustalX with the neighbor-joining algorithm. For
Figure 2-5 B, the reciprocal best-match BLAST hits between Drosophila CycY and
proteins from several divergent species were aligned using ClustalW followed by
manual corrections to improve identities. Only the top matching CycY-like protein from
each species is shown. The proteins aligned were as follows, where Genbank
accession

numbers

are

in

parentheses:

Aedes

aegypti

hypothetical

protein

AaeL_AAEL010543 (XP_001660900.1); Caenorhabditis elegans hypothetical protein
ZK353.1a

(NP_498858.2);

Danio

rerio

hypothetical

protein

LOC767752

(NP_001070188.1); Drosophila melanogaster CG14939-PA (NP_609519.1); Gallus
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Table 2-3. Drosophila-Human reciprocal best-match proteins.
Drosophila protein

Genbank ID

Human Gene

Human protein

Genbank ID

CG14939-PA (CycY)

NP_609519

CCNY

Cyclin Y

NP_659449.3

CG14939-PA (CycY)

NP_609519

CCNYL1

Cyclin Y-like 1

NP_689736.1

CycA-PA

NP_524030

CCNA1

Cyclin A1

NP_001104516

CycA-PA

NP_524030

CCNA2

Cyclin A2

NP_001228.1

CycB-PB

NP_726246

CCNB1

Cyclin B1

NP_114172.1

CycB-PB

NP_726246

CCNB1

Cyclin B2

NP_004692.1

CycB3-PA

NP_651303

CCNB3

Cyclin B3

NP_149020.2

CycC-PA

NP_476848

CCNC

Cyclin C

NP_005181.2

CycD-PF (PC)

NP_727913.1

CCND2

Cyclin D2

NP_001750.1

CycD-PF (PC)

NP_727913.1

CCND3

Cyclin D3

NP_001751.1

CycD-PF (PC)

NP_727913.1

CCND1

Cyclin D1

NP_444284.1

CycE-PD

NP_723925

CCNE1

Cyclin E1

NP_001229.1

CycE-PD

NP_723925

CCNE2

Cyclin E2

NP_477097.1

CycG-PC

AAF57169.2

CCNG1

Cyclin G1

NP_004051.1

CycG-PC

AAF57169.2

CCNG2

Cyclin G2

NP_004345.1

CycH-PA

NP_524207

CCNH

Cyclin H

NP_001230.1

CycJ-PA

NP_523903

CCNJ

Cyclin J

NP_001127847.1

CG16903-PA

NP_569980

CCNL2

Cyclin L2

NP_112199.2

CG16903-PB

NP_569980

CCNL1

Cyclin L1

NP_064703.1

CycK-PB

NP_788083

CCNK

Cyclin K

NP_001092872.1

CycT-PB

NP_524127

CCNT2

Cyclin T2

NP_001232.1

CycT-PB

NP_524127

CCNT1

Cyclin T1

NP_001231.2

Koko-PA

NP_650721

FAM58A

Family 58A

NP_689487.2

Koko-PA

NP_650721

FAM58B

Family 58B

NP_001098987.1
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Figure 2-5. CG14939 encodes a highly conserved Y-type cyclin. (A) Phylogenetic
tree resulting from alignment of all Drosophila cyclins and cyclin-like proteins and their
corresponding human orthologs. Blue dots at branch points indicate that the attached
nodes (proteins) are reciprocal best-match BLAST hits between Drosophila and human
(see Materials and Methods). Lengths of the horizontal lines between nodes and branch
points indicate relative sequence similarity; e.g., the human and Drosophila Y-type
cyclins (red line) are more similar to each other than are any other human and
Drosophila cyclins except for CycC.
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Figure 2-5. CG14939 encodes a highly conserved Y-type cyclin. (B) Alignment of Drosophila CycY
and the most similar proteins from several other species. The sequences available for Nematostella and
Trichoplax may be truncated because the genome sequences were still in draft form. Yellow or grey
shaded amino acids are identical or similar, respectively, in at least 8 out of the 11 species shown, or 7 of
9 species where the N- and C-terminal sequences of Nematostella and Trichoplax appear to be missing.
Blue-shaded amino acids in the D. melanogaster sequence are known to be phosphorylated in embryos
(Zhai et al., 2008). Red-shaded serines, corresponding to S389 in D. melanogaster, are highly conserved
and phosphorylated in both Drosophila and human CycY (Beausoleil et al., 2004; Olsen et al., 2006; Zhai
et al., 2008). The N-terminal region of H. sapiens CycY contains a putative myristoylation signal (green
lettering), previously noted by Jiang et al., (Jiang et al., 2009), which appears to be conserved in many
other species. All of the sequences contain the conserved cyclin domain (underlined), corresponding to
amino acids 205 to 328 of Drosophila CycY; this domain is annotated in these sequences by the
Conserved Domain Database (Marchler-Bauer et al., 2009) and corresponds to pfam (Finn et al., 2009),
domain pfam:00134, “Cyclin_N”, the N-terminal cyclin fold found in the cyclin superfamily. Dashes
indicate gaps in the alignment. Asterisks in the D. melanogaster sequence indicate unaligned residues
that were removed and are shown below the alignment; one sequence is histidine-rich and the other is
glycine-rich, and neither appears to be conserved. The unaligned N-terminal region of the Monsiga
brevicollis sequence is also shown below. Numbers above the lines indicate residue numbers for the
Drosophila protein. Gene names are listed in Materials and Methods.
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gallus CCNYL1 cyclin Y-like 1 (XP_425973.2); Homo sapiens cyclin fold protein 1
variant b (AAL78999.1); Mus musculus cyclin fold protein 1 (NP_080760.2); Xenopus
laevis hypothetical protein LOC431857 (NP_001084816.1); Nematostella vectensis
predicted

protein

(XP_001641126);

Trichoplax

adhaerens

hypothetical

protein

(XP_002116466); Monosiga brevicollis hypothetical protein (XP_001750168).
To identify proteins with similarity to CycY in more distant species, reciprocal
best-match BLAST hits between Drosophila CycY and proteins in the species listed
below were determined. The identified proteins were also determined to be reciprocal
best-match BLAST hits with the human CCNY protein. For all of the identified proteins
the sequence similarity with the human or Drosophila CycY proteins was restricted to
the annotated cyclin domain (Marchler-Bauer et al., 2009) and immediate flanking
regions, referred to as the “cyclin+” region in Figure 2-6. The cyclin+ regions were
aligned using ClustalW and a consensus sequence was determined by identifying
residues that were found in >50% of the sequences (Figure 2-6A). The dendrogram
shown in Figure 2-6B was obtained by aligning the cyclin+ region of the proteins most
similar to CycY, and the annotated cyclin domains of reciprocal best-match hits of
Drosophila CycA and CycB for the species shown. Only the top matching CycY-like
protein from each species is shown; gene or genome duplications in some lineages
have resulted in several parologous CycY-like proteins (not shown). The following
proteins from non-metazoan species were reciprocal best-match hits of Drosophila
CycY or the human CCNY protein, where Genbank accession numbers are in
parentheses: Arabidopsis thaliana CYCP4;3 (NP_196362.1); Coprinopsis cinerea
predicted protein (XP_001832875); Cryptococcus neoformans cyclin (XP_566770);
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Figure 2-6. The cyclin domain of Y-type cyclins is novel and conserved
throughout the eukaryotic kingdom. (A) Alignment of the cyclin domains from the
proteins that are reciprocal best-match BLAST hits of Drosophila CycY in many nonmetazoan species. These proteins are also reciprocal best-match BLAST hits of human
CycY. Alignments include the cyclin domains (arrows) as annotated by the Conserved
Domain Database (Marchler-Bauer et al., 2009) along with the indicated flanking region
of each protein. A consensus sequence was obtained as 31 residues that are identical
in at least 50% of the proteins (colored); the Drosophila and human proteins each share
27 of these consensus residues. Only the top related protein from each species is
shown.
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Figure 2-6. The cyclin domain of Y-type cyclins is novel and conserved
throughout the eukaryotic kingdom. (B) Dendrogram showing sequence similarity
among the cyclin domains from several distant species. Cyclin domains from Drosophila
melanogaster (Dm) CycA, CycB, and CycY and their reciprocal best-match BLAST hits
in

human

(Hs),

Monosiga

brevicollis

(Mb),

Arabidopsis

thaliana

(At),

and

Saccharomyces cerevisiae (Sc) were aligned. The cyclin domains from the Y-type
cyclins included the annotated cyclin domain and small flanking regions as shown in
Figure 2-6A (cyclin+). Only the top related protein from each species is shown. The
length of the lines is proportional to sequence similarity. The lower cluster of Y-type
cyclin domains and the upper cluster of A and B-type cyclin domains are separated by a
relative distance of 9 (see scale bar for relative distances).
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Dictyostelium discoideum cyclin domain-containing protein (XP_642568); Giardia
intestinalis Cyclin fold protein 1 (EET00183.1); Laccaria bicolor predicted protein
(XP_001886042); Medicago truncatula unknown (ACJ84314); Paramecium tetraurelia
hypothetical

protein

(XP_001460214);

Perkinsus

marinus

hypothetical

protein

(EER16009); Phaeodactylum tricornutum CYCP1 (XP_002182703.1); Phytophthora
infestans

cyclin-Y-like

(XP_002302113);

(EEY67633.1);

Ricinus

communis

Populus
cyclin

trichocarpa

predicted

(XP_002520742.1);

protein

Saccharomyces

cerevisiae PCL1 (NP_014110.1); Tetrahymena thermophila Cyclin, N-terminal domain
containing protein (EAS05969); Toxoplasma gondii cyclin, N-terminal domain-containing
protein (EEE19730); Trypanosoma cruzi cyclin 6 (AAG44389.1); Yarrowia lipolytica
hypothetical protein (XP_505742).

2.2.13 Yeast two-hybrid assays
Yeast two-hybrid assays (Fields and Song, 1989) were performed using the LexA
system (Gyuris et al., 1993) and interaction mating assays (Finley and Brent, 1994).
Yeast strains and vectors, the protocol for one-on-one mating assays, and the reporter
scoring methods were previously described (Zhong et al., 2003). All of the cyclins tested
were expressed as activation domain (AD) fusions, whereas all of the Cdks were
expressed as DNA-binding domain (BD) fusions. AD and BD strains were obtained from
the arrays of LexA-based yeast two-hybrid clones previously described (Stanyon et al.,
2004).

2.2.14 Tandem affinity purification (TAP)
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Tandem affinity purification was performed as previously described (Puig et al.,
2001; Veraksa et al., 2005). Drosophila S2R+ cells were cotransfected with pDL4-CycY
and pMT-Gal4 in a 100mm dish. Cells were induced with CuSO4, harvested, and lysed
as described above. About 10-15mg clarified cell lysate was incubated with 100μl of
settled IgG agarose beads (Sigma A2909) at cold room for 2 hours on a nutator. The
lysate/beads mixture was loaded to a poly-prep column (0.8 x 4 cm, BioRad 731-1550),
which was then washed 3 times with 10ml of lysis buffer and once with 10ml of TEV
cleavage buffer (10mM Tris.HCl pH8.0, 150mM NaCl, 0.1% NP-40, 0.5mM EDTA, 1mM
DTT). 100 units of AcTEV protease (Invitrogen 12575-023) in 1ml of TEV cleavage
buffer was added to the beads and the mixture was incubated at 16°C for two hours.
Three volumes of calmodulin binding buffer (10mM β-mercaptoethanol, 10mM Tris.HCl
pH8.0, 150mM NaCl, 1mM Mg-acetate, 1mM imidazole, 2mM CaCl2, 0.1% NP40) and
3/1000 volume of 1M CaCl2 were added to the elute from TEV cleavage to promote the
binding with calmodulin beads and titrate the EDTA coming from the TEV cleavage
buffer. 100μl of settled calmodulin beads were incubated with the above elute at 4°C for
2 hours. Beads were then washed with 4ml of calmodulin binding buffer and finally,
purified proteins were eluted from the beads with 400μl of calmodulin elution buffer
(10mM β-mercaptoethanol, 10mM Tris.HCl pH8.0, 150mM NaCl, 1mM Mg-acetate,
1mM imidazole, 2mM EGTA, 0.1% NP40). Concentrated elute was sent to the
University of Michigan, Michigan Proteome Consortium, for MALDI/MS-MS.
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2.3 RESULTS AND DISCUSSION

2.3.1 CycY is a conserved uncharacterized cyclin
Drosophila CG14939 has a single predicted transcript that encodes a protein with
406 residues (Figure 2-1, 2-5B). Between amino acids 205 and 328 lies a cyclin
domain, a conserved region that defines the cyclin family of proteins. The closest
human homolog of CG14939 is a poorly characterized gene called Cyclin Y (CCNY).
Genes in a number of other species have also been named Cyclin Y based on their
sequence similarity to human CCNY. CG14939 is more similar to the Y cyclins from
other species than it is to any other Drosophila melanogaster gene (Figure 2-5)
indicating that it belongs to this orthologous family of proteins. We therefore renamed
CG14939 Cyclin Y (CycY). Outside of the cyclin domain the protein has virtually no
sequence similarity to other cyclins. However, CycY has been highly conserved through
evolution. Clear CycY orthologs are found in all metazoans with fully sequenced
genomes, including bilaterians (e.g., insects, nematodes, vertebrates), cnidarians (e.g.,
the sea anenome, Nematostella vectensis), and the placozoan, Trichoplax adhaerens.
Cyclin Y is also found in the choanoflagellate, Monosiga brevicollis, the closest known
unicellular relative of metazoans, suggesting that the Y-type cyclins originated prior to
the first multicellular species. Cyclin Y proteins from all of these species share
substantial sequence similarity over most their length, including regions outside of the
cyclin domain (Figure 2-5B). In contrast, plants, fungi, and other non-metazoan species
do not have proteins with extensive sequence similarity to CycY, though they do contain
the CycY-specific cyclin domain; this cyclin domain is distinct from other cyclin domains
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and appears to be conserved throughout the eukaryotic kingdom (Figure 2-6). In
metazoan species the level of CycY conservation is particularly high. For example, the
Drosophila protein shares 52% identity with the human CCNY protein. This level of
conservation is much higher than that observed for the cell cycle cyclins (e.g., Cyclins
A, B, D, and E), which share between 20 and 41% identity between human and
Drosophila (Finley et al., 1996). This suggests that CycY has an important and
potentially conserved function. Surprisingly, the function of Cyclin Y has not been
studied and CycY mutants have not been reported for any model organism.

2.3.2 Generation of a CycY mutant
To determine the function of Drosophila CycY, I set out to generate a loss-offunction mutant allele. I took advantage of the availability of a strain, d03228, bearing a
P-element inserted 1,958 bp downstream of the CycY stop codon and 5,723 bp
upstream of the start codon of the neighboring gene, crol (Figure 2-1). This insertion
itself has no visible effect on the function of any genes in this region since the
homozygous d03228 adults are completely viable and normal. I used imprecise excision
to generate a small deletion around the original P-element. The deletion, E8, completely
removed the CycY coding region while leaving the coding regions of the neighboring
genes intact (Figure 2-1), as determined by PCR and sequencing (Materials and
Methods). Expression of the neighboring genes, crol and Pde1c, was confirmed using
RNA extracted from homozygous and heterozygous E8 second instar larvae (Figure 27). In contrast, CycY transcription was undetectable in homozygous E8 larvae.
Hereafter we refer to the E8 deletion as CycYE8.
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Figure 2-7. Reverse-transcription PCR detecting expression of CycY, crol, Pde1c,
or β-tubulin in homozygous CycYE8 or heterozygous CycYE8 (CycYE8/+) second
instar larvae. The “+” chromosome is a CyO balancer with Act5C-GFP. A band of the
expected size is detected for all genes in both genotypes. The band is missing in the
homozygous CycYE8 larvae as expected.
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Two additional lines of evidence indicate that CycY is the only gene affected in
strain CycYE8. First, CycYE8 fully complemented crol04418, a lethal null allele of the
neighboring gene (D'Avino and Thummel, 1998); crol04418 also complemented the
mutant phenotype of CycYE8 (see below). Thus, although CycYE8 lacks the first noncoding exon of crol, a crol transcript is expressed and appears to be fully functional.
Second, as described in detail below, all of the abnormalities that I observed in
homozygous CycYE8 mutants can be rescued either by a CycY genomic transgene
(Figure 2-1) or by ubiquitous expression of a CycY cDNA using heat shock induction
(see below). Combined these results indicate that the CycYE8 mutant strain is a null
mutant for CycY.

2.3.3 CycY null mutants show delayed entry into pupariation and are pupal lethal
Homozygous CycYE8 mutants or CycYE8 over a deficiency that removes CycY
(Df(2L)Exel6030) produce no viable adults indicating that CycY is an essential gene. To
analyze the lethal phase, eggs from a self cross of CycYE8/CyO flies were collected for
12 hours and aged for another 30 hours. Of 366 embryos examined, 89 (24.3%)
remained unhatched while 277 (75.7%) hatched to first instar larvae. Since roughly 25%
of the embryos from this cross should be homozygous CyO, which is lethal during
embryogenesis, a third of the embryos that hatched should be homozygous CycYE8,
indicating that zygotic expression of CycY is not essential for embryogenesis.
To evaluate whether CycY is required during larval and pupal development, I
picked 180-200 first instar larvae of CycY null mutants (homozygous CycYE8 or CycYE8/
Df(2L)Exel6030) or their siblings and followed their morphology and development for 15
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days, after which no additional adults eclosed. CycY null mutants did not show obvious
larval lethality since the majority (90% or 93%) of first instar larvae developed into
pupae, which is a rate similar to their heterozygous siblings (84% or 94%, respectively)
(Table 2-4). However, I did observe delayed growth during larval development. By the
time third instar larvae in the heterozygous group reached the wandering stage, CycY
null mutant larvae were still at the feeding stage and exhibited dramatically smaller body
sizes (Figure 2-8 A, B, G, H; Figure 2-9 A, B). The CycYE8 homozygotes eventually
grew to sizes that were 80-90% of the heterozygotes before pupariation (Figure 2-8 G,
J). The delay in larval growth could be rescued with a genomic CycY transgene (Figure
2-8 C, D, I; Figure 2-9 C, D). The delay was also evident in the timing of pupariation. As
shown in Figure 2-8 A and B, the first pupa of CycYE8 heterozygotes was observed at 6
days after egg deposition (AED), while the first pupa of CycYE8 homozygotes was
observed at 7 days AED. Based on the number of pupae that formed each day in the
two strains I estimated that puparium formation of CycYE8 homozygous mutants was
delayed for about 13 hours relative to that of the heterozygous controls (Materials and
Methods). The genomic CycY transgene shortened this delay to about 5 hours. Similar
results were obtained with the CycYE8/Df(2L)Exel6030 mutants (Figure 2-9).
CycY null mutants were arrested predominately during pupal stages, but with
variable expressivity. I scored the final developmental stages of animals from each
genotype based on the presence of defined morphological markers (Bainbridge and
Bownes, 1981). Two major lethal phases were observed. The early lethal phase was
between pupal stages P3 and P5; for example, all 162 CycYE8 mutants that pupated
developed to stage P3 but only 61% reached stage P5 (Table 2-4). In contrast, all of the
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Table 2-4. CycY and Eip63E mutants display variable expressivitya
Genotype

b

CycYE8/+
E8

CycY

E8

CycY /+; P{CycY}
E8

CycY ; P{CycY}
E8

CycY /+ and
Df(2L)Exel6030/+
E8

CycY /Df(2L)Exel6030
E8

CycY /+; P{CycY} and
Df(2L)Exel6030/+; P{CycY}
E8

CycY /Df(2L)Exel6030
; P{CycY}
GN50

/+ and
Eip63E
Eip63E81/+
GN50

Eip63E
a

81

/Eip63E

L1

w. L3

P1

P3

P4

P5

P14

P15

A

n

180

152

152

152

152

152

151

150

150

%

100

84

84

84

84

84

84

83

83

n

180

162

162

162

158

110

74

23

%

100

90

90

90

88

61

41

13

n

200

180

180

180

180

180

180

180

%

100

90

90

90

90

90

90

90

n

200

185

185

185

185

185

185

177

%

100

93

93

93

93

93

93

89

89

n

200

187

187

187

187

187

187

174

174

%

100

94

94

94

94

94

94

87

87

n

200

186

186

186

182

144

88

31

%

100

93

93

93

91

72

44

16

n

200

178

178

178

178

178

178

177

%

100

89

89

89

89

89

89

89

89

n

200

179

179

179

179

179

179

176

176

%

100

90

90

90

90

90

90

88

88

n

180

164

164

164

164

164

164

162

162

%

100

91

91

91

91

91

91

90

90

n

180

135

129

129

76

59

0

0

0

%

100

75

72

72

42

33

0

0

0

15

c

8
180

d

90
177

19

e

f

g

10
177

h

i

180 or 200 newly eclosed first instar larvae (L1) from each genotype were followed and the number that
reached each stage, including wandering third instar larvae (w. L3), pupal stages (P1-P5, P14, and P15),
and adults (A), was recorded.
b
P{CycY} represents a genomic CycY transgene (Figure 1). In CycYE8/+ and Df(2L)Exel6030/+, “+”
stands for an Act5C-GFP-marked CyO balancer chromosome presumed to be wild type for CycY. In
Eip63E81/+ and Eip63EGN50/+, “+” stands for an Act5C-GFP-marked TM3, Ser balancer chromosome
presumed to be wild type for Eip63E.
c
13 out of the 15 CycYE8 adults that eclosed had leg and wing defects and died quickly, while the
remaining two were much smaller than their heterozygous siblings and died within two days.
d
3 out of the 180 CycYE8/+; P{CycY} adults were found dead on the food surface with the wing still folded
and without other obvious morphological defects.
e
18 out of the 177 CycYE8; P{CycY} adults were found dead on the food surface with the wing still folded
and without other obvious morphological defects.
f
One out of the 174 CycYE8/+ and Df(2L)Exel6030/+ adults was found dead on the food surface with the
wing still folded and without other obvious morphological defects.
g
All of the 19 CycYE8/Df(2L)Exel6030 adults that eclosed had leg and wing defects and died quickly.
h
6 out of the 177 CycYE8/+; P{CycY} and Df(2L)Exel6030/+; P{CycY} adults were found dead on the food
surface with the wing still folded and without other obvious morphological defects.
i
13 out of the 176 CycYE8/Df(2L)Exel6030; P{CycY} adults were found dead on the food surface with the
wing still folded and without other obvious morphological defects.
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Figure 2-8. Developmental timing of CycY and Eip63E mutants. (A-F) The
development of 180 first instar larvae (L1) of each genotype were followed for 15 days.
Genotypes include heterozygous CycYE8 (A and C) or homozygous CycYE8 (B and D).
Larvae in C and D harbored a genomic CycY transgene on the third chromosome
(P{CycY}). Larvae heterozygous for the Eip63E mutants, Eip63EGN50 or Eip63E81 (E), or
transheterozygous Eip63EGN50/Eip63E81 (F) were also analyzed. The percentage of first
instar larvae that developed into wandering third instar larvae (w L3), pupae (P), and
adults (A) on each day after egg deposition (AED) is shown. (G-J) Typical third instar
larvae of CycYE8/+ (G), CycYE8 (H), CycYE8; P{CycY} (I) at the same time point, and
CycYE8 after an additional day (J). In A, C, and G, “+” stands for an Act5C-GFP-marked
CyO balancer chromosome; in E, “+” stands for an Act5C-GFP-marked TM3, Ser
balancer chromosome.
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Figure 2-9. Developmental timing of CycY null mutants with and without a CycY
genomic transgene. The development of 200 first instar larvae of each genotype was
followed for 15 days. Genotypes shown include CycYE8/+ and Df(2L)Exel6030/+
combined (A), CycYE8/Df(2L)Exel6030 (B), CycYE8/+; P{CycY} and Df(2L)Exel6030/+;
P{CycY} combined (C), CycYE8/Df(2L)Exel6030; P{CycY} (D). The percentage of first
instar larvae (L1) that developed into wandering third instar larvae (w L3), pupae (P),
and adults (A) on each day after egg deposition (AED) is shown. “+” stands for an
Act5C-GFP-marked CyO balancer chromosome presumed to be wild type for CycY.
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152 heterozygotes that pupated reached stage P5, and all but two eventually emerged
as adults. The CycY null pupae that were arrested at stage P3 or P4 showed a variety
of developmental defects, including defects in gas bubble translocation, head eversion,
leg elongation, and adult tissue growth (Figure 2-10 and Table 2-5). Many mutant
individuals stopped further development with the newly formed gas bubble still in the
middle of the abdomen (Figure 2-10 E). In others the gas bubble translocated to the
posterior portion of the puparium as in wild-type, but then failed to completely relocate
to the anterior (Figure 2-10 H), which may hinder head eversion (Chadfield and
Sparrow, 1985). Many of the mutant pupae showed different amounts of empty space
inside the pupal case (Figure 2-10 D-I), which was probably due either to the failure of
gas bubble translocation, or to insufficient adult tissue growth. A defect in leg elongation
was also prevalent. Some mutant individuals had partially elongated legs that were
either shorter than normal and did not reach the bottom of the abdomen, or were bent
(e.g., Figure 2-10 G). More severe cases showed no sign of leg elongation (Figure 2-10
D). Wings also did not achieve full extension. The CycYE8/Df(2L)Exel6030 mutant had
the same range of phenotypes as homozygous CycYE8 (Table 2-5 and Figure 2-11).
The late lethal phase of the CycY null was between stages P14 and P15, almost
at the end of pupal development. For example, while 41% of the CycYE8 homozygous
pupae reached stage P14, only 13% reached stage P15 (Table 2-4). The P14-arrested
mutants exhibited the prominent malformed leg phenotype that was also observed
during earlier pupal stages (Figure 2-10 Q). In addition to the morphological defects,
CycY null pupae were generally shorter and much lighter than wild type pupae (Table 26, Appendix F).
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Figure 2-10. Metamorphosis defects in CycY and Eip63E mutants. (A-O) Representative early pupae
from ventral, dorsal, and lateral views (left, middle and right columns, respectively). Genotypes include
CycYE8/+ (A-C), homozygous CycYE8 (D-I), homozygous CycYE8 with the P{CycY} transgene (J-L), and
Eip63E81/Eip63EGN50 (M-O). Defects are indicated by colored arrows. The CycYE8 homozygous mutant
early pupae (second and third rows) and Eip63E null mutant early pupae (fifth row) show defects of leg
elongation (red), head eversion (blue), gas bubble translocation (green), and adult tissue growth (purple).
Early pupae of CycYE8 homozygotes with a genomic CycY transgene have no defects (fourth row). (P-R)
Representative pharate adults of CycYE8/+ (P), homozygous CycYE8 (Q), and homozygous CycYE8 with
the P{CycY} transgene (R). Homozygous CycYE8 mutant pharate adults have an obvious bent leg
phenotype (yellow arrow in (Q). CycYE8 homozygous mutant adult escapers either die soon after eclosion
or survive for less than two days and have a much smaller body size (W) than heterozygous control
adults (V), or CycYE8 mutants complemented with the P{CycY} transgene (X). Many of the adult escapers
had malformed legs (T, yellow arrow), whereas legs were normal in heterozygous control adults (S), or
CycYE8 mutants complemented with the P{CycY} transgene (U). In CycYE8 mutants arrested during
eclosion (Y and Z), when the pupal case was manually removed (Z) a layer of white tissue (arrowhead)
was evident. “+” stands for a CyO balancer chromosome with Act5C-GFP.
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Figure 2-11. Metamorphosis defects in CycY transheterozygous null mutants.
Genotypes

shown

include

CycYE8/Df(2L)Exel6030;

P{CycY}

(A-F)

and

CycYE8/Df(2L)Exel6030 (G-L). Representative early pupae (A-C, G-I), pharate adults (D,
J), dissected legs (E, K), or adults (F, L) are shown. For early pupae, the first, second,
and third columns present the ventral, dorsal, and lateral views, respectively. Defects
are indicated by colored arrows. The CycYE8/Df(2L)Exel6030 transheterozygous mutant
early pupae (G-I) show defects of leg elongation (red), head eversion (blue), gas bubble
translocation (green), and adult tissue growth (purple). CycYE8/Df(2L)Exel6030
transheterozygous mutant pharate adults have an obvious bent leg phenotype (J, yellow
arrow), but the dorsal view is indistinguishable from the control (data not shown).
CycYE8/Df(2L)Exel6030 transheterozygous mutant adult escapers die soon after
eclosion, some of which also have malformed legs (K, yellow arrow). Some were
arrested during eclosion (L).
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Table 2-5. Metamorphosis defects in CycY and Eip63E mutantsa
Genotypes
E8

CycY

E8
CycY ; P{CycY}

CycY /Df(2L)Exel6030

CycYE8/Df(2L)Exel6030
;P{CycY}

Eip63E

a

GN50

/Eip63E

Eclosed
(%)

Defects

162

14

185

E8

81

Arrested between P1 and P14 (%)

Total
pupae

186

179

129

96

17

98

0

-

+

++

+++

Leg elongation

18

9

22

37

Empty space inside pupal case

17

16

40

13

Head eversion

44

18

10

14

Leg elongation

4

0

0

0

Empty space inside pupal case

4

0

0

0

Head eversion

4

0

0

0

Leg elongation

20

24

16

23

Empty space inside pupal case

19

24

28

12

Head eversion

27

35

11

10

Leg elongation

2

0

0

0

Empty space inside pupal case

2

0

0

0

Head eversion

2

0

0

0

Leg elongation

2

17

17

64

Empty space inside pupal case

32

26

23

20

Head eversion

33

23

4

40

Mutants terminally arrested between pupal stages P1 and P14 (Table 2-4) were

scored for metamorphosis defects (leg elongation, head eversion, or empty space
inside the pupal case). - no defect; + mild defect; ++ moderate defect; +++ severe
defect.

Table 2-6. CycY and Eip63E mutant pupae are smaller than wild type pupae
Average weighta
Genotypec

mg (%)

CycYE8/+

1.12 (100)

CycYE8/+ and Df(2L)Exel6030/+

n

161

100 ± 4.0

31

1.18 (100)

239

100 ± 4.8

44

CycYE8

0.65 (58)

137

90 ± 8.6

36

CycYE8/Df(2L)Exel6030

0.75 (64)

230

92 ± 6.4

44

CycYE8/+; P{CycY}

1.19 (100)

265

100 ± 4.9

72

CycYE8; P{CycY}

1.13 (95)

239

102 ± 5.0

72

CycYE8/+; P{CycY} and Df(2L)Exel6030/+; P{CycY}

1.21 (100)

246

100 ± 4.4

47

CycYE8/Df(2L)Exel6030; P{CycY}

1.14 (94)

279

101 ± 4.2

48

Eip63EGN50/+ and Eip63E81/+

1.25 (100)

104

100 ± 3.7

30

Eip63EGN50/Eip63E81

0.75 (60)

142

90 ± 5.3

40

Percent of average weight is calculated relative to heterozygous siblings (100%).

b

Percent of average length is calculated relative to heterozygous siblings (100%).
The plus symbol (+) stands for an Act5C-GFP-marked balancer chromosome; either CyO with CycYE8 and
Df(2L)Exel6030, or TM3, Ser with Eip63EGN50 and Eip63E81.
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% ± SD

n

a

c

Average lengthb
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Among the small fraction of CycYE8 pupae that reached stage P15, 8 out of 23
(35%) arrested during the process of eclosion. The remainder eclosed into adults, but
the majority (13 out of 15) died very quickly with their wings still folded. Most of these
adults displayed short bent legs (Figure 2-10 T). Only two animals successfully eclosed
into adults that looked normal, though they were smaller than newly emerged
heterozygous control adults (Figure 2-10 V, W) and they survived for less than two
days. When the mutants that were arrested during eclosion were manually dissected
from the pupal case, a layer of white tissue could be seen, which seemed to adhere
adult structures to the inside wall of the pupal case (Figure 2-10 Y, Z). All of the CycY
null mutant defects described above could be rescued by introduction of a CycY
genomic transgene (Figure 2-10 and 2-11, Table 2-4, 2-5, and 2-6).

2.3.4 The expression of CycY is essential during the transition from third instar
larvae to prepupae
The null mutant phenotype of CycY suggested an important function during
metamorphosis. To determine the developmental time point at which CycY expression
is required, I generated transgenic flies that expressed myc-tagged CycY from a heat
shock promoter. A series of different heat shock regimes were performed to compare
their ability to rescue the lethality of homozygous CycYE8 (Figure 2-12). Heat shock on
the first 3 days after egg laying failed to rescue the viability of homozygous CycYE8
mutants. However, when heat shock was extended for one or two more days, which
included late third instar larvae, the rescue ability was dramatically increased to 30%35%. If CycY was also provided during early pupal stages, the rescue ability increased
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Figure 2-12. Temporal requirements for the expression of CycY. Embryos from a
CycYE8/CyO; hs-CycY/TM3, Ser self cross were collected for 24 hours and heat
shocked for different regimes. Each row indicates a different heat shock schedule. On
the left side, each bar represents a single 1h heat shock at 37ºC on that particular day.
The efficiencies of rescue to adulthood are shown on the right. The genotype of each
adult was determined by the presence or absence of CyO and Ser balancer
chromosomes (Materials and Methods). Representative adult genotypes were
confirmed by single-fly PCR. For each condition, the total number of adults analyzed
was between 200 and 300.
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further to 50-60%. If CycY expression was withheld until 4 days after egg-laying, a 50%
rescue rate could still be achieved. However, if heat shock was delayed for one more
day, the rescue ability decreased to only 13% (Figure 2-12). Combined, these data
suggest that the most important period for zygotic CycY expression is from the late
larvae to the early stages of pupal development, consistent with the first major lethal
phase of the CycYE8 mutant.
To see whether CycY is expressed at the developmental times when it appears
to be needed, I used quantitative real-time PCR to determine the CycY mRNA levels. I
found that the relative abundance of CycY mRNA fluctuated over a narrow range during
development (Figure 2-13). The highest mRNA level was observed in 0-1h embryos,
most likely due to maternal deposition. CycY message levels then decreased from later
embryogenesis through the first and second instar larval stages but increased again in
third instar larvae and peaked at pupal stages. The transcription variation of CycY is
thus consistent with its essential requirement for pupariation.

2.3.5 CycY shows a maternal effect that can be partially rescued by zygotic
expression
The mutant phenotypes described above were based on zygotic null mutants,
which showed normal embryogenesis and slow but otherwise normal larval
development. To test whether maternally expressed CycY contributes to early
development I generated maternal null mutants using the ovoD1 dominant female sterile
technique (Chou et al., 1993). Hs-FLP/w*; CycYE8 FRT40A/ovoD1 FRT40A females were
heat shocked for 2 hours during larval development to express FLP recombinase and
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Figure 2-13. Developmental expression pattern of CycY. Total RNA was extracted
from Drosophila tissues at the indicated developmental time points and mRNA levels of
CycY were determined by quantitative real-time PCR (qPCR) as described in Materials
and Methods. Expression was normalized to the mRNA levels of the internal control
rp49.
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promote homologous recombination between the CycYE8 FRT40A and ovoD1 FRT40A
chromosomes. Since ovoD1 is dominant female sterile, mothers will only lay eggs if
homozygous CycYE8 FRT40A germline cells are generated and CycY is not essential for
oogenesis. Mothers that received heat shock treatment during larval development were
crossed with w1118 males and the number and development of the eggs laid were
monitored. I observed that heat shock treated CycYE8 FRT40A/ovoD1 FRT40A females
could lay similar numbers of eggs as heat shock treated FRT40A/ovoD1 FRT40A
females, indicating that CycY is not essential for at least some of the major processes of
oogenesis. However, nearly 40% of the eggs from CycYE8 mothers had fused dorsal
appendages or translucent body or both (Figure 2-14). These two morphological defects
in some cases are common phenotypes in mutants of genes involved in axis
specification (Cook et al., 2004) (G. Atikukke and R. Finley, unpublished), suggesting
that CycY may play a role in axis specification.
To test for a maternal contribution to embryogenesis, females with homozygous
CycYE8 germline cells were generated using the ovoD1 dominant female sterile
technique (Chou et al., 1993), and were crossed with CycYE8/CyO, Act5C-GFP males.
Zygotic null progeny were identified by absence of the GFP balancer. Interestingly, the
majority (99.6%) of zygotic null embryos from null mothers failed to hatch, suggesting
that maternal expression of CycY is essential for embryogenesis. Surprisingly, when
females with homozygous CycYE8 germline cells were crossed with w1118 males, 7.3%
of the embryos hatched into first instar larvae and 73% of these larvae developed into
normal adults. Taken together, these data suggest that maternally provided CycY plays
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Figure 2-14. Eggs developed from homozygous CycYE8 germline cells show fused
dorsal appendages or translucent body defects. A. FRT40A, a wild type egg
showing the normal two dorsal appendages. B. CycYE8 FRT40A, egg with fused dorsal
appendages. C. CycYE8 FRT40A, egg with translucent body.
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an important role during embryogenesis, but that this role can be accomplished at least
to a limited extent by zygotic expression.

2.3.6 Eip63E is a potential binding partner of CycY
Cyclin proteins generally serve as regulatory subunits for Cdks. In a previous
high throughput yeast two-hybrid screen (Stanyon et al., 2004) we identified an
interaction between CycY and Eip63E, a Cdk with no known cyclin partner (Rascle et al.,
2003; Stowers et al., 2000). To test specificity, I conducted additional two-hybrid assays
using additional Cdks and cyclins (Table 2-7). I found that CycY interacted only weakly
or not at all with other Cdks, including Cdk1, Cdk2, Cdk4, Cdk5, Cdk7, Cdc2rk, and
CG7597. Likewise, Eip63E interacted with CycY and CycC, a protein known to be
promiscuous in two-hybrid assays, but only weakly or not at all with CycA, CycB,
CycB3, CycD, CycE, CycG, CycH, CycJ, CycK, CycT, koko, and CG16903.
As another approach to try to identify CycY partners, I set out to do tandem
affinity purification (TAP) followed by mass spectrometry (MALDI/MS-MS). I transiently
expressed NTAP-CycY, which has an N-terminal protein A binding site and calmodulin
binding domain, in Drosophila S2R+ cells and did a sequential protein purification by
using IgG beads and calmodulin beads. Co-purified proteins were identified by
MALDI/MS-MS (Materials and Methods). I did not identify a Cdk or any of the interactors
that were found by yeast two-hybrid. In addition to the bait protein, NTAP-CycY, I only
identified three putative CycY-associated proteins, Hsc70, Act5C, and αTub84D. All of
these are abundant proteins that are among the most common nonspecific proteins
often identified in co-AP/MS experiments. This result may be due to the transient
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Table 2-7. CycY/Eip63E interaction specificity by yeast two-hybrid assay

CycY
CycA
CycB
CycB3
CycC
CycD
CycE
CycG
CycH
CycJ
CycK
CycT
Koko
CG16903

Eip63E
Leu2
LacZ
3
1
0
0
0
0
0
1
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

CycY
Eip63E
Cdk1
Cdk2
Cdk4
Cdk5
Cdk7
Cdc2rk
CG7597

Leu2
3
1
1
0.5
0.5
0
0.5
0

LacZ
1
0
0
0
0
0
0
0

Interactions between LexA DNA-binding domain (BD)-tagged Eip63E and activation
domain (AD)-tagged cyclins (left), or AD-tagged CycY and BD-tagged Cdks (right) were
tested by yeast two-hybrid mating assays. Activity for the two reporter genes, LEU2 and
lacZ, was scored by the growth on plates lacking leucine (scale 0-3, where 0=no growth,
3=heavy growth) and blue color on X-gal plates (scale 0-5, where 0=white, 5=dark
blue).
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transfection approach I used to express the bait protein. Due to the low transfection
efficiency, the abundance of the bait proteins may be very high in some cells but low or
absent in others. This could lead to the relatively high contamination rate observed. The
establishment of stably expressing cell lines should circumvent this problem and
therefore is strongly recommended for future studies. Although Hsc70, Act5C, and
αTub84D are common contaminants in co-AP/MS experiments, it is of course possible
that any of these proteins actually interacts with CycY. It is interesting to consider actin,
which is an abundant component of the cytoskeleton. Actin has also been identified as
one of the subunits of the Brahma (Brm) chromatin-remodeling complex. Its initial
identification as a member of this complex was also under suspicion due to its high
abundance in the cytoplasma and the lack of evidence of its nuclear localization.
Several convincing experiments, however, demonstrated the existence of nuclear actin;
for example, the careful isolation of nuclei from Xenopus oocytes to avoid contamination
with cytoplasmic proteins and the development of antibody that specifically recognizes
nuclear actin (G-actin instead of F-actin, which can be recognized by phalloidin)
demonstrated that actin is indeed in the nucleus (Olave et al., 2002). The existence of
stoichiometric amounts of actin and actin related proteins in chromatin-remodeling
complexes has now been well established (Olave et al., 2002). It has been proposed
that actin promotes the assembly and stability of the complex, modulates the binding of
the remodeling complex to chromatin, and enhances the ATPase activity (Mohrmann
and Verrijzer, 2005). Interestingly, I identified both physical and genetic interactions
between CycY and the Brm chromatin-remodeling complex (discussed in Chapter 3),
raising the possibility that the CycY-actin interaction is genuine.
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As an alternative approach to confirm and test the specificity of the Eip63E-CycY
interaction identified by yeast two-hybrid, I expressed tagged versions of Cdks and
cyclins in cultured Drosophila cells and tested interaction by co-affinity purification (coAP) followed by immunoblotting (Materials and Methods). In the co-AP assay, CycY
interacted strongly with Eip63E but only weakly or not at all with Cdk2, Cdk4, or Cdc2rk
(Figure 2-15 A, B). Eip63E, on the other hand, interacted much more strongly with CycY
than with other cyclins tested, including CycK, CycD, and CG31232 (Koko) (Figure 2-15
C). As expected, Glycine 243 (G243) of Eip63E, which is essential for its function in vivo
(Stowers et al., 2000), is required for binding to CycY (Figure 2-15 D). In further support
of the interaction between these proteins, a recent study demonstrated an interaction
between the human homolog of Eip63E, PFTK1, and human CycY using yeast twohybrid and co-AP assays from human cells (Jiang et al., 2009). Taken together, our
data and the studies with the human orthologs support the notion that CycY and Eip63E
constitute a conserved cyclin-Cdk pair.
A recent large-scale phosphoproteome study in Drosophila embryos identified
several phosphorylated peptides from the CycY protein (Zhai et al., 2008). A number of
the phosphorylation sites are in highly conserved serine residues, suggesting that they
may affect CycY function (Figure 2-5 B). One of these residues, S389, has also been
found to be phosphorylated in human CycY, both in nuclear and cytoplasmic fractions
(Beausoleil et al., 2004; Olsen et al., 2006). Position Ser389 in the Drosophila protein is
conserved in every species that we examined (Figure 2-5 B). Moreover in one of the
two preceding positions of every CycY there is another serine (S388 in Drosophila),
which was also identified as a phosphorylated residue in the human protein. As a first
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Figure 2-15. CycY preferentially interacts with Eip63E in Drosophila S2R+ cells.
Cells were cotransfected with the indicated constructs and lysed for co-affinity
purification (co-AP) using IgG beads. Co-purified proteins were further detected by
western blot using anti-Myc or anti-protein A (PrA) antibody. (A) CycY interacts with
Eip63E. (B) CycY interacts much more strongly with Eip63E than with Cdk2, Cdk4, or
Cdc2rk. (C) Eip63E interacts much more strongly with CycY than with CycD, CycK, or
CG31232 (Koko). (D) Eip63E G243A mutant interacts poorly with CycY. (E) CycY
S389A mutants display decreased affinity for Eip63E.
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test of the potential importance of these residues I generated a Drosophila CycY S389A
mutant and S388A/S389A double mutant and tested their Cdk-binding ability. The
Ser389A mutant had a dramatically decreased ability to bind Eip63E (Figure 2-15E).
The double mutant did not further diminish Cdk binding indicating that S388 does not
contribute to the interaction. While these results point to a role for S389 in Cdk
interaction, I was unable to show that phosphorylation is important, since a S389E
mutant also failed to interact with the Cdk (data not shown).

2.3.7 CycY and Eip63E have similar mutant phenotypes
If Eip63E and CycY form a functional Cdk/cyclin complex in vivo, we might
expect their mutant phenotypes to be similar. Previous studies have shown that Eip63E
is important for embryogenesis, larval development, and morphogenesis (Stowers et al.,
2000). Those studies demonstrated that the majority of Eip63E null mutants die during
larval development, while a small percentage survive to pupal stages with an occasional
adult escaper. Stowers et al., also showed that puparium formation in Eip63E mutants is
delayed by 2-3 days, pupae are small, and the rare adult escapers have a bent-leg
phenotype and short life spans (Stowers et al., 2000). All of these phenotypes are
similar to those I observed for CycYE8. To further compare the Eip63E and CycY loss-offunction phenotypes, I performed a detailed side-by-side phenotypic characterization. I
used a transheterozygous null mutant, Eip63E81/Eip63EGN50 (Stowers et al., 2000) and
compared its phenotype with that of CycYE8. I found that CycY and Eip63E null mutants
showed similar developmental defects, though the Eip63E null mutant phenotype was
generally more severe. Both mutants displayed a major lethal phase during
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metamorphosis (Figure 2-8 A, B, E, F). While CycY mutants showed lethality during
early or late pupal stages, the majority of Eip63E mutants died at earlier pupal stages
(Table 2-4). Both mutants also showed similar metamorphosis defects, including gas
bubble translocation defects, failed head eversion, and leg elongation defects (Figure 210; Table 2-5). In addition, pupae of both mutants were similarly small in weight and
length (Table 2-6). Finally, both mutants exhibited delayed puparium formation, for 13
hours in the case of CycY, and 37 hours for Eip63E (Figure 2-8). I also note that
Stowers et al. (Stowers et al., 2000) showed that Eip63E has a zygotically rescuable
maternal contribution to embryogenesis, similar to my observation for CycY. The striking
similarity between the mutant phenotypes of Eip63E and CycY, combined with the
specific physical interaction between the proteins in yeast two-hybrid and co-AP assays,
supports the idea that CycY and Eip63E may function together in vivo. We cannot
exclude the possibility, however, that one or both proteins have additional partners. For
example, one potential explanation for the earlier lethality and more severe phenotype
of Eip63E mutants relative to the CycY null is that Eip63E may have functions
independent of CycY and these may involve other cyclin partners. Alternatively, the
subtle differences in CycY and Eip63E mutant phenotypes may be due to differences in
the levels of perdurance of their maternal components. Further in vivo analysis of the
interaction will be needed to distinguish these possibilities.
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2.4 CONCLUSIONS
Cyclin Y is a highly conserved protein that has not been characterized in any
model organism. Only minimal information is available for the human ortholog, CCNY.
The gene is broadly expressed in human tissues, with particularly high levels in testis
(Jiang et al., 2009; Li et al., 2009). Localization studies with GFP fusions in cell lines
have shown that one isoform of human CycY, which has also been called CycX, is
nuclear while another isoform may be anchored to the cell membrane via a conserved
myristoylation signal (Jiang et al., 2009). Recently, CCNY was identified as a potential
susceptibility factor for inflammatory bowel disease (IBD), a complicated genetic
disorder affecting the intestinal mucosa. A single nucleotide polymorphism (SNP)
located in an intron of CCNY was found to be strongly associated with the two IBD
subphenotypes, Crohn’s disease and ulcerative colitis (Franke et al., 2008; Weersma et
al., 2009), though it is not yet clear whether CCNY plays a direct role in these diseases.
Another study found that human CycY is among a number of proteins that are
significantly upregulated in metastatic colorectal cancer cells (Ying-Tao et al., 2005),
though again it is not clear whether this cyclin contributes to the phenotype of these
cells. The establishment of a CycY-deficient animal model could provide a system for
studying conserved functions of Cyclin Y and for understanding its potential role in
human diseases.
Here I described the first mutant allele for a Y-type cyclin, a null for Drosophila
CycY. I showed that CycY is an essential gene that is required for a broad range of
developmental processes, including normal oogenesis, embryogenesis, larval and pupal
development. The most obvious defects in the null were visualized during pupal
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development, and included defects in gas bubble translocation, head eversion, leg
elongation, and adult tissue growth. Similar phenotypes have been described for a
number of genes involved in the response to the steroid hormone ecdysone, including
E74, EcR, BR-C, and crol (Bender et al., 1997; D'Avino and Thummel, 1998; Fletcher
and Thummel, 1995b; Kiss et al., 1988). CycY may also be involved in the ecdysone
response. Consistent with this possibility, I provide several lines of evidence suggesting
that at least one of the Cdk partners for CycY is the ecdysone-inducible protein, Eip63E.
CycY and Eip63E preferentially interact in yeast two-hybrid assays and in co-AP assays
from cultured Drosophila cells. The human orthologs of these proteins have also been
shown to interact and to colocalize in human cell lines (Jiang et al., 2009). Finally, the
mutations in Eip63E and CycY show a similar range of phenotypes. Our findings in
Drosophila should provide a model system for further biochemical and genetic studies
on the function of this conserved Cdk/cyclin pair.
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CHAPTER 3

CYCLIN Y GENETICALLY INTERACTS WITH BRM COMPLEX COMPONENTS
IN DROSOPHILA

3.1 INTRODUCTION
CycY is a highly conserved protein found in all metazoans. I previously showed
that CycY is an essential gene that is required for many developmental processes (Liu
and Finley Jr, 2010). A null mutant of CycY is lethal and exhibits delayed larval growth
and major developmental defects during metamorphosis. Analysis of germline mutant
clones also revealed a role of CycY during oogenesis and embryogenesis. CycY
interacts specifically with the Cdk, Eip63E, both in yeast two-hybrid assays and in co-AP
assays in cultured Drosophila cells (Liu and Finley Jr, 2010; Stanyon et al., 2004). The
striking phenotypic similarity between CycY and Eip63E null mutants and the physical
interaction between CycY and Eip63E supports the notion that CycY and Eip63E
constitute a conserved cyclin-Cdk pair. This conclusion was further supported by
several recent studies with human cell lines, in which the orthologs of CycY and Eip63E,
which is generically known as Cdk14, were shown to interact and co-localize to the
plasma membrane (Davidson et al., 2009; Jiang et al., 2009). While the Drosophila null
phenotypes of CycY and Eip63E indicate that they are essential for development, they
have not provided clues about potential tissue-specific or cell-specific functions of the
CycY/Eip63E complex. A recent study found that both CycY and Eip63E are required
for maximal phosphorylation of the Wnt co-receptor, LRP6, and for maximal Wnt
signaling in cultured cells (Davidson et al., 2009). This led to a model in which
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membrane-associated CycY recruits Cdk14 to the membrane where it phosphorylates
LRP6 to help prime LRP6 for activation by Wnt. However, it is not clear whether or not
CycY plays a role in Wnt signaling in vivo in Drosophila. The null phenotypes of CycY
and Eip63E are not typical of wingless pathway mutants. This suggests that CycY may
belong to other important pathways instead of or in addition to the Wnt signaling
pathway. Here I set out to find pathways to which CycY may belong by testing for
tissue- or cell-specific requirements for CycY and screening for genetic interactions with
candidate pathway members.
The early pupal lethality of the CycY null makes it difficult to study the gene’s
potential role in later stages or in particular tissues. This difficulty can be overcome by
conditionally knocking down gene expression in a spatially and temporally controlled
manner by regulated synthesis of double-stranded RNAs (dsRNAs). dsRNA induces
gene-specific silencing, a highly conserved phenomenon known as RNA interference
(RNAi) (Fire, 1999; Fire et al., 1998). In Drosophila, long dsRNAs can be used as a tool
to knock down expression of specific genes because Drosophila lacks the interferonmediated immune response, which shuts down global protein synthesis and promotes
general mRNA degradation in mammalian cells (Echeverri and Perrimon, 2006). Long
dsRNAs expressed in or introduced into Drosophila cells are cleaved by the enzyme
Dicer into short interfering RNAs (siRNAs), which are then incorporated into the RNAinduced silencing complex (RISC) to induce target mRNA degradation. Tissue-specific
gene knockdown can be achieved by expressing the dsRNA using the Gal4/UAS
system (Brand and Perrimon, 1993). In this system, dsRNA expression is put under
control of the Upstream Activating Sequence (UAS) form yeast, which harbors binding
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sites for the Gal4 transcription factor. Transgenic flies containing the UAS-dsRNA gene
can be crossed with any of a variety of available lines that express Gal4 in specific
tissues. In the progeny, dsRNAs will be generated only in the tissues where Gal4 is
expressed. Here I used the Gal4/UAS system and dsRNA directed at CycY to knock
down CycY expression in specific tissues to reveal a role for the gene in wing
development.
CycY has been identified to physically interact with Snr1 in a high throughput
yeast two-hybrid screen (Giot et al., 2003). This prompted us to investigate the
relationship between CycY and Snr1, and to test whether Snr1 is a downstream target
of CycY/Eip63E. Snr1 is a core subunit of the Brm chromatin-remodeling complex in
Drosophila, which is involved in regulation of transcription. There are two subclasses of
Brm complex, BAP and PBAP, which differ in their subunit structure and function
(Moshkin et al., 2007). Snr1 is a member of both complexes, as are Brm, Mor, actin,
BAP55 (actin related protein), BAP60, BAP111, and possibly BAP74 (Hsc70-4) (Kal et
al., 2000; Mollaaghababa et al., 2001; Papoulas et al., 1998). BAP and PBAP
complexes also have distinct accessory components called signature components
(Chalkley et al., 2008; Collins et al., 1999; Kaeser et al., 2008; Mohrmann et al., 2004).
The core subunits provide the basic structure and enzymatic activity of the complex,
while the signature components provide distinct functional specificity (Moshkin et al.,
2007). BAP and PBAP function coordinately, independently, or antagonistically on
target gene transcription and modulate distinct biological processes. For example, the
well-known functional requirement of the Brm complex for entry into mitosis is believed
to be executed by BAP, but not PBAP (Moshkin et al., 2007). An important cell cycle
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regulator, stg (cdc25 phosphatase), which triggers mitosis, was down regulated in
cultured Drosophila cells in which BAP components were knocked down by RNAi, and
in Snr1 temperature-sensitive mutants (Moshkin et al., 2007; Zraly et al., 2004). A direct
interaction between BAP and the stg promoter region has also been demonstrated by
chromatin immunoprecipitation (ChIP) (Moshkin et al., 2007).
By modulating chromatin structures, the Brm complex is involved in both gene
activation and suppression. Several interesting groups of genes have been identified to
be the direct targets of Brm complex regulation. These include the Hox genes, a group
of related genes that specify the anterior-posterior axis and determine the segment
identity during early embryonic development. Hox genes include the Antennapedia
complex (ANT-C) and the bithorax complex (BX-C), which encode homeodomain
transcription factors (Duncan, 1987; Kaufman et al., 1990). The transcription of Hox
genes is ultimately sustained in the off or on state in late embryogenesis by the action of
the Polycomb group (PcG) of repressors and the trithorax group (trxG) of activators,
respectively (Harding and Levine, 1988; Ingham, 1988; Orlando and Paro, 1995). Brm
was initially identified as a member of the trithorax group that dominantly suppressed
Polycomb (Pc) mutations (Kennison and Tamkun, 1988). BAP, the osa-containing Brm
complex, represses transcription of Wg target genes, such as nub and dpp (Collins and
Treisman, 2000). BAP is also required for activation of several targets of EGFR
signaling involved in wing vein development, such as Delta, rhomboid, and argos
(Marenda et al., 2004; Terriente-Felix and de Celis, 2009), though it is still unclear if the
complex regulates these genes directly. Finally, a cluster of Ecdysone-induced genes
(Eig) were found to be strongly misregulated in Brm and Snr1 mutants and these genes
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were further shown to be the direct targets regulated by the Brm complex in cultured
cells (Zraly et al., 2006). This established a direct connection between chromatin
structure modification and ecdysone signaling.
The core subunit of the Brm complex, Brm ATPase, is expressed at all
developmental stages with a relatively high level throughout embryogenesis and in
pupae (Elfring et al., 1998). In addition to the ATPase domain, Brm proteins possess a
Bromodomain, which is ~ 110 amino acids and specifically recognizes acetylated lysine
in the histone tail (Mohrmann and Verrijzer, 2005). Surprisingly, deletion of the
Bromodomain does not affect chromatin binding and appears to be dispensable for Brm
function. On the other hand, domain II, which is located N-terminal to the ATPase
domain, contributes essential functions to the assembly or stability of the Brm complex
(Elfring et al., 1998). Lysine (K) 804 is a conserved amino acid in the ATP-binding site.
Mutation of this lysine to arginine (R) eliminates enzymatic activity but conserves the
protein’s ability to assemble into the 2 megadalton (MD) Brm complex. This mutant is
used widely as a dominant negative antimorphic allele of Brm for functional studies. By
analyzing animals ectopically expressing BrmK804R, or mosaic animals created with a
Brm null allele, Brm has been shown to be important for the development of the
peripheral nervous system, preventing homeotic transformations, and cell viability
(Elfring et al., 1998).
Snr1 has been suggested to function as a regulatory subunit by recruiting other
transcription factors to constrain Brm complex activity in particular tissues (Marenda et
al., 2004). The spatial and temporal expression pattern of Snr1 is similar to that of Brm
(Dingwall et al., 1995), except for a few differences (Zraly et al., 2003). One striking
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example is that Snr1 is barely detected in leg imaginal discs where Brm is highly
expressed, suggesting that Snr1 only functions in a subset of Brm complexes (Zraly et
al., 2003). Snr1 homozygous zygotic null mutants die before entering the third instar
larval stage (Dingwall et al., 1995), while germline clone analysis revealed its essential
function during oogenesis (Zraly et al., 2003). Mosaic animals with somatic null clones
showed similar phenotypes to Brm mutants, such as reduced cell viability and
peripheral nervous system defects. However, consistent with the expression differences
between Snr1 and Brm, clones of a Snr1 null revealed no function during leg
development (Zraly et al., 2003). Surprisingly, Snr1 is required for adult viability, which
has not yet been linked with Brm in Drosophila (Marenda et al., 2003; Zraly et al., 2003).
However, in human adrenal cortex carcinoma derived cell line SW13, Brg1 could induce
a senescent-like morphology (Shanahan et al., 1999). In addition, Brm1 levels increase
in the liver of old mice (Iakova et al., 2003). Not only ATP-dependent chromatin
remodeling,

but

other

chromatin

modifications,

such

as

histone

acetylation,

deacetylation, DNA methylation, have also been suggested in organismal aging
(Bandyopadhyay and Medrano, 2003).
Drosophila Snr1 and its orthologs in yeast (SNF5) and human (hSNF5/INI1)
share a highly conserved domain, including two direct repeats and a coiled-coil (CC)
region. The repeat domain in Snr1 and INI1 has been shown to mediate protein-protein
interactions to direct the metazoan SWI/SNF complex to target loci (Cheng et al., 1999;
Kalpana et al., 1994; Rozenblatt-Rosen et al., 1998). Contrary to the nuclear localization
of wild type, a truncated Snr1 mutant, Snr1-2, which lacks the CC domain and part of
repeat 2, is predominately localized in the cytoplasm, probably due to the exposure of
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the nuclear export signal (NES, 248-261) immediately N-terminal to the truncation site
(Brumby et al., 2002; Zraly et al., 2003). A small fraction of Snr1-2 mutant protein still
localizes to the nucleus and assembles into the Brm complex (Zraly et al., 2003). Since
Snr1-2 phenotypes are sensitive to Snr1 dosage, Snr1-2 has been used as a dominant
negative allele of Snr1. Ectopic expression of Snr1-2 led to several striking
developmental defects including extra wing vein along L2, incomplete abdominal tergite
fusion along the dorsal midline, and decreased adult viability (Zraly et al., 2003).
In this chapter, I describe the consequences of conditionally knocking down
CycY expression in specific tissues. I show that CycY is required for wing growth and
sustained adult viability. I also show that CycY genetically interacts with Snr1 and Brm,
two components of the Brm ATP-dependent chromatin-remodeling complexes, and that
the CycY protein can physically interact with Snr1. Furthermore, I show that the
downstream targets of Brm complexes, Eig71Eh and Eig71Ei, are misregulated in CycY
mutants. Taken together, these data suggest that CycY may be involved in gene
regulation by modulating Brm complex activity.
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3.2 MATERIALS AND METHODS

3.2.1 Fly stocks
All fly stocks were maintained in vials containing standard cornmeal molasses
medium. GMR-Gal4, en-Gal4, 69B-Gal4, e22c-Gal4, and Act5C-Gal4 were obtained
from the Bloomington stock center (stock numbers 1104, 6356, 1774, 1973 and 4414
respectively). UAS-Snr1-2, Snr1R3 (Zraly et al., 2003) was kindly provided by Dr.
Andrew K. Dingwall. UAS-BrmK804R (Elfring et al., 1998) was kindly provided by Dr.
Jessica E.Treisman. y1w* hs-FLP; Ubi-GFP FRT40A was kindly provided by Dr.
Dongbin Xu. The UAS-RNAi lines, UAS-dicer2, UAS-Snr1i, and UAS-Brmi, were
obtained from the Vienna Drosophila Resource Center (transformant IDs 60008, 12644,
and 37720 respectively). CycYE8, CycYE8 FRT40A, UAS-CycY, and hs-CycY have been
described previously (Liu and Finley Jr, 2010). All fly strains used in this study are listed
in Appendix G.

3.2.2 Plasmid cloning for P-element transformation
pWIZ-CycYiN was constructed by first subcloning an XbaI/XbaI fragment which
included the 5’ 605bp of the CycY cDNA, beginning with the ATG, into the NheI site of
pWIZ (Lee and Carthew, 2003) in the sense orientation to make pWIZ-CycYiN-sense.
This XbaI/XbaI fragment was generated by PCR from pAS1-CycY (Finley lab # 897)
using oligonucleotides [forward: 5’ ATGCTCTAGAATGGGCAACAAGAACTCG (Finley
lab # 679); reverse: 5’ ATGTCCTCTAGACGATCCGATTGCCGATTC (Finley lab #
680)], which provided XbaI digestion site at both ends. Next, an XbaI/EcoRI fragment
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containing the same 5’ 605bp of the CycY cDNA, beginning with the ATG, was
subcloned into the AvrII/EcoRI site of pWIZ-CycYiN-sense in the anti-sense orientation
to make pWIZ-CycYiN. This XbaI/EcoRI fragment was generated by PCR from pAS1CycY (Finley lab # 897) using oligonucleotides [forward: 5’ ATGCTCTAGAATGGGCAA
CAAGAACTCG (Finley lab # 679); reverse: 5’ ATGTCCGAATTCCGATCCGATTGCCG
ATTC (Finley lab # 681)], which provided XbaI and EcoRI digestion site at each end
respectively. pWIZ-CycYiC was constructed similarly, by subcloning the 3’ 616bp of the
CycY cDNA ending with the stop codon in both orientations into pWIZ. In this case, the
XbaI/XbaI fragment was generated by PCR from pAS1-CycY (Finley lab # 897) using
oligonucleotides [forward: 5’ GCAATCTCTAGACCGGCTGGACATCTTCGACG (Finley
lab # 682); reverse: 5’ GCTTGGTCTAGATCACGATAGTATGGCCACG (Finley lab #
683)], which provided XbaI digestion site at both ends. The XbaI/EcoRI fragment was
generated by PCR from pAS1-CycY (Finley lab # 897) using oligonucleotides [forward:
5’ GCAATCTCTAGACCGGCTGGACATCTTCGACG (Finley lab # 682); reverse: 5’
GCTTGGGAATTCTCACGATAGTATGGCCACG (Finley lab # 684)], which provided
XbaI and EcoRI digestion site at each end respectively. P-element mediated
transformation was performed as previously described (Rubin and Spradling, 1982).
Plasmids used or constructed for this study are listed in Appendix H. All transgenic lines
generated for this study are listed in Appendix I.

3.2.3 Analysis of the wing phenotype
Wings were dissected from adult flies and mounted for microscopic examination
in mineral oil. Pictures were taken with Leitz fluorescence microscope and SPOT RT3
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camera. The entire wing was photographed with 100x magnification and a close-up of
defined area of the wing was photographed with 630x magnification. The sizes of the
posterior and anterior areas of the wing were independently measured using Image J
software (Collins, 2007) and the ratio of the posterior to anterior areas (P/A) was
calculated. For each genotype analyzed, twenty wings were scored. To count cell
numbers, defined areas of the posterior and anterior compartments of the wing, as
indicated in Figure 3-2A, were photographed and the number of bristles in the picture
was counted; the number of bristles was taken as the number of cells in each area
since each wing cell secret only one bristle during development (Meyer et al., 2000).
Error bars indicate standard deviation of 20 individual measures. The ratio of posterior
cell size to anterior cell size is equal to the number of cells in the defined area in the
anterior region divided by that in the posterior region. The ratio of the posterior cell
number to anterior cell number is equal to the ratio of the posterior to anterior areas
divided by the ratio of the posterior to anterior cell sizes.

3.2.4 Immunostaining
Wing imaginal discs from third instar larvae were dissected in 1 x PBS and put
quickly on ice. Discs were fixed in freshly made 4% paraformaldehyde in 1 x PBS at
room temperature for 30 minutes and washed with PBS 3 times. Discs were then
incubated with primary antibody at 4°C overnight followed by 2-3 hours incubation at
room temperature with secondary antibody. The following antibodies were used: rabbit
anti-GFP (1:50; Invitrogen); rabbit polyclonal anti-Histone H3 phospho-Ser10 (1:50;
Upstate Biotechnology); FITC-conjugated goat anti-rabbit IgG (1:200; Jackson
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Immunoresearch); Texas Red goat anti-rabbit IgG (1:200; Invitrogen); Alexa Fluor® 488
goat anti-rabbit (1:200; Invitrogen). DAPI (1μg/ml; Sigma) was used to counterstain the
DNA. TUNEL staining was performed as previously described with minor modification
(Wang et al., 1999). Briefly, after secondary antibody incubation, discs were blocked in
block buffer (50mM Tris.HCl pH6.8, 150mM NaCl, 0.5% NP-40, 5mg/ml BSA) at 4°C
overnight and then incubated in 100mM Na-Citrate, 0.1% TritonX-100 at 65°C in a water
bath for 30 minutes. After three quick washes in wash buffer (50mM Tris.HCl pH6.8,
150mM NaCl, 0.5% NP-40, 1mg/ml BSA), discs were incubated in TUNEL dilution
buffer (Roche) twice for 5 minutes each time at room temperature. After 30 minutes
incubation in 50μl of labeling solution (in situ cell death detection TMR Red kit, Roche)
at 37°C in a water bath, 5μl of Terminal deoxynucleotidyl transferase (TdT) enzyme
solution was added and discs were incubated for 2 more hours. Discs were washed in
wash buffer and mounted in Vectashield (Vector laboratories) for imaging.

3.2.5 Analysis of adult lifespan
For each genotype analyzed, males and females were collected within 24 hours
of eclosion and were maintained in vials with fresh cornmeal molasses medium at the
indicated temperature. Each vial contained either 30 males or 30 females. A total of 150
adults were analyzed for each genotype and sex. Adults were transferred to fresh vials
every 1-2 days for 25 to 50 days and the number of dead adults was counted after each
transfer. For analyzing the adult lifespan of the CycYE8 homozygous mutant, since it is
lethal during metamorphosis, I rescued mutant animals to adults by expressing a CycY
cDNA under control of a heat-shock promoter (Liu and Finley Jr, 2010). Heat shock was
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applied once every day at 37°C in a water bath from one day after egg laying until adult
eclosion, and then the adults were kept at 25°C. CycYE8 heterozygous control animals
were similarly treated with heat shock although the exogenous CycY is not required for
these animals to reach the adult stage. To test whether the adult requirement of CycY
can be rescued by providing exogenous CycY, in a separate experiment, these animals
were continuously applied heat shock treatment once everyday from one day after egg
laying until 35 days after adult eclosion.

3.2.6 Gene expression
Gene expression was assayed by reverse-transcription and quantitative real-time
PCR (RT-qPCR) as previously described (Liu and Finley Jr, 2010). First instar larvae
with the desired genotypes were collected and transferred to standard fly medium.
Newly formed white prepupae (0 hour prepupae) were collected and transferred to a
petri dish with a piece of wet filter paper and allowed to age at 25°C for the times
indicated in Figure 3-9 (Fletcher and Thummel, 1995a). About 30 pupae were collected
at each time point for RNA isolation. qPCR reactions were carried out in triplicate for
each RNA sample. The primers used in this work are listed in Table 3-1. rp49 was used
as the internal control gene and the mRNA level of each analyzed gene was normalized
to rp49 levels.

3.2.7 Co-affinity purification (co-AP) assays
Co-AP assays were conducted as previously described (Liu and Finley Jr, 2010).
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Table 3-1. Primers used for qPCR in this study
Product
length (bp)

5’- GTTGACTGTCTGCTTCCTGGTGAT

41-64

230

DL165

5’- TTGCTCGATTCGGAGAAGCTATCG

247-270

DL149

5’- CTGCCATTAGCTATTGTGTGCCTG

51-74

DL150

5’- ATCGGCTAACATCTGACCATCCAG

229-252

DL172

5’- TTGATGTGCCAGGTCCTAACTCAG

77-100

DL173

5’- TTATTAAGACCGCAGGCTATCGGC

314-337

DL174

5’- CTGCCGAAAGTTAAGGGACACTTG

116-139

DL175

5’- GGCATTCTTCTAAGTTCGCCTTGG

327-350

DL176

5’- TCAGGCGTATAATGAGTCAACCCG

1624-1647

DL177

5’- CCACCTTCATCGAGAACATTTGGC

1945-1968

DL155

5’- CAACCATCGGAACAATGACTACGC

3398-3421

DL156

5’- GATTCGCACTTGATGTGACTGCTG

3770-3793

DL170

5’- GGCCACTGAAATCAAAGAGGAACC

531-554

DL171

5’- CCAATTGGCGAGTTCTGGATCAAC

741-764

DL168

5’- GTCGCAATACATGGAGAAGCATCC

1007-1030

DL169

5’- GTAGGTATCACGTATGCCCGGAAA

1350-1373

DL118

5’-GATATGCTAAGCTGTCGCACAAATGGC

95-121

DL119

5’-GTGCGCTTGTTCGATCCGTAACCG

189-212

Primers

Sequence

Eig71Eh

DL147

Eig71Ei
Eig71Eg
Eig71Ef
EcR
Eip93F
ImpE2
Eip63E
rp49

a

Positiona

Gene

Inclusive nucleotide positions in predicted transcript RA for each gene.

202
261
235
345
396
234
367
118
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3.3 RESULTS

3.3.1 Generation of CycY conditional knockdown transgenic flies
I set out to generate transgenic Drosophila that express long double-stranded
RNA (dsRNA) to knock down the expression of CycY in a temporally and spatially
controlled manner using the UAS/Gal4 system (Brand and Perrimon, 1993; Lee and
Carthew, 2003). To avoid misinterpreting gene knockdown phenotypes that may arise
from off-target effects (Dietzl et al., 2007; Kulkarni et al., 2006; Ma et al., 2006; Ni et al.,
2009), I generated two nonoverlapping CycY RNAi constructs. One (UAS-CycYiN)
targeted the N-terminal coding region and the other (UAS-CycYiC) targeted the Cterminal coding region (Figure 3-1A). To test the knockdown efficiency, Drosophila
S2R+ cells were cotransfected with each RNAi construct along with a construct that
expresses NTAP-tagged CycY. Both the N-terminal and C-terminal RNAi constructs
efficiently knocked down the ectopically expressed CycY, while the control RNAi
(targeting Koko) had no effect (Figure 3-1B). I generated multiple transgenic fly strains
containing each CycYi construct and tested the gene knockdown effect in different
tissues using different Gal4 driver lines. Ubiquitous expression of both CycYi constructs
using Act5C-Gal4 induced lethality. CycYiN knockdown flies did not survive beyond
second instar larval stage, which is an earlier lethal phase than CycYE8 null mutants,
most of which survive to pupal stages (Liu and Finley Jr, 2010). Ubiquitous knockdown
with CycYiC showed a lethal phase and morphological defects similar to CycYE8 null
mutants (Liu and Finley Jr, 2010). Both RNAi constructs result in similar levels of
transcript knockdown in second instar larvae (Figure 3-1C).
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Figure 3-1. Generation of CycY conditional knockdown transgenic flies. (A) CycY
transcript. The cDNA corresponding to the single CycY transcript is indicated by the
box. The ATG is shown with a back line while the stop codon is indicated with a red line.
The coding regions used to generate CycYiN and CycYiC RNAi constructs are indicated.
(B) Western blot to detect the in vitro knock down efficiency of exogenously expressed
NTAP-CycY by CycYiN, CycYiC, Kokoi (unrelated control), or vector only (pWIZ) in
Drosophila S2R+ cells. The immunoblot was probed with antibody to NTAP or β-tubulin.
(C) RT-qPCR to detect the in vivo knock down efficiency of endogenous CycY in
second instar larvae by CycYiN and CycYiC RNAi constructs driven by the ubiquitous
driver, Act-Gal4. Two independent insertion lines (N1 and N2 or C1 and C2) were tested
for each construct. (D-G) Adult fly eyes harboring the indicated CycY RNAi constructs
and the GMR-Gal4 driver.
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Expression of CycYiC and CycYiN in the posterior region of the eye imaginal disc
using the GMR-Gal4 driver (Freeman, 1996) resulted in dramatically different effects.
Whereas CycYiC did not induce eye defects (Figure 3-1 F-G), CycYiN resulted in rough
eyes with variable levels of dark pigmentation. Some eyes were yellow to orange with
random black spots, while others were totally black (Figure 3-1 D-E and data not
shown). The severity of the eye defects induced by different CycYiN insertion lines
correlated with the level of CycY knockdown (Figure 3-1 C-E). The eye phenotype
induced by CycYiN is unexpected based on the CycYE8 null mutant, which displayed no
eye defects in adult escapers or pharate adults (Liu and Finley Jr, 2010). Thus, I
surmise that CycYiN may knock down expression of a gene(s) in addition to CycY, a
possibility that could also explain why ubiquitous CycYiN expression leads to earlier
lethality than the CycYE8 mutant. The similarities between the CycYiC and CycYE8
phenotypes on the other hand, suggest that CycYiC specifically knocks down CycY,
which I further confirmed in cDNA rescue experiments described below.

3.3.2 CycY is required for wing growth
To test whether CycY is required for normal cell proliferation or differentiation I
expressed CycYiC in cells of the posterior compartment of wing imaginal discs using the
en-Gal4 driver (Brand and Perrimon, 1993; Sigrist and Lehner, 1997). Two independent
CycYiC insertion lines (CycYiC1 and CycYiC2) were crossed with the en-Gal4 driver line
to knock down expression of CycY in the posterior wing. To quantitatively evaluate the
effect on wing tissue growth, I measured the size of the wing in the posterior
compartment relative to the anterior compartment (P/A). CycY knockdown resulted in
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smaller posterior wing compartments compared to wild type (Figure 3-2 A-C, I). Two
copies of UAS-CycYi enhanced the wing size phenotype, as did coexpression of Dicer2,
an enzyme that enhances RNAi by cleaving dsRNA into siRNA (Figure 3-2 D-E, I) (Lee
et al., 2004). The decreased compartment size could be partially rescued by
overexpressing CycY with one copy of UAS-CycY whereas two copies rescued even
better (Figure 3-2 F-G, I), but failed to be rescued by UAS-GFP (Figure 3-2 H-I),
indicating that the observed phenotype was due to the decreased expression of CycY
rather than any potential off-target effect.
To determine whether the decreased wing size was the result of decreased cell
number, cell size, or both, I measured the relative cell numbers and sizes in defined
areas of the anterior and posterior compartments (see Materials and Methods for
details). Cell numbers were determined by counting the number of bristles since each
wing cell secrets only one bristle during development (Meyer et al., 2000), whereas cell
sizes were estimated by the density of cells in a particular area. Decreasing CycY
expression did not significantly change cell size. The reduced wing size resulting from
CycY knockdown was primarily due to decreased cell numbers (Figure 3-2J).
To address whether a decrease in cell number caused by loss of CycY might be
caused by decreased cell proliferation or increased cell death, I also made mitotic
clones with the CycY deletion mutant, CycYE8 (see Chapter 4, section 4.2.10 for details).
I stained the wing imaginal discs with CycYE8 null clones for phosphorylated histone H3
(PH3) to detect cells undergoing mitosis, or stained the wing imaginal discs with CycY
knocked down in the posterior compartment by TUNEL approach to detect cells
undergoing apoptosis. However, I did not observe any abnormal proportion of mitotic
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Figure 3-2. CycY is required for wing growth. (A-H) Adult fly wings harboring the enGal4 driver and indicated UAS constructs. The number in the upper right corner is the
ratio of the posterior to anterior wing sizes (P/A). The red boxes in (A) indicate the
defined area for counting the cell numbers in the posterior and anterior region
respectively. (I) The P/A area ratio for each indicated genotype. (J) The P/A ratio of
wing area, cell size, and cell number for control and CycY knock down fly wings.
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wing imaginal disc cells in clones lacking CycY (Figure 4-5 S-U) or apoptotic wing
imaginal disc cells upon knockdown of CycY (Appendix J). It is possible that these
assays are not sufficiently sensitive to detect changes that lead to only a 20% reduction
in cell number.

3.3.3 CycY is required for sustained adult viability
I previously showed that CycY is required for embryogenesis, larval growth, and
metamorphosis, and that it plays a role in oogenesis (Liu and Finley Jr, 2010). To test
whether CycY is also required during adult life, I rescued CycYE8 null mutants into
adults by expressing a CycY cDNA under control of a heat-shock promoter. Heat shockinduced expression was ceased after eclosion and adult viability was followed for 50
days. CycYE8 adults showed reduced lifespan compared with their heterozygous
siblings and this effect was more severe for males than for females (Figure 3-3A). This
phenotype can be partially rescued by continuously providing CycY in adults by heatshock treatment of the adults once every day (Figure 3-3B). This finding is consistent
with the expression data showing that CycY is expressed in both male and female
adults and is relatively higher in males (Liu and Finley Jr, 2010). In summary, CycY
appears to be important throughout the Drosophila life cycle. Using the adult viability
phenotype and tissue-specific knockdown should enable exploration of the genetic
pathways to which CycY may belong.
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Figure 3-3. CycY is required for adult viability. (A) CycYE8 null mutants that harbor a
CycY transgene under heat-shock promoter control (hs-CycY) were rescued to adult
stage by continuous heat shock treatment once every day after egg laying until adult
eclosion to provide exogenously expressed CycY. These CycYE8 null mutants displayed
significantly decreased lifespan relative to their heterozygous siblings. The decrease in
life span was more dramatic in males than in females. (B) Continuous heat-shock
treatment of adult homozygous CycYE8 mutants that harbor the hs-CycY transgene
partially rescued the reduced longevity phenotype. While continuous heat shock
reduced viability relative to no heat shock, the difference between homozygous and
heterozygous CycYE8 mutants was minimal.
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3.3.4 Snr1 interacts with CycY and is a potential downstream target
To gain insight into the cellular functions of CycY and to identify the signaling
pathways to which CycY belongs, I began by examining the available protein interaction
data for CycY (Figure 3-4A). Previously, I showed that CycY physically interacts with
Eip63E/Cdk14 in Drosophila, which has been supported by studies with human cells
(Davidson et al., 2009; Jiang et al., 2009; Liu and Finley Jr, 2010). To focus on potential
downstream targets of the CycY/Eip63E complex I excluded physical interactors that
are more likely to be upstream regulators. These included other cyclins, the Cdk
inhibitor protein Dacapo, and 14-3-3, a scaffold protein that binds to and modulates the
function of a variety of signaling proteins, especially their phosphorylated forms (Fu et
al., 2000). I searched among the remaining interactors for proteins that may be required
at similar developmental times as Eip63E and CycY. Two of the interactors are encoded
by novel genes, CG5783 and CG8997, which have not been studied. Another two, PIF1B, and PIF-2, are cysteine-rich proteins. Both were identified to interact with the nonconserved N-terminal histidine-rich domain of Eip63E. It has been proposed that the
function of PIF binding is to counter the inhibitory effect of the long N-terminal extension
of Eip63E, which may inhibit the protein’s kinase activity (Rascle et al., 2003). Mri is a
poorly characterized glycerol kinase. Interestingly, it has been identified in a genomewide study to be involved in autophagic cell death in salivary glands (Gorski et al.,
2003), which is one of the dramatic developmental changes that happen during
metamorphosis. The essential requirement of CycY and Eip63E during metamorphosis
makes this interaction a good candidate for future studies. Another Eip63E interactor is
Trx-2 (thioredoxin-2), one of the three classical thioredoxins that function to reduce
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Figure 3-4. CycY physically interacts with Snr1. (A) Protein interactions centered on
Cdk14 and CycY in Drosophila. Protein-protein interactions initially detected in yeast
two-hybrid screens using Drosophila proteins (black lines), human orthologous proteins
(blue lines) or orthologous proteins from both species (red lines) (Davidson et al., 2009;
Gao et al., 2006a; Giot et al., 2003; Jiang et al., 2009; Liu and Finley Jr, 2010; Rascle et
al., 2003; Shu et al., 2007; Stanyon et al., 2004). The interactions indicated by blue lines
are predicted interactions between Drosophila proteins based on the interactions
identified with human orthologs. Interactions that have been verified by some other
assay such as co-affinity purification are indicated by solid lines. Dashed lines indicate
two-hybrid interactions not yet validated by another assay. (B) CycY interacts with Snr1
in Drosophila S2R+ cells. Cells were cotransfected with the indicated constructs and
lysed for co-affinity purification (co-AP) using IgG beads.
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disulfide bonds in other proteins. Trx-2 has been reported to play a role in adult
longevity and tolerance to oxidative stress; homozygous null mutants, however, are
viable and fertile (Svensson and Larsson, 2007). The final CycY interactor is Snr1, the
Drosophila counterpart of yeast SNF5, a core subunit of SWI/SNF ATP-dependent
chromatin-remodeling complex. Snr1 has a number of properties consistent with a
possible role in a common pathway with CycY and Cdk14.
First, previous analysis of a temperature-sensitive allele, Snr1E1, revealed an
essential role for Snr1 during the window of time one day before and after pupariation
(Marenda et al., 2003), which is coincident with the time frame when zygotic CycY is
critically required (Liu and Finley Jr, 2010). Second, germline clone analysis has shown
that Snr1 is essential for oogenesis (Zraly et al., 2003) and CycY is also required for
normal oogenesis (Liu and Finley Jr, 2010). Third, Snr1 mRNA levels oscillate during
late larval and pupal development coincident with transient ecdysone pulses (Zraly et
al., 2003). Similarly, I have shown that CycY mRNA levels oscillate along with ecdysone
pulses (Liu and Finley Jr, 2010), while Stowers et al., showed that one of the transcripts
of Cdk14/Eip63E is induced by ecdysone (Stowers et al., 2000). Based on the similar
developmental requirements and expression profiles for Cdk14, CycY, and Snr1, I
hypothesized that these genes belong to a common gene regulatory pathway. As a first
step to test this hypothesis, I confirmed the physical interaction in vitro by co-affinity
purification (co-AP) in Drosophila S2R+ cells (Figure 3-4B). I then screened for genetic
interactions between CycY and members of the SWI/SNF complex, which in Drosophila
is known as the Brahma (Brm) complex.
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3.3.5 CycY genetically interacts with Snr1 and Brm, key members of the Brm
complex
It has been reported that Snr1 is required for sustained adult viability (Marenda et
al., 2003; Zraly et al., 2003). Dingwall and colleagues constructed and characterized a
number of Snr1 mutants (Dingwall et al., 1995; Marenda et al., 2003; Zraly et al., 2003).
One mutant is Snr1-2, a putative dominant negative. It was previously shown that
overexpression of Snr1-2 using the Act5C-Gal4 driver in animals that are heterozygous
for a Snr1 null mutant (Snr1R3) dramatically decreases adult viability (Zraly et al., 2003).
To test whether CycY mutants enhance or suppress the Snr1 associated viability defect,
I combined heterozygous CycYE8 null mutants with a combination of the Snr1-2
dominant-negative and the null allele Snr1R3. Ubiquitous expression of Snr1-2 in the
heterozygous Snr1R3 background alone at 30°C decreased adult viability significantly in
males (Figure 3-5), though this effect was much weaker than previously reported (Zraly
et al., 2003). The viability of heterozygous CycYE8 mutants was not significantly different
from wild-type (Figure 3-5 and data not shown). Strikingly, removal of one copy of CycY
dramatically enhanced the adult viability defect of the Snr1 mutants, particularly in
males (Figure 3-5).
Another morphological defect induced by ubiquitous expression of the dominant
negative Snr1-2 is incomplete abdominal tergite fusion along the dorsal midline,
suggesting functions for Snr1 and presumably the Brm complex in developing
histoblasts (Zraly et al., 2003). I used the dorsal midline phenotype as a second assay
to test for genetic interaction between Snr1 and CycY. Similar to our observation with
the longevity phenotype, when one copy of CycY was removed while expressing the
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Figure 3-5. CycY mutants genetically enhance the reduced lifespan induced by
Snr1 mutants. (A-B) Expression of an Snr1 dominant negative (UAS-Snr1-2)
ubiquitously using the Act5C-Gal4 driver in a heterozygous Snr1 loss-of-function mutant
(Snr1R3/+) results in reduced adult viability. Removal of one copy of CycY enhanced the
adult viability defect in Snr1 mutants. This effect is more pronounced in males (A) than
in females (B).
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Snr1-2 dominant negative (in a heterozygous Snr1R3 background) I observed a dramatic
enhancement of the dorsal midline fusion defect (Figure 3-6, Table 3-2). Since Snr1 is a
key subunit of the Brm complex, I wished to ask whether CycY also genetically interacts
with Brm. However, use of the Act5C-Gal4 driver to ubiquitously knock down expression
of Brm or CycY, or to express the Brm dominant negative, BrmK804R resulted in lethality.
Thus, it was not possible to test for genetic interactions using the dorsal midline defect
and the Act5C-Gal4 driver. Previously, Zraly et al. showed that expression of Snr1-2
using the e22c-Gal4 driver, which is highly expressed in abdomen, also resulted in the
dorsal midline fusion defect (Zraly et al., 2003). However, when I used the e22c-Gal4
driver to express the Brm dsRNA, BrmK804R, the CycYiC, or to knock down both CycY
and Brm together, I did not observe any dorsal midline fusion defects (Table 3-2). This
result suggests that either CycY and Snr1 function independent of the Brm complex in
histoblasts, or the e22c-Gal4 driver is not strong enough to induce any visible
phenotype with CycY and Brm knockdown.
As a further test for genetic interactions between CycY and the Brm complex I
turned to phenotypes generated by knocking down expression in the wing imaginal disc.
As discussed above, knocking down CycY in the posterior compartment of the wing
using the en-Gal4 driver led to decreased cell numbers and tissue size. I tested whether
this phenotype is modified by mutants of Snr1 or Brm. Expression of Snr1-2 or Snr1
dsRNA using the en-Gal4 driver resulted in no change in posterior compartment size
(Figure 3-7 A-B) and failed to modify the decreased posterior wing phenotype induced
by CycY knockdown (Figure 3-7C and D compared with Figure 3-7H and I). Knockdown
of Brm expression with en-Gal4 showed a very weak reduction in tissue size (Figure 3-
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Figure 3-6. CycY enhances the dorsal midline fusion defect associated with Snr1
mutants. (A) Abdominal tergite of a wild type adult. (B-D) Expression of the Snr1-2
dominant negative in a Snr1R3 heterozygous background resulted in incomplete
abdominal tergite fusion along the dorsal midline. This phenotype was enhanced by
heterozygous CycYE8 (Table 3.2). Examples of different levels of severity of the defect
are shown; mild + (B), medium ++ (C), and severe +++ (D).
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Table 3-2. CycY genetically enhances the dorsal midline fusion defects
associated with Snr1 mutants.

Genotype

a

n

Dorsal midline defectsa
-

+

++

+++

Act-Gal4/CyO; UAS-Snr1-2, Snr1R3/TM3 Ser

326

86%

9%

5%

1%

CycYE8/CyO

120

100%

0%

0%

0%

CycYE8/Act-Gal4; UAS-Snr1-2, Snr1R3/TM3 Ser

145

51%

26%

13%

10%

e22c-Gal4/+; UAS-BrmK804R/+

301

100%

0%

0%

0%

e22c-Gal4/+; UAS-Brmi/+

129

100%

0%

0%

0%

e22c-Gal4/+; UAS-CycYiC1/+

113

100%

0%

0%

0%

e22c-Gal4/+; UAS-Brmi/UAS-CycYiC1

147

100%

0%

0%

0%

CycYE8/ e22c-Gal4; UAS-Brmi/+

77

100%

0%

0%

0%

The severity of the dorsal midline fusion defect was quantitatively scored as wild type

(-), mild (+), medium (++), and severe (+++). A representative image for each level of
severity is shown in Figure 3-6.
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Figure 3-7. Genetic interaction between CycY and Brm mutants in the wing. (A-H)
Adult fly wings harboring en-Gal4 and the indicated UAS constructs. The number in the
upper right corner is the ratio of the posterior wing size to that of the anterior (P/A). (I)
The P/A area ratio for each indicated genotype. en-Gal4/+; UAS-CycYiC1/UAS-BrmK804R
are completely pupal lethal.
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7E). Knockdown of both CycY and Brm together also resulted the decreased posterior
wing size, but also produced a remarkable novel phenotype. The L4 vein structure was
severely disrupted and the overall wing morphology was distorted or crumpled,
especially between veins L4 and L5 (Figure 3-7G and I). The loss of vein and crumpled
wing blade is similar to the phenotype previously described for knockdown of several
Brm complex components, including Brm, Snr1, Osa, and Mor using Sal-Gal4 or 638Gal4 drivers (Terriente-Felix and de Celis, 2009). The fact that I visualized the same
phenotype with a combined knockdown of Brm and CycY together, but not with
knockdown of Brm alone, indicates that loss of CycY enhances the Brm knockdown
phenotype. I also observed a synthetic lethal genetic interaction between CycY and
Brm. Ectopic expression of BrmK804R by en-Gal4 was lethal at 25°C. At 20°C, however, I
observed some viable adults that showed decreased posterior wing sizes, a notch along
the posterior wing margin, and partial loss of L4 and L5 wing veins (Figure 3-7F and I).
Knockdown of CycY in the same animals resulted in complete lethality. In summary, I
observed that knockdown of CycY enhances the wing developmental defects induced
by both Brm knockdown and expression of a Brm dominant negative mutant, suggesting
that CycY and Brm function cooperatively to regulate some of the same processes in
the wing.
To further test for genetic interaction between CycY and Snr1 I used the 69BGal4 driver line, which drives expression of Gal4 throughout most of the wing disc
(Brand and Perrimon, 1993). Expression of the CycY dsRNA driven by 69B-Gal4 at
25°C induced extra wing-vein tissue to the anterior side of the L2 vein in 10.9% of the
animals and extra wing veins on both sides of L2 in a small percentage of the animals
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(Figure 3-8 B and C). The extra vein phenotypes can be suppressed by overexpressing
CycY with a UAS-CycY transgene (Table 3-3), indicating that this phenotype is induced
by specific knock down of CycY. As expected, increasing the temperature to 30°C,
which leads to elevated levels of Gal4 (Brand and Perrimon, 1993), resulted in a more
severe phenotype than observed at 25°C; for example, after increasing the temperature,
the fraction of normal wings went from 88% to 30% while the fraction of wings with extra
veins on both sides of L2 went from 0.8% to 29% (Table 3-3). Similarly, knockdown of
Snr1 resulted in an extra wing vein along the anterior side of L2 (Table 3-3), similar to
the phenotype previously observed for expression of Snr1-2 (Zraly et al., 2003) . Knock
down of both CycY and Snr1 together significantly enhanced the wing vein phenotype
relative to knock down of either gene alone; for example, the fraction of normal wings
was reduced from 30 or 50% for CycY or Snr1 knockdown, respectively, to 15% in the
double knockdown animals (Table 3-3). Removal of one copy of CycY, however, did not
modify the Snr1 phenotype (Table 3-3). Knockdown of Brm using 69B-Gal4 was lethal
at 30°C, but did not lead to any obvious defects at 25°C (Figure 3-8D). Strikingly,
knockdown of Brm in combination with CycY suppressed the extra wing vein phenotype
induced by knockdown of CycY and resulted in a highly penetrant novel phenotype. The
whole wing blade mildly curved to the ventral side along the midline between the L3 and
L4 longitudinal veins. When flattened with a coverslip, a deep crease was evident
(Figure 3-8E and Table 3-3). A similar though weaker effect was observed by knocking
down Brm in a heterozygous CycYE8 background (Figure 3-8F and Table 3-3). The fact
that CycY knockdown and heterozygous CycYE8 showed similar but different levels of
modification of the Brm mutant phenotypes suggests a dosage effect and supports
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Figure 3-8. Knock down of CycY enhances Snr1 knock down phenotypes and
leads to synthetic effects with Brm mutants. Knock down of CycY or Snr1 by
expressing dsRNA transgenes (CycYiC or Snr1i) with the 69B-Gal4 driver showed extra
wing vein tissue along the anterior or posterior side of L2. Representative wings of wild
type “-“ (A), extra vein (arrowhead) along one side of L2 “+” (B), and extra vein
(arrowhead) along both sides of L2 “++” (C) are shown. (D-F) Wings from 69BGal4/UAS-Brmi (D), UAS-CycYiC2/+; 69B-Gal4/UAS-Brmi (E), and CycYE8/+; 69BGal4/UAS-Brmi (F) adults reared at 25°C.

Table 3-3. Genetic interactions revealed by double knockdown of CycY and Brm or Snr1.

Temp

Genotype

30°C

UAS-CycYiC2/+; 69B-Gal4/+

a

Curved wing

-

+

++

-

+

237

30.4%

40.9%

28.7%

100%

0%

69B-Gal4/UAS-Snr1i

795

49.8%

50.2%

0%

100%

0%

UAS-CycYiC2/+; 69B-Gal4/UAS-Snr1i

127

15%

28.3%

56.7%

100%

0%

CycYE8/+; 69B-Gal4/UAS-Snr1i

324

52.5%

47.2%

0.3%

100%

0%

UAS-CycYiC2/+; 69B-Gal4/+

222

88.3%

10.9%

0.8%

100%

0%

UAS-CycYiC2/+; 69B-Gal4/UAS-CycY

172

99.4%

0.6%

0%

100%

0%

69B-Gal4/UAS-Brmi

114

100%

0%

0%

100%

0%

UAS-CycYiC2/+; 69B-Gal4/UAS-Brmi

130

100%

0%

0%

0%

100%

CycYE8/+; 69B-Gal4/UAS-Brmi

147

100%

0%

0%

0%

100%

Wing vein defects were quantitatively scored as wild type (-), extra vein along one side of L2 (+), and extra vein along

both sides of L2 (++). A representative image for each class is shown in Figure 3-8 A-C.
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25°C

n

Extra wing veina
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conclusion that the CycY knockdown effect was specific. The phenotype of double
knockdown of Brm and CycY is similar to the previously described Contrabithorax (Cbx)
phenotype, which is a curving of the wing indicating a partial transformation of wing to
haltere due to misregulated Ubx expression (Cabrera et al., 1985; Faucheux et al.,
2003). Interestingly, BrmK804R mutants exhibit partial haltere-to-wing transformation
(Elfring et al., 1998), which is opposite to the curved wing or wing-to-haltere
transformation phenotype. Thus, it would seem that Brm knock down and Brm dominant
negative mutants display opposite effects with respect to this phenotype. A possible
explanation is that the Brm ATPase subunit may have multiple roles in the Brm complex,
which can activate some genes but repress others. In the case of Brm knockdown
mutants, all function of Brm should be diminished, whereas the dominant negative may
only impair a subset of Brm function.
In summary, I detected tissue-specific genetic interactions between CycY and
two members of the Brm complex, Snr1 or Brm. Removal of one copy of CycY
genetically enhanced the defects in adult viability and dorsal midline fusion induced by a
Snr1 dominant negative. Knockdown of CycY enhanced the extra wing vein phenotype
induced by Snr1 knockdown and enhanced the wing phenotype of Brm knockdown or a
Brm dominant negative. These genetic interactions indicate that CycY functions with the
Brm complex to control specific aspects of wing development.
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3.3.6 CycY is required for maximal expression of some genes regulated by the
Brm complex
The functional relationship between CycY and the Brm complex genes may be
one where they act in the same pathway to regulate gene transcription. For example,
one possibility is that CycY may modulate Brm complex activity to regulate specific
genes. To begin to test this possibility, I examined the transcription level of several Brm
complex targets in CycYE8 homozygous mutants. One set of Brm complex targets
appears to be the Eig71E genes, a cluster of 11 ecdysone-regulated genes located at
cytological position 71E. These genes encode small, secreted, cysteine-rich peptides
proposed to be involved in an antimicrobial defense system, based on their sequence
similarity to vertebrate defensins (Wright et al., 1996). Both Snr1 and Brm proteins have
been detected at the promoters of Eig71E genes in Drosophila S2 cells suggesting that
these genes are direct targets of the Brm complex. In support of this, Zraly et al.
showed that expression of a dominant negative Brm in early pupae results in
downregulation of most of the Eig71E genes, whereas Snr1 mutants lead to
upregulation, further suggesting that Brm and Snr1 have opposing roles in their
regulation Eig71E genes in pupae (Zraly et al., 2006). To test whether CycY also
regulates Eig71E gene expression I quantified mRNA levels in early pupae (0-14 hr
after puparium formation) that were homozygous or heterozygous for CycYE8 (Figure 39 A-D). I found that in wild-type pupae, the transcription pattern of Eig71Eh, Eig71Ei,
Eig71Eg, and Eig71Ef was very similar, with a gradual increase in expression peaking
at 6 hr after puparium formation followed by a decrease. In CycYE8 mutants, the overall
transcription of each gene at most time points was significantly decreased, with the
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most dramatic difference evident at the 6 hour peak. This phenotype is similar to Brm
mutants but opposite to Snr1 mutants in which these genes are up regulated (Zraly et
al., 2006). Interestingly, transcription of three other ecdysone-responsive genes (Eip93F,
ImpE2, Eip63E) and the ecdysone receptor gene (EcR) were mildly up regulated in the
CycY mutant (Figure 3-9 E-H). None of these genes has been shown to be markedly
affected in either Snr1 or Brm mutants. Combined, these data suggest that CycY is
required for maximal expression of at least some of the genes that are regulated by the
Brm complex.
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Figure 3-9. Gene expression in CycYE8 mutants. Total RNA was extracted from
prepupae at the indicated developmental time points and mRNA levels of each tested
gene were determined by RT-qPCR. Expression was normalized to the mRNA levels of
the internal control gene, rp49. (A) Eig71Eh, (B) Eig71Ei, (C) Eig71Eg, (D) Eig71Ef, (E)
EcR, (F) Eip93F, (G) ImpE2, (H) Eip63E.
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3.4 DISCUSSION
In the current study, I identified additional developmental processes that require
CycY, including adult viability, abdominal dorsal midline fusion, and wing development.
More importantly, I identified that CycY genetically interacts with the Brm complex
components, Snr1 and Brm, in controlling these developmental processes. The
maximum expression of some of the Brm complex target genes, such as Eig71E genes,
is not achieved in CycY null mutants. I also showed that CycY can physically interact
with Snr1 in Drosophila cells. Taken together, these results lead us to hypothesize that
CycY may modulate the activity of Brm chromatin-remodeling complexes, possibly by
phosphorylating Snr1 or other components of the complex, and thereby regulate the
transcription of genes involved in a broad spectrum of developmental processes.

3.4.1 CycY may modulate the Brm ATP-dependent chromatin-remodeling complex
activity through phosphorylation
CycY and the Brm complex are required for a similar spectrum of developmental
processes, consistent with the possibility that they function in a common pathway. Like
Snr1 and Brm, CycY is an essential gene that is required throughout the Drosophila life
cycle, from oogenesis, embryogenesis, and larval growth, to metamorphosis, and adult
viability. Mutations in CycY and Brm complex components have also revealed common
tissue-specific requirements, including development of the integument of the adult
abdomen and development of wing veins. The integument of the adult abdomen
develops from nests of larval histoblast cells. After a continuous proliferation between 3
and 15 hours after pupariation, the abdominal histoblast cells begin to migrate and

121
displace the larval epidermal cells, which are then histolyzed by apoptosis (Fristrom and
Fristrom, 1993). Dominant negative Snr1-2 blocked abdominal tergite fusion along the
dorsal midline and this phenotype was dramatically enhanced by removal of one copy of
CycY (Figure 3-6, Table 3-2). A similar abdominal dorsal midline fusion defect has been
observed for mutants of the Drosophila caspase, Ice (Muro et al., 2006). Thus, it is
possible that CycY and Snr1 are involved in histoblast proliferation, migration, or
differentiation, or in apoptosis of larval epidermal cells. Clonal analysis with the mutants
described in this dissertation may help distinguish these possibilities.
The cell fate determination of wing veins and intervein regions initiates from the
larval wing imaginal blade, when broad “provein” and intervein regions are specified by
the differential expression of cell signaling molecules,

Hedgehog (Hh) and

decapentaplegic (Dpp), and intervein specific transcription factors, blistered (bs), Net,
Plexus (px), and provein specific transcription factors, Iroquois (Iro) (for veins L1, L3
and L5), knirps (kni) and knirps-like (knrl) (vein L2), abrupt (ab) (vein L5) (De Celis,
2003). The vein cell fate of each provein is determined by a specific combination of
transcription factors. However, vein commitment depends on restriction by Notch
signaling and activation by EGFR signaling pathways. Snr1 dominant negative mutants
display extra wing vein tissue, whereas Brm mutants exhibit loss of wing vein,
suggesting an inhibitory effect of Snr1 on Brm complex activity in this tissue. Several
EGFR signaling targets, such as Delta, rhomboid, and agros, and other vein cell fate
determination factors or signaling molecules, such as bs and dpp, were found to be
misregulated in mutants of Brm complex subunits (Marenda et al., 2004; Terriente-Felix
and de Celis, 2009). Knockdown of CycY showed a similar extra wing vein defect to
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knockdown of Snr1. Snr1 knockdown enhanced the extra vein defect induced by CycY
knockdown (Figure 3-8, Table 3-3). Therefore CycY is also involved in vein cell fate
determination, and may function by modulating Brm complex regulation of vein cell fate
genes.
Taken together, the similar developmental requirement for CycY and Snr1/Brm,
and the genetic interaction between them suggests that CycY may be involved in a
common signaling pathway with the Brm complex. However, CycY is unlikely to function
downstream of the Brm complex since direct downstream targets of the complex are
misregulated in CycY mutants (Figure 3-9 A-D). The simplest interpretation of these
results is that CycY acts in parallel or upstream of the Brm complex. The molecular
function of the Brm complex is thought to be primarily transcriptional regulation (Tamkun,
1995) whereas the molecular function of cyclins like CycY is to activate cyclindependant kinases to phosphorylate downstream substrates. Our finding that Snr1 and
CycY can physically interact (Figure 3-4B) is consistent with the possibility that
CycY/Cdk14 phosphorylates either Snr1 or another component of the Brm complex to
regulate its activity. Snr1 is phosphorylated at threonine 102 by dDYRK2 and MNB in
vitro and in vivo and this phosphorylation was proposed to regulate the
nuclear/cytoplasmic distribution of Snr1 (Kinstrie et al., 2006). In fact, phosphorylation is
an important mechanism by which the Brm complex activity is regulated. The human
orthologs of Brm (hBrm/Brg1) and Mor (BAF155) have been reported to be inactivated
by phosphorylation prior to the onset of mitosis (Muchardt et al., 1996; Sif et al., 1998),
a time when chromatin becomes condensed and transcription is inhibited. Brg1 and
BAF155 were later shown to be associated with and phosphorylated by CycE/Cdk2
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(Shanahan et al., 1999). Thus, it is possible that CycY/Cdk14 also regulates Brm
complex activity by phosphorylating one or more of the Brm complex components. In
Chapter 4, I describe efforts to detect phosphorylation of Snr1 by CycY/Cdk14.

3.4.2 CycY may modulate Brm complex activity in a cell-type- and temporalspecific manner
Several lines of evidence indicate that the Brm complex can activate or repress
transcription of specific genes in a cell-type specific manner. For example, Eig71E
genes are oppositely regulated in BrmK804R mutant pupae and in Brm knockdown
Drosophila S2 cells. In BrmK804R mutant pupae, most of the Eig71E genes are down
regulated, whereas in Brm knockdown cells, ecdysone-induced expression of these
genes is advanced (Zraly et al., 2006). The expression of another gene, String (Stg), is
also differentially regulated by the Brm complex in different cells. Knockdown of Snr1 or
Brm in S2 cells results in down regulation of Stg and arrest in G2/M phase (Moshkin et
al., 2007). However, in pupae, down regulation of Stg was only observed in Snr1E1
mutants, but not in BrmK804R mutants (Zraly et al., 2004). More strikingly, the human Brm
ortholog, Brg1, is a well-known tumor suppressor. However, it is also essential for the
viability of some types of cells (Mohrmann and Verrijzer, 2005). All of these results
might be due to cell type specific activation or repression of specific gene by the ATPdependent chromatin-remodeling complexes. Snr1, a core subunit of Brm complex,
plays the role of an activator or repressor and may be responsible for determining
whether the complex activates or represses a gene in a specific cell type. For example,
in the intervein cells, rhomboid expression is inhibited by Snr1, which blocks the
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activation effect of Brm, whereas in the provein cells, rhomboid expression is activated
by Brm due to the absence of Snr1-recruited repressors (Marenda et al., 2004). Thus,
the different regulatory effects of Snr1 may be determined by the availability of tissuespecific transcription factors.
The regulation of Brm complex activity by CycY is also cell-type specific (Figure
3-10). Most of the genetic interaction data indicate that CycY positively regulates Snr1
function, which may either cooperate or antagonize with Brm. For example CycY
genetically enhances the longevity and dorsal midline fusion defect induced by ectopic
expression of truncated Snr1 (Figure 3-5 and 3-6, Table 3-2). Knockdown of Snr1 or
CycY resulted in similar extra wing vein phenotypes, while the double knockdown
showed a much stronger effect (Figure 3-8, Table 3-3). CycY appears to activate Snr1
function, whether it is serving to activate or repress genes. For instance, in the intervein
cells, Snr1 recruits gene-specific repressors to inhibit the expression of vein-specific
genes, and therefore Snr1 knockdown wings display extra wing vein tissue (Marenda et
al., 2004). Knockdown of Snr1 enhanced the extra wing vein phenotype induced by
CycY knockdown, whereas Brm knockdown suppressed this phenotype (Figure 3-8,
Table 3-3). Thus in intervein cells, CycY and Snr1 work together to antagonize Brm. On
the other hand, in the provein cells, Snr1 functions with the Brm complex to turn on
vein-specific gene expression and this role of Snr1 is also positively regulated by CycY
since reducing CycY can enhance the loss-of-vein phenotypes induced by Brm
knockdown (Figure 3-7G). The above model helps explain the tissue-specific genetic
interaction between CycY, Snr1, and Brm. Examination of Eig71E gene expression in
pupae, however, suggests a more complicated relationship. The Eig71E genes were
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Figure 3-10. CycY may modulate Brm complex activity in a cell-type- and
temporal-specific manner. Snr1 may constrain Brm complex activity by recruiting
transcriptional inhibitors to repress gene expression at some cell types (for example,
intervein cells) or at specific developmental time points (for instance, at 0h after
puparium formation or APF) to repress the expression of provein genes or Eig71E
genes, respectively. Snr1 may also operate with Brm complex to activate gene
expression in other cell types (for example, provein cells) or at other developmental time
points (for instance, at 6h APF) to activate the expression of these same genes. Under
any circumstance, CycY, presumably with its Cdk14 partner, positively regulates Snr1
function to regulate gene expression.
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upregulated in the Snr1E1 mutant, but downregulated in BrmK804R mutants, which are a
collection of pupae between 0 and 24 hours after puparium formation. My expression
data is consistent with previous reports that the expression of Eig71E genes is
repressed at the beginning of puparium formation, but is induced by ecdysone signaling
during the prepupal stage (Wright et al., 1996). Ecdysone-induced expression is
downregulated in CycYE8 mutants, especially at the 6 hour peak. These data seem to
conflict with our proposed model that CycY positively regulates Snr1 function. However,
it is possible that CycY cooperates with Snr1 to either promote or repress the Brm
complex activity in a temporal-specific manner (Figure 3-10). The gene expression
analysis with 0-24 pupae may reflect an overall inhibitory effect of Snr1 on Brm complex
activity, while my analysis was carried out during the stage of ecdysone-induced
expression when presumably Snr1 has an activating role on the Brm complex. Similar
analysis of the expression of these Eig71E genes at specific developmental time points
in Snr1 or Brm mutants is needed to further test this model.

3.4.3 Does CycY play a role in cell cycle regulation?
Thus far it is uncertain whether or not CycY plays a direct role in regulating the
cell cycle although I have detected genetic interactions between CycY and the Brm
complex, which has been substantially connected with cell cycle regulation. In mammals,
the Brm complex cooperates with Rb to inhibit expression of CycE and CycA, and
therefore regulates the exit from G1 and S phase progression. On the other hand,
CycE/Cdk2 has been found to bind and phosphorylate Brm subunits Brg1 and BAF155
(orthologs of Drosophila Brm and Mor, respectively) to maintain chromatin in a
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transcriptionally permissive state (Reisman et al., 2009). In Drosophila, it has been
proposed that the Brm complex may exert an inhibitory effect on DNA replication origins
by recruiting a repressor through Snr1. After Cdk2/CycE is also recruited to replication
origins by associating with cdc6, Brm complex subunits are phosphorylated by
Cdk2/CycE mediated by association with Snr1, and therefore the Brm complex and its
inhibitory effect is removed from the replication origins to facilitate the DNA synthesis
(Brumby et al., 2002).
Some findings argue against a role for CycY in cell cycle regulation. CycY has
not been identified in genome-wide RNAi screens for cell cycle regulators in human or
Drosophila cells, and I have found that knockdown of CycY expression in cultured
Drosophila cells does not produce obvious defects in the cell cycle (data not shown). I
did not observe any functions of CycY during the development of eye, a best tissue for
studying cell proliferation and differentiation. The eyes from CycYE8 pharate adults or
adult escapers look normal (Liu and Finley Jr, 2010), and knockdown of CycY in the
posterior compartment of the eye imaginal disc generated viable adults with normal
eyes (Figure 3-1 F-G). Cdk14/Eip63E has also been shown not to be required for cell
division in the eye (Stowers et al., 2000).
However, several studies support a direct or at least indirect role for CycY/Cdk14
in cell cycle regulation. The decreased wing size phenotype induced by CycY
knockdown by en-Gal4 supports a function related with cell growth, cell proliferation, or
cell death (Figure 3-2). Unfortunately, I failed to detect any abnormal percentage of
mutant cells that undergo mitosis or apoptosis in third instar larval imaginal discs
(Figure 4-5 S-U, Appendix J). The human Cdk14 ortholog, also called PFTK1, functions
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as a Cdk to regulate cell cycle progression, cell proliferation, and activation of Wnt
signaling (Davidson et al., 2009; Shu et al., 2007). Two cyclin binding partners for
PFTK1 have been identified, CCND3 (human CycD3) and CCNY (human CycY)
(Davidson et al., 2009; Jiang et al., 2009; Shu et al., 2007). PFTK1 knockdown led to
G1 arrest, whereas ectopic expression promoted S-phase entry (Shu et al., 2007),
suggesting a positive role during the G1 to S phase transition. However, Davidson et al.
showed that CCNY oscillates throughout the cell cycle and peaks at G2/M phase
(Davidson et al., 2009). Although CCNY/PFTK1 complex peaks at G2/M to activate Wnt
signaling by phosphorylating the Wnt co-receptor LRP6, a direct cell cycle regulatory
function during G2/M still has not been described. However, direct downstream targets
of the Wnt pathway transcription complex β-catenin/LEF-1 include the G1/S genes
CycD1 and c-myc (Nollet et al., 1999). It is also not clear whether the cell cycle related
PFTK1 kinase activity during G1 to S phase is activated by CCND3, CCNY, or both. It is
possible that both CCND3 and CCNY activate PFTK1 but with different substrate
specificities. It is possible that CCND3 promotes the phosphorylation of Rb while CCNY
promotes the phosphorylation of SWI/SNF complex subunits, and both phosphorylation
events would promote the G1 to S phase transition. In Drosophila, however, there is
only one CycD, which apparently does not have functions independent of Cdk4, and
CycD/Cdk4 complex has been found to be required for cellular growth but not for
progression through G1 (Datar et al., 2000; Meyer et al., 2000). Yeast two-hybrid and
co-AP data also argue against the interaction between Drosophila CycD and Eip63E
(Liu and Finley Jr, 2010). Whether Drosophila CycY and its related kinase are involved
in cell cycle regulation in both human and Drosophila requires further investigation.
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3.4.4 CycY, Brm complex, and Wg/Wnt signaling
CycY and Cdk14 have been reported to phosphorylate the Wnt co-receptor
LRP6/arrow in human and Drosophila cultured cells to activate Wg/Wnt signaling
(Davidson et al., 2009). We do not know, however, whether the CycY/Cdk14 complex
regulates Wg signaling in vivo or whether there are specific developmental processes
where CycY/Cdk14 modulate Wg signaling. The genetic interaction between CycY and
Wg signaling has not been explored. Interestingly, the Brm complex has been found to
inhibit the expression of Wg targets (Collins and Treisman, 2000). Thus, it is possible
that some or all of the genetic interactions I observed between CycY and the Brm
complex are due to CycY’s role in Wg signaling. The null mutant phenotypes of CycY
and Eip63E have more similarities to that of Brm complex components than to that of
Wg components, suggesting that both CycY and Brm have functions that are
independent of Wg signaling. The epistatic relationship between CycY, the Brm
complex, and Wg targets should be investigated further. The CycY mutants and genetic
tools created here should help in this endeavor.
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CHAPTER 4

SEARCHING FOR CYCLIN Y’S PATHWAYS IN DROSOPHILA

4.1 INTRODUCTION
The studies described in Chapters 2 and 3 provided an initial characterization of
the essential roles that CycY plays in Drosophila and suggested that CycY may bind
Cdk14 and activate its kinase activity to regulate the Brm chromatin-remodeling
complex. This hypothesis needs to be tested further in vivo. The studies also raised
many questions about CycY function. In this chapter I set out to answer some of these
questions. Most of the results described in this chapter are negative and failed to
provide evidence either in support of the hypothesis being tested, or disproving it.
Nevertheless the results from these experiments are likely to be useful for guiding future
studies aimed at a better understanding of the biological functions of CycY and
identifying the signaling pathways in which it is involved.
Data presented in Chapter 2 showed that CycY physically interacts with Eip63E
as demonstrated by Y2H and co-AP assays. I also showed that CycY and Eip63E null
mutants have similar phenotypes. Both are required for almost all developmental
stages. The major developmental defects of zygotic nulls are manifested during
metamorphosis, especially during prepupal development, a process that is mainly
regulated by the steroid hormone, ecdysone. Interestingly, one of the Eip63E transcripts
is also ecdysone inducible. Taken together, these data suggest that CycY and Eip63E
are bona fide in vivo Cyclin/Cdk partners, a proposal that has been further supported by
the identification of the CCNY/PFTK1 interaction in human cell lines. However, we still
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lack direct in vivo evidence from Drosophila. Since I do not have antibodies to either
CycY or Eip63E, I was unable to do in vivo immunoprecipitation. As an alternative
approach, I decided to test whether CycY and Eip63E genetically interact with each
other. The essential requirement of CycY and Eip63E during metamorphosis and the
ecdysone induced expression of Eip63E prompted me to test whether CycY is required
for some key developmental events during metamorphosis, for example the glue protein
synthesis, secretion, or extrusion, and autophagic cell death.
Data presented in Chapter 3 showed that CycY genetically interacts with
components of the Brm chromatin-remodeling complex and that CycY also physically
interacts with Snr1, a core subunit of the complex. However, the molecular mechanism
behind these interactions is unknown. Considering that the likely molecular function of
the CycY/Eip63E complex is to phosphorylate downstream targets, a simple hypothesis
is that Snr1 is one of the substrates. To test this hypothesis, I expressed and purified
MBP-tagged Snr1 and several mutant variants and used these fusion proteins as
substrates for in vitro kinase assays.
I show here that CycY does not genetically modify the hatching rate defect
associated with Eip63E81 allele. I also show that CycY null mutants display normal
starvation induced autophagy during early L3 stage. Interestingly, the process of glue
extrusion, which is regulated by ecdysone, is misregulated in the CycY mutant. Due to
the failure of generating high quality CycY Ab and the non-specificity of RNA in situ
hybridization, I was unable to show the endogenous CycY protein or mRNA localization.
Consistent with studies with human cells, I showed that CycY with an N-terminal tag is
mainly localized in the cytoplasm. Finally, in vitro kinase assays suggest that Snr1 may
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not be a direct phosphorylation target of CycY/Eip63E complex. This result suggests an
alternative hypothesis for how CycY/Cdk14 may regulate the Brm complex.
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4.2 MATERIALS AND METHODS

4.2.1 Fly stocks
All fly stocks were maintained in vials containing standard cornmeal molasses
medium and raised at 25°C unless otherwise stated. Most of the fly strains used in this
study have larval markers for identifying larvae with specific genotypes. A double
balancer strain that have a [y+] transgene on the second chromosome in a y1
background and a Tb allele on the third chromosome was kindly provided by Dr. Lei
Zhang (University of Texas Southwestern Medical Center; Shanghai Institute of
Biochemistry and Cell Biology) (Finley lab # 442). Fly strains used in this study are
listed in Appendix K.

4.2.2 Embryo hatching rate
Roughly equal numbers of newly emerged virgin females (~20) of each genotype
were mated with w1118 males (~30) or males with the indicated genotypes in a regular
vial for 2 days. These adults were then transferred to egg chambers after 2 days of
mating and eggs were collected on apple juice plates once every 12 hours for two days.
After incubating the collected eggs for about another 12 hours, the number of hatched
first instar larvae was counted. The hatched larvae were discarded after counting. The
number of hatched first instar larvae was counted again after another 12 hours. The
reason for counting twice is to prevent too many larvae from accumulating on the apple
juice plates since they will crawl to the cover of the plate and dry out or dig through the
agar when it is over crowded. The number of eggs that failed to hatch eventually after
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aging for at least 24 hours at 25°C was also counted. Hatching rate is the total number
of hatched first instar larvae divided by the sum of larvae and unhatched eggs.

4.2.3 Assay of glue synthesis and extrusion from salivary glands during prepupal
development
Egg chambers were set up with Finley lab strain # 710 (y1w*; CycYE8/CyO [y+];
sgs3-GFP/TM6b Tb). Larvae with black mouth hooks (y1w*; CycYE8/CyO [y+]; sgs3GFP/TM6b Tb or y1w*; CycYE8/CyO [y+]; sgs3-GFP) and yellow mouth hooks (y1w*;
CycYE8; sgs3-GFP/TM6b Tb or y1w*; CycYE8; sgs3-GFP) were collected separately and
transferred to regular vials. 0h prepupae were collected and transferred to a petri dish
with a piece of wet filter paper. The glue secretion from salivary glands was monitored
under a dissection fluorescence microscope once every half hour for a total of 4 hours.
All the pupae under study were classified into five different groups on the basis of the
GFP intensity, which represents the glue protein sgs3 level, during the first four hours
after puparium formation. Group 1 had lost almost all GFP; group 2, had only a weak
GFP signal; group 3 had medium levels of GFP signal; group 4 had strong GFP signal
at the time of puparium formation, but the signal went away in less than 1.5h; group 5
had GFP signal that remained longer than all the above mentioned situations.

4.2.4 LysoTracker staining
An egg chamber was set up with Finley lab fly strain # 693 (w*; CycYE8/CyO
Act5C-GFP). CycYE8 heterozygous (GFP positive) and homozygous (GFP negative) first
instar larvae were transferred separately into regular vials (about 20 per vial) from apple
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juice plates. Well-fed early third instar larvae were collected for direct dissection or were
transferred into 5ml of 20% sucrose/PBS for 4 hours before dissection for protein
starvation experiments (Britton and Edgar, 1998). I followed the LysoTracker staining
protocol as described by Neufeld with minor modification (Neufeld, 2008). Early third
instar larvae were dissected in a 6-well dissection dish containing PBS and the
dissected salivary glands and fat body tissue that were attached to the mouth hooks
were immediately transferred to an eppendorf tube with PBS on ice. After finishing the
dissection of all larvae (~10), PBS was removed and replaced with 1ml of 2 μg/ml
Hoechst 33342 (Invitrogen H1399, 1mg/ml stock solution). After 10-minute incubation,
Hoechst 33342 was removed and the dissected tissues were washed twice with PBS (5
minutes for each wash). The eppendorf tube was kept on the bench without shaking
during the washing step. After washing with PBS, the tissues were incubated with 1ml of
1μM LysoTracker Red DND-99 (Molecular Probes L-7528, 1mM stock solution) for 2
minutes. After washing twice with PBS (5 minutes for each wash), the salivary glands
and fat body were mounted with PBS and photographed immediately.

4.2.5 Expression and purification of MBP-tagged fusion proteins from bacterial
cells
I followed the following protocol, which I modified based on the NEB instruction
manual for pMAL Protein Fusion and Purification System. Transform the expression
vector into NEB express cells (NEB C25231, fhuA2 [lon] ompT gal sulA11 R(mcr73::miniTn10--TetS)2 [dcm] R(zgb-210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10).
Inoculate 10ml of rich media (per liter: 10g tryptone, 5g yeast extract, 5g NaCl, 2g
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glucose, 100μg/ml ampicillin) with a single colony. Inoculate 1L of rich media with the
10ml of overnight culture and grow to OD600 ~0.6, which usually takes about 2.5-3h. Add
IPTG to a final concentration of 0.6mM to induce the fusion protein expression and
incubate with shaking at 37°C for 4 hours. Spin down and measure the weight of the
wet pellet. Resuspend 1g pellet in 10 ml of lysis buffer [1xPBS, 1mM PMSF,
1mMEDTA, 1xProtease inhibitor cocktail (Roche)]. Add rLysozyme (Novagen) ~ 50KU/g
cell pellet and shake at room temperature for 1h (200RPM). Store the cell lysate at 20°C freezer over night. Thaw rapidly at 37°C in a water bath and then return to ice.
Transfer the cell lysate to a 50ml centrifugation tube and keep the volume around 20ml,
no more than 25ml. Sonicate on ice (8 x 15 seconds each, pulsed 15s in between, duty
cycle 50%, setting 5, microtip max). Spin at 17,000 rpm at 4°C for 30 min. Filter the
supernatant with a 0.4µm membrane. Quantify protein concentration with the BioRad
protein assay reagent. Dilute the supernatant to 2.5mg protein/ml with MOPS column
buffer (50mM MOPS pH 7.5, 200mM NaCl, 1mM EDTA, 1mM PMSF). Load to a 15ml
amylose (NEB) column (1ml/min) equilibrated with 150ml of MOPS column buffer. Wash
the column with 180ml of MOPS column buffer (3ml/min). Elute MBP-tagged fusion
proteins with the MOPS column buffer supplemented with 10mM maltose. Collect 15
fractions (1ml/min), each ~ 1.5ml. Quantify the protein concentration in each fraction
and run an SDS-PAGE gel and stain with Coomassie to identify the purified protein
fractions. The following MBP-fusion proteins have been expressed and purified for this
study (Table 4-1).
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Table 4-1. MBP-fusion proteins expressed and purified for this study
Plasmids
Finely lab #

Plasmid names

Expressed proteins

Used for

1030

pMalc2-nCycY

MBP-nCycY

CycY Ab purification

1010

pMalc2-Snr1

MBP-Snr1

Substrate for kinase assay

1033

pMalc2-Snr1 T102/198A

MBP-Snr1 T102/198A

Substrate for kinase assay

1034

pMalc2-Snr1 T102A

MBP-Snr1 T102A

Substrate for kinase assay

1035

pMalc2-Snr1 T198A

MBP-Snr1 T198A

Substrate for kinase assay
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4.2.6 Generation and purification of CycY peptide antibody
A 14 amino acid small peptide DRKSKDMPPVFEER (CycY 16-29) was
synthesized and used for the immunization of a guinea pig by Open Biosystems. Forty
five ml of crude serum was received and directly used for western blot (1:250) to detect
CycY. To purify the anti-CycY serum, a small MBP-tagged N-terminal CycY (1-115,
MBP-nCycY; expression vector pMalc2-nCycY is Finley lab plasmid # 1030) was
expressed in E.coli, purified (see section 4.2.5 for details), and coupled to the Affi-Gel
15 (Bio-Rad). Affinity purification of CycY antiserum is based on the manufacturer’s
protocol (Bio-Rad).

4.2.7 RNA in situ hybridization
I followed the following protocol adapted from the protocol provided by Dr. Ye
Tao (The University of Texas M. D. Anderson Cancer Center) and Dr. Russell Finley
(WSU).
4.2.7.1 Collect and fix embryos for hybridization
Set up an egg chamber and collect eggs at room temperature (22°C) for 20-24
hours. Wash eggs off the egg laying plate into a sieve and wash several more times to
remove as much debris as possible. Immerse the eggs in the sieve in 50% bleach for 5
minutes to dissolve the egg chorions. Wash several times with water and blot dry. Using
a paint brush with soft hair, transfer the eggs immediately into a glass scintillation vial
containing equal volumes of fixative solution (3.7% formaldehyde in PEM; PEM: 100mM
PIPES, 1mM MgCl2, 1mM EGTA, pH 6.9) and heptane; place the glass vial on a shaker
and shake at 400 rpm for 20 minutes at room temperature. Using a pasteur pipet,
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remove and discard the lower phase and add an equivalent volume of methanol
(precooled to -70°C) into the vial. Shake the vial vigorously by hand for 1 minute.
Discard the upper phase in the vial, and any embryos that remain at the interface
should be discarded as well. Remove the embryos from the bottom phase and transfer
into a 1ml tube. Rehydrate the embryos through a graded methanol:PBS (130mM NaCl,
7mM Na2HPO4, 3mM NaH2PO4, pH7.4) series (7:3, 5:5, 3:7, 0:10), 10 minutes each. Fix
the embryos for 20 minutes with 3.7% formaldehyde. Wash in 1xPBS, then dehydrate
through graded methanol:PBS series (3:7, 5:5, 7:3, 10:0), 10 minutes each. Store the
embryos at -20°C for further treatment.
4.2.7.2 Probe synthesis
Using pAS1-CycY as template, PCR with primers 5' TGTGGGATGACCAGGCC
GTTTGG (Finley lab # 792) and 5'-GGCCAGTGAATTGTAATACGACTCACTATAGGG
AGGCGGCGGAATTAGCTTGGCTGCAG-3' (Finley lab # 497) to amplify a CycY cDNA
fragment (C-terminal 359bp) with a T7 promoter at the 3’ end. Alternatively, PCR with
primers Finlab # 497 and 5’RT-F (Finley lab # 891) to amplify full length CycY cDNA
with a T7 promoter at the 3’ end. Set up the following RNA labeling reaction with the
DIG RNA Labeling Kit (SP6/T7) from Roche Applied Science (11-175-025-910): 10μl of
PCR products from above (~ 1μg DNA); 2μl of 10 x Transcription buffer; 2μl of l0x
nucleotide mix (with digoxigenin-UTP); 1μl of RNase inhibitor; 2μl of T7 RNA
polymerase. Add RNase-free water to give a final reaction volume of 20μl. Incubate the
reaction mixture at 37°C for 2 hours. Clean up the in vitro synthesized labeled RNA
probes with Megaclear RNA purification kit (Ambion). Add 2µl of RNase inhibitor (40U)
to the purified RNA probe. Aliquot the probe and store at -70°C.
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4.2.7.3 Preabsorb anti-Dig Ab
Remove methanol from the fixed embryos (~50μl). Add 1ml of PTW (PBS, 0.1%
Tween-20) and 5μl of Roche HRP conjugated anti-digoxigenin antibody. Rotate at 4°C
overnight. Add NaN3 to the preabsorbed Ab solution to a final concentration of 0.1% to
stabilize the Ab. Preabsorbed Ab may be stored for several months at 4°C and diluted
further 1:10 when used.
4.2.7.4 Pretreatment, hybridization and washing
Rehydrate the fixed embryos through 70%, 50%, 30%, 0% methanol in PTW
(PBS, 0.1% Tween-20). Five minutes for each step. Incubate the embryos in 50μg/ml
proteinase K in PTW at room temperature for 4 minutes. Rinse the embryos twice for 1
minute in PTW. Wash with PTW twice for 5 minutes. Fix the embryos in 4%
paraformaldehyde in PBS for 20 minutes at room temperature. Rinse the embryos five
times for 1 minute in PTW.
Rinse the embryos in 1:1 PTW: hybridization buffer (50% deionized formamide,
5x SSC, 100μg/ml tRNA, 50μg/ml heparin, 0.1% Tween-20; SSC: 0.15M NaCl and
15mM tri-sodium citrate; adjust pH to 4.5 with 1M citric acid if the hybridization
temperature is 70°C, otherwise do not adjust pH). Resuspend the embryos in
hybridization buffer and transfer to a 0.6ml tube. Prehybridize overnight (~20h) at 70°C
or 55°C. Heat the probe (1:25-1:100 in hybridization buffer) to 90°C for 5 minutes. Put
the heated probe on ice immediately. Remove prehybridization buffer from the 0.6ml
tube and add 200μl fresh hybridization buffer containing heat denatured probe.
Hybridize overnight in 70°C or 55°C water bath.
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Remove hybridization buffer containing the probe and rinse the embryos in fresh
hybridization buffer once and wash once for 20 minutes at 70°C or 55°C. Wash the
embryos in 1:1 PTW: hybridization buffer for 20 minutes at 70°C or 55°C. Wash in PTW
five times for 20 minutes at room temperature.
4.2.7.5 Immunodetection of the probes
Incubate the hybridized embryos with preabsorbed anti-dig Ab (further dilute 1:10
in PTW to make a final 1:2000) for 2 hours at room temperature. Wash four times for 20
minutes in PTW. Rinse twice for 1 minute in fresh-made detection solution (100mM
NaCl, 50mM MgCl2, 100mM Tris-HCl pH 9.5, 0.1% Tween-20). Resuspend the embryos
in 1ml of detection solution and add 20μl of NBT/BCIP mixture solution (Roche). Monitor
the reaction under the microscope. When the stain appears, stop the reaction with
several rinses in PTW. Mount the embryos in 70% glycerol. Use small pieces of No.1
coverslip as supports for the main coverslip to prevent the embryos from being
squashed.

4.2.8 Immunofluorescence staining of Drosophila S2R+ cells
I followed the following protocol provided by Bridget Elsa Varughese (WSU).
4.2.8.1 Coat coverslip with Concanavalin A (ConA)
Immerse coverslips into nitric acid for about 2 minutes. Wash with abundant
amounts of sterile water. Make sure the final pH of the wash is ~neutral. Dry the
coverslips on paper towel and put one in each well of a 6-well plate. Spread 100-200µl
ConA (250µg/ml, Sigma C5275) on each coverslip. Incubate at 37°C for 2 hours.
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Remove the extra ConA with a pipette and rinse with sterile dH2O 3 times. Store the
coverslips in water at 4°C for future use.
4.2.8.2 Seed cells
Dislodge S2R+ cells and count the cell density. Dilute the cell suspension to
5x105 cells/ml with fresh media. Remove extra water from the 6-well plate with ConAcoated coverslips. Plate 200µl of the cells (105 cells in total) onto each coverslip. Wait
30min for the cells to settle down. Remove excess cell suspension form the coverslip
with a pipette.
4.2.8.3 Staining
Fix the cells with 1ml of 4% paraformaldehyde (pre-warmed at 37°C) for 10 min
at room temperature. Wash 3 times with 1xPBS (10 minutes for each wash). Block with
1ml of 0.1% PBT (Triton), 5% BSA for 1h at room temperature or 4°C overnight or
longer. Add 200µl of 1°Ab (mouse anti-myc Ab 1:100, Santa Cruz; rabbit anti-GST Ab
1:100, Santa Cruz) to a piece of parafilm then put the coverslip on the top of it with the
cells facing down. Incubate at 4°C overnight or for 1-3h at room temperature. Wash 3
times with 1xPBS (10 minutes for each wash). Add 200µl of 2°Ab (FITC conjugate Goat
anti-mouse IgG 1:200, Sigma; Texas Red® goat anti-rabbit IgG 1:200, Invitrogen) to a
piece of parafilm then put the coverslip on the top of it with the cells facing down.
Incubate at room temperature for 1h. Wash 3 times with 1xPBS (10 minutes for each
wash). Mount with vectashield mounting media with DAPI. Seal the edge with nail
polish. Keep slides at room temperature in the dark overnight to fully dry. Stained slides
can be stored at 4°C in the dark for months. Images were taken with a Zeiss Axio
imager upright microscope and Zeiss AxioCam MRm camera.
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4.2.9 Immunoprecipitation and kinase assay
I followed the following protocol provided by Dr. Stephen Guest (WSU) with
minor modification. Transfect S2R+ cells with plasmids and prepare cell lysate as
described in Chapter 2 (section 2.2.11). Quantify protein concentration in the cell lysate
and aliquot 500μg of total protein to an epppendorf tube. Add fresh-made lysis buffer
(20mM Tris.HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1mM EGTA, 1mM NaF, 1mM
Na3VO4, 1mM β-Glycerophosphate, 1 x protease inhibitor cocktail, 1mM PMSF) to make
it a total of 1ml. Add 10μl of anti-myc Ab (Santa Cruz) to the above cell lysate and rotate
at 4°C for an hour. Add 20μl of protein A agarose beads (Santa Cruz sc-2001) and
continue to incubate on a nutator at 4°C overnight. Centrifuge immunoprecipitation
reactions at 2500rpm at 4°C for 5 minutes. Remove supernatant and wash the beads 3
times with kinase assay buffer (50mM Hepes pH7.5, 10mM MgCl2, 1mM DTT). After the
final wash, add 20μl of kinase reaction mix to each immunoprecipitate (1 x kinase assay
buffer, 50μM cold ATP, 4.5μCi [γ32P] ATP, and 2μg of potential kinase substrate).
Incubate at 30°C for 30 minutes. Stop the reaction by adding 20μl of 2 x Laemmli
sample buffer and analyze by SDS-PAGE.

4.2.10 Mosaic analysis
y1w* hs-FLP; Ubi-GFP FRT40A (Finley lab # 434) virgin females were crossed
with y1w*; CycYE8 FRT40A/CyO [y+]; TM6B Tb/Sb (Finley lab # 705) males or y1w*;
FRT40A/CyO [y+]; TM6B Tb/Sb (Finley lab # 704) males as control in glass vials. Eggs
were collected for 24 hours. Twenty-four and 48 hours after egg laying, the glass vials
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were heat-shocked in a 37°C water bath for 2 hours to initiate FRT-mediated mitotic
recombination (Xu and Rubin, 1993). These vials were kept at 25°C otherwise. Third
instar larvae with yellow mouth hooks (y1w* hs-FLP; CycYE8 FRT40A/Ubi-GFP FRT40A
or y1w* hs-FLP; FRT40A/Ubi-GFP FRT40A) were collected and dissected. Dissected
imaginal discs were fixed in 4% paraformaldehyde in PBS for 30 minutes at room
temperature. After washing 3 times with PBST, staining 10 minutes in 1μg/ml
DAPI/PBST (Sigma), and a final 10-minute wash in PBST, imaginal discs were
incubated with antifade solution (0.5% p-Phenylenediamine and 40% glycerol in PBS)
for 20 minutes and mounted on a slide. Similarly, y1w* ey-FLP; Ubi-GFP FRT40A (Finley
lab # 435) virgin females were crossed with y1w*; CycYE8 FRT40A/CyO [y+]; TM6B
Tb/Sb (Finley lab # 705) or y1w*; FRT40A/CyO [y+]; TM6B Tb/Sb (Finley lab # 704)
males to create mosaic clones specifically in the eye.
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4.3 RESULTS AND DISCUSSION

4.3.1 CycY does not genetically modify the hatching rate defect associated with
the Eip63E81 allele
I have shown that CycY physically interacts with Eip63E and that null mutants of
the two genes have strikingly similar phenotypes, suggesting that CycY and Eip63E
function together in vivo. To further test this possibility I set out to screen for a genetic
interaction between the two genes. Since there is a maternal requirement for both CycY
and Eip63E during embryogenesis, I compared the hatching rate of embryos from
female heterozygous for Eip63E or CycY mutants with that of double mutants when
mated with w1118 males (Table 4-2). However, I only identified a decreased hatching
rate associated with the Eip63E81 allele, but not with any allele of CycY or the other two
Eip63E deficiency alleles. Embryos from double heterozygous mutants (CycYE8/+;
Eip63E81/+) had similar hatching rate as those from the heterozygous Eip63E81 mutant.
The same was true when the father was heterozygous for a CycY allele, an Eip63E
allele, or both. These data suggested that the decreased hatching rate is an allelespecific phenotype of Eip63E81 that is not modified by decreasing the dosage of CycY.
There are several possibilities to explain the differences between the Eip63E81 allele
and the two Eip63E deficiency lines. Eip63E81 has an in frame deletion of the DNA
sequences that encode amino acids 226-241 within a region conserved among Cdks,
including the highly conserved lysine 234, which is essential for ATP binding. Stowers et
al. proposed that Eip63E81 is a null (Stowers et al., 2000). However, it is more likely to
be a dominant negative since this truncated Eip63E may maintain its ability to interact
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Table 4-2. Embryo hatching rates of CycY and Eip63E mutants.
Maternal genotype

Paternal genotype

Embryos collected

Hatching rate (%)

CycYE8/+

w1118

906

98

CycYDf6030/+

w1118

721

99

Eip63E81/+

w1118

2273

73

Eip63EDf6096/+

w1118

771

98

CycYE8/+; Eip63E81/+

w1118

2519

74

CycYDf6030/+; Eip63EDf6096/+

w1118

1184

98

CycYDf6030/+; Eip63EDf6095/+

w1118

1030

99

CycYDf6030/+

CycYE8/+

772

98

Eip63E81/+

Eip63EDf6096/+

1178

75

CycYE8/+; Eip63E81/+

CycYDf6030/+; Eip63EDf6095/+

3127

78

CycYE8/+; Eip63E81/+

CycYDf6030/+; Eip63EDf6096/+

1888

78
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with the cyclin binding partner, even though it has lost its kinase activity. This may
cause the different behaviors of Eip63E81 and the deficiency. It is also possible that
there is a second site mutation on the Eip63E81 chromosome that contributes to or
causes the hatching defect. Although these results did not provide further evidence to
support the idea that CycY and Eip63E function together, the failure to detect a genetic
interaction does not weaken the hypothesis. For interaction partners, lowering the
dosage of the two proteins simultaneously may not enhance the phenotype associated
with either single mutant. It is also possible that CycY and Eip63E function together only
in specific tissues or at specific developmental times, one of which may not be
embryogenesis. Thus, other phenotypic assays, perhaps using other alleles, may yet
reveal genetic interactions between CycY and Eip63E.

4.3.2 CycYE8 mutants show delayed glue extrusion from salivary glands
Homozygous CycY mutants are lethal and have major developmental defects
during metamorphosis, a process tightly regulated by ecdysone. This combined with the
fact that at least one of the Eip63E transcripts is induced by ecdysone led me to
hypothesize that CycY/Eip63E are involved in the ecdysone signaling or response
pathways. To search for processes that CycY may regulate I considered ecdysoneregulated processes that are required for normal metamorphosis. One such process is
synthesis of glue mixture. Glue mixture is a substance secreted by salivary glands prior
to pupariation and serves to help attach the pupae to a dry surface. It is composed of
several glycoproteins, one of which is sgs3. Sgs3 is expressed during the second half of
third instar larval development only in the salivary glands. A few hours before
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pupariation, sgs3 starts to be secreted to the salivary ducts and lumen and at puparium
formation it is expelled from the salivary gland. This series of responses is under the
regulation of ecdysone. A convenient tool for monitoring glue synthesis, secretion, and
extrusion is a transgene, sgs3-GFP, which has an identical expression pattern as the
endogenous sgs3 (Biyasheva et al., 2001). I examined sgs3-GFP activity in CycY
mutants. Homozygous CycYE8 mutants showed normal glue synthesis and secretion
compared to the heterozygous control (Figure 4-1 C-D compared to A-B). However, it
took the mutants longer to expel the glue proteins to the outside of the salivary gland as
visualized by the longer time to keep the GFP signal inside the pupae (Figure 4-1 J-M,
Table 4-3). The failure to expel the secreted glue proteins to the ventral side of the body
surface may be due to neural signal transduction or muscle contraction defects. The
mechanism of how the loss of CycY may lead to delayed glue extrusion still requires
further investigation. However, the identification of a specific biological process in which
CycY is involved, should be useful for further delineation of CycY signaling pathways.
This phenotype can be used to ask specific questions about potential upstream
regulators or downstream targets. For example, from the list of potential genes that
might be responsible for glue extrusion, which genes are misregulated in CycY
mutants? Are they misregulated in Brm mutants too and are they direct targets of Brm
complex?

4.3.3 CycY loss-of-function mutants show normal starvation-induced autophagic
effects during the early L3 stage
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Figure 4-1. CycYE8 mutants show normal glue synthesis and secretion but
delayed glue extrusion from salivary glands. (A-D) Salivary glands from late third
instar larvae were dissected from heterozygous CycYE8 (A and B) or homozygous
CycYE8 (C and D), which also harbored a sgs3-GFP transgene on the third
chromosome. Glue protein was synthesized in the cytoplasm and absent from the nuclei
(A and C) and then secreted to the ducts and lumen in the late third instar larvae (B and
D). The glue protein-free layer of cells surrounding the lumen filled with green glue
proteins is weakly visible. (E-N) Glue protein was directly visualized from synchronized
prepupae at 0h (E, J), 0.5h (F, K), 1h (G, L), 1.5h (H, M), and 2h (I, N) in heterozygous
CycYE8/CyO [y+] (E-I) or homozygous CycYE8 (J-N), which also harbored a sgs3-GFP
transgene on the third chromosome.
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Table 4-3. Glue protein extrusion is delayed in CycYE8 mutants

Genotypes

Total
pupae

Groupsa (%)
1

2

3

4

5

y1w*; CyO [y+]/Sp; sgs3-GFP

25

64

16

4

8

8

y1w*; CycYE8/CyO [y+]; sgs3-GFP

46

77

9

5

0

9

y1w*; CycYE8; sgs3-GFP

42

0

0

3

3

94

a

Group 1, GFP signal almost lost at the time of puparium formation; group 2, only weak

GFP signal at the time of puparium formation; group 3, medium levels of GFP signal at
the time of puparium formation; group 4, strong GFP signal at the time of puparium
formation, but the signal disappeared in less than 1.5h; group 5, GFP signal persisted
longer than all the above mentioned situations.

151
Autophagy is a lysosome-mediated process of bulk cytoplasmic degradation
through which long-lived proteins, organelles, and other components of the cytoplasm
are engulfed within autophagosomes, the hallmark of autophagic cell death. In contrast
to apoptotic cell death, cells that die with an autophagic cell death digest their own
contents without the aid of engulfing phagocytes. Under starvation conditions,
eukaryotic cells recover nutrients via autophagy. In addition to survival of starvation,
autophagy has been implicated in many aspects of health and development, such as
pathogen infection, cancer, and cell growth (Scott et al., 2007). Several lines of
evidence prompted me to hypothesize that CycY is involved in an autophagy signaling
pathway. First, CycY and several autophagy genes have been associated with human
Crohn’s disease, a complex inflammatory disease involving the small intestine affected
by over 30 genetic loci (Barrett et al., 2008). Human CycY (CCNY) and the autophagy
gene, ATG16L1 and IRGM, were identified as susceptibility factors for Crohn’s disease
(Franke et al., 2008; Mizushima et al., 2003; Parkes et al., 2007; Weersma et al., 2009),
suggesting that they may be involved in a common pathway. Second, autophagy is an
important mechanism for eliminating obsolete larval tissues during Drosophila
metamorphosis, a period when CycY is essential. Third, Snr1, a potential target of CycY
(see Chapter 3), promotes the expression of autophagy genes (Zraly et al., 2006). To
test whether CycY is involved in the autophagic response, I dissected well-fed and
starved early L3 larvae of CycYE8 heterozygous and homozygous mutants and stained
the fat body tissue with LysoTracker Red, a lysosome-specific fluorescent dye, to detect
the presence of the autophagic response. As shown in Figure 4-2, in CycYE8
heterozygotes mutants, this response is induced by starvation in the fat body, as
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Figure 4-2. CycY loss-of-function mutants show normal starvation induced
autophagic effects during early L3 stage. Fat bodies from well-fed (A and C) or
starved (B and D) early L3 of CycYE8 heterozygotes (A-B) or homozygotes (C-D) were
stained with LysoTracker (Red) and Hoechst 33342 (Blue). Fat bodies from starved
larvae in both samples show induced autophagy as indicated by the appearance of
lysosome staining.
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expected (Figure 4-2B). Homozygous CycYE8 mutants showed a similar strong
autophagic response under starvation conditions, indicating that CycY is not required for
autophagy, at least not during the early L3 developmental stage (Figure 4-2D). Whether
CycY is required for autophagic response during other developmental stages requires
further investigation.
Autophagy is known to be inhibited by TOR (target of rapamycin) signaling and
Atg5 and TOR double mutants show a strong genetic enhancement of larval growth
defects (Scott et al., 2004). To test whether CycY is involved in the autophagic
response using an independent approach, I generated CycY/Atg1 and CycY/TOR
double mutants to look for genetic interactions. However, I was unable to detect any
genetic interactions between CycY and Atg1 or CycY and TOR. The larval size of
CycY/Atg1 double mutants (CycYE8; Atg1Δ3D) is similar to that of Atg1Δ3D single mutants.
The same is true when comparing the larval size of CycY/TOR double mutants (TORΔ6B;
Tub-Gal4/CycYiC1) to that of TORΔ6B single mutants (see Chapter 3 for details about
CycYiC1, a CycY knockdown transgene). Taken together, I did not detect any genetic
interaction between CycY and Atg1 or TOR as far as the phenotypes I checked.

4.3.4 The CycY expression pattern
Revealing the tissue expression pattern and subcellular localization of the CycY
protein in vivo may provide clues about its biological functions. To this end, I first
generated antibodies directed at a CycY peptide (see Materials and Methods) and
tested the crude serum by western blot and immunostaining. However, the crude serum
turned out to have high background and low sensitivity. Only high levels of exogenous
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expression from a transgene could be detected, but endogenous expression could not
be detected. I then tried affinity purification, but the affinity purified CycY antibody did
not perform better than the crude serum. In short, the CycY antibody generated from
guinea pig with a small peptide as antigen was not useful for this study. A better way to
generate CycY antibodies in the future may be to immunize rabbits with purified MBPnCycY and purify the rabbit serum, which will be available in larger quantities than
serum from a guinea pig, with MBP-nCycY-coupled to beads (e.g., Affi-Gel 15).
To determine the CycY mRNA expression pattern, I tried RNA in situ
hybridization. I synthesized two CycY probes and used them for RNA in situ
hybridization (see Materials and Methods) of wild type and CycYE8 mutant embryos and
imaginal discs. Unfortunately, I did not detect any difference between the staining
patterns in wild type and CycYE8 mutants in either embryos or imaginal discs. This
suggested that the probes do not specifically recognize CycY. Use of additional
nonoverlapping probes in the future may overcome this problem.
An alternative approach to using antibodies to determine protein expression
patterns is to use transgenes that express tagged proteins. Such an approach should
be feasible for CycY. I have generated a CycY genomic transgene that can fully rescue
the CycYE8 null mutant to the adult stage (Chapter 2, section 2.3.3), suggesting that it
may mimic the endogenous CycY function and expression pattern. This CycY genomic
transgene includes the entire CycY gene and putative regulatory regions flanking the
transcript, including sequences 4,032 bp upstream of the CycY start codon, and 1,970
bp downstream of the stop codon, and none of the coding regions of crol or Pde1c
(Chapter 2, section 2.2.2). On the basis of this vector (pCaSpeR2-CycY, Finley lab #
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977), a C-terminal GFP-tagged CycY genomic vector could be generated by regular
molecular cloning approaches. For example, there are two unique restriction enzyme
digestion sites upstream and downstream of the CycY TGA stop codon, AvrII and MfeI
respectively. By regular PCR, three fragments can be amplified, from AvrII to the last
codon of CycY, ORF of GFP tag, and from CycY stop codon TGA to MfeI genomic
region. By including suitable restriction enzyme digestion sites at each end of the PCR
products, these three fragments could be sequentially cloned into a cloning vector. PCR
of the three ligated fragments would generate a fragment that could replace the original
AvrII/MfeI fragment in pCaSpeR2-CycY by gap repair or by restriction digestion and
ligation. In this modified vector, a C-terminal GFP tag would be added just in front of the
CycY TGA stop codon. Transgenic flies could then be generated and used to determine
the spatial, temporal expression pattern, and subcellular localization of CycY by
following GFP fluorescence signal.

4.3.5 Subcellular localization of a complementing myc-CycY fusion protein
Two recent publications about human CycY (CCNY) in cultured cells
independently concluded that the N-terminus of CycY has a myristoylation signal, which
anchors the protein to the cell membrane. Mutation of the putative myristoylation site,
glycine 2, to an alanine abolished membrane localization in cultured cells, as did fusion
to N-terminal tags such as GFP or HA. Forced expression of CycY resulted in
relocalization of GFP-PFTK1 from the cytoplasm to the plasma membrane, indicating
that this cyclin is capable of recruiting the Cdk to the membrane (Davidson et al., 2009;
Jiang et al., 2009). The presence of a myristoylation signal and the localization of CycY
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to the plasma membrane make it likely that CycY functions at least in part by localizing
Cdk activity to the plasma membrane to direct phosphorylation of membrane-associated
substrates. One such substrate identified by Davidson et al is LRP6, a Wnt co-receptor
(Davidson et al., 2009). Their data suggest that phosphorylation of LRP6 by
CycY/PFTK1 primes the subsequent Wnt-dependant phosphorylation and hence
activates the Wnt signaling pathway. They showed that mutation of the myristoylation
signal of CycY decreased the PFTK1-dependent phosphorylation of LRP6. The
potential importance of the membrane localization and myristoylation of CycY function
in human cells raises the question of whether it is also important in Drosophila. Due to
the lack of a good anti-CycY antibody, I tested the subcellular localization of an Nterminally myc-tagged CycY expressed in Drosophila S2R+ cells. Consistent with the
data with human cells, in Drosophila cells CycY with an N-terminal myc tag is mainly
localized in the cytoplasm, as is myc-Eip63E (Figure 4-3). I surmise that the N-terminal
myc tag is blocking membrane localization; however, I have not tried a C-terminally
tagged CycY to verify that the lack of an N-terminal tag would result in membrane
localization. This experiment should be done to see where native CycY localizes. In the
meantime, results with the myc-tagged CycY suggest that membrane localization may
not be very important for in vivo function. Evidence for this comes from
complementation studies I conducted with myc-CycY. I generated transgenic flies
expressing myc-tagged CycY from a cDNA, under control of either UAS or the heat
shock promoter. Myc-CycY expressed from the heat shock promoter or using a
ubiquitous Gal4 driver line rescued CycYE8 null mutants to the adult stage, suggesting
that myc-CycY has no obvious functional defects, at least in Drosophila. Combined with
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Figure 4-3. The subcellular localization of N-terminal myc-tagged CycY and
Eip63E. Drosophila S2R+ cells expressing myc-CycY (A-C) or myc-Eip63E (D-F) were
stained with myc Ab (green, A and D) and DAPI (blue, B and E).
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the fact that N-terminal tags can disrupt membrane localization and we observed no
membrane localization for myc-CycY, these data suggests that membrane anchoring is
not important for CycY function in Drosophila. Alternatively, overexpression of mycCycY in vivo may bypass the requirement for membrane localization. Further analysis of
the requirement for a myristoylation signal in vivo will be required to resolve this
question.
The cytoplasmic localization and full rescue ability of myc-CycY bring up more
interesting questions. Does CycY/Eip63E complex also have an active role in Wg
signaling transduction in Drosophila as in human and Drosophila cells? Is the
membrane localization of CycY essential to fulfill this function in Drosophila? How does
loss of CycY in vivo influence Wg signaling? If the membrane-anchored CycY is
essential for Wg signaling transduction, then can we explain the full rescue ability of
myc-CycY? One possibility is that a small amount of myc-CycY is anchored to the
membrane and this is sufficient for LRP6 phosphorylation and Wg pathway function in
vivo. Another possibility is that there are other redundant cyclins to replace CycY at
least for phosphorylation of arrow/LRP6 or that this phosphorylation can be fulfilled by
other known arrow/LRP6 kinase, sgg/GSK3, in vivo. Finally, it is possible that
arrow/LRP6 phosphorylation by a CycY kinase is only one of several CycY functions
and that it is not essential for viability. To distinguish these possibilities and to gain a
better understanding of the importance of membrane localization for in vivo CycY
function, the generation of CycYM2A mutant transgenic flies seems necessary.
It is interesting to note that the N-terminally truncated isoform of human CycY,
which lacks the myristoylation signal, has been shown to be predominantly localized in
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the nucleus. It has also been shown to activate the transcriptional activities of c-Myc (Li
et al., 2009), which is one of the downstream regulatory targets of Wnt/β-catenin
signaling (He et al., 1998). Does this suggest that the short isoform of CycY, which is
not a membrane anchored protein, also regulates Wnt signaling by phosphorylating
LRP6? Alternatively, it is possible that the short isoform of CycY functions in the nucleus
to modulate the transcriptional activities of myc.

4.3.6 The CycY/Eip63E complexes expressed in Drosophila cells is unable to
phosphorylate Snr1 in vitro
Since Snr1 physically interacts with CycY in vitro and the molecular function of
the cyclin/Cdk complexes is to phosphorylate downstream targets, a simple hypothesis
to explain the genetic interaction between CycY and the Brm complex is that Snr1 is the
substrate of CycY/Eip63E. To test this hypothesis, I expressed and purified MBP-Snr1,
MBP-Snr1 T102A, MBP-Snr1 T198A, and MBP-Snr1 T102/198A fusion proteins from
E.coli and used them as substrates for in vitro kinase assays using CycY/Eip63E
expressed in Drosophila S2R+ cells. I expressed myc-tagged CycY, Eip63E, or both
and various controls, then affinity purified the tagged fusion proteins and used them for
in vitro kinase assays as previously described (Kolonin and Finley, 2000) (Guest et al. in
prep.). The results provided no evidence for specific phosphorylation of Snr1 by
CycY/Eip63E (Figure 4-4). Although MBP-Snr1 appeared to be more strongly
phosphorylated by purified myc-Eip63E than by the control (lane 2 vs. lane 9), the signal
was the same with the myc-Eip63E kinase-dead mutant (lane 2 vs. lane 4). Moreover,
Snr1 phosphorylation was not strengthened in the presence of CycY (lane 2 vs. lane 6).
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Figure 4-4. The CycY/Eip63E complex is unable to phosphorylate Snr1 in vitro.
Drosophila S2R+ cells were cotransfected with the indicated constructs and lysed for
pull down with myc antibody. γ32P [ATP] was added along with maltose binding protein
(MBP) fusion proteins purified from E.coli expression as indicated to each
immunoprecipitate as in vitro substrates. Both lane 8 and 9 are negative controls. Lane
8 had no immunoprecipitate, while lane 9 had anti-myc immunoprecipitate from
untransfected cells.
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These results indicate that MBP-Snr1 is weakly phosphorylated by a kinase that coimmunoprecipitates with myc-Eip63E. The relatively weak phosphorylation signal from
MBP-Snr1 T102/198A suggests that threonine 102 or 198 are among the
phosphorylation sites (lane 6 vs. lane 7).
One possible explanation for our failure to detect Snr1 phosphorylation by
CycY/Eip63E is that some coactivators of the Eip63E kinase may be missing from the
cultured cells or the immunoprecipitates. For example PIF-1B is an Eip63E-interacting
protein that has been proposed to counter the inhibitory effect of the long N-terminal
extension of Eip63E (Rascle et al., 2003). We do not know whether PIF-1B is expressed
in the S2R+ cells. Another possible explanation for the kinase assay results is that Snr1
may not be a direct substrate of CycY/Eip63E and may function as a bridge to bring
CycY/Eip63E to the vicinity of the Brm multi-protein complex to phosphorylate other
components. The possible CycY-dependent phosphorylation of other components in the
Brm complex should be tested in the future.

4.3.7 CycYE8 null mutant clones do not show defective cell growth or proliferation
in third instar larvae imaginal discs and fat bodies compared to wild type sister
clones
Genetic mosaic techniques provide a way to examine a lethal homozygous
mutation in just a subset of cells in vivo. To look for developmental defects associated
with loss of CycY from sets of cells, I generated CycYE8 null clones either specifically in
the eye with ey-FLP or in all developing tissues with hs-FLP by FRT-mediated mitotic
recombination (Xu and Rubin, 1993). Consistent with the normal eye of CycYE8 adult
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escapers or pharate adults (Liu and Finley Jr, 2010), the eye of the adults with CycYE8
null clones also look normal (data not shown). To check the CycYE8 null clones induced
by ubiquitous FLP, third instar larvae with yellow mouth hooks (y1w* hs-FLP; CycYE8
FRT40A/Ubi-GFP FRT40A) were dissected. The GFP+ cells (CycYE8/Ubi-GFP or UbiGFP/Ubi-GFP) and the GFP- cells (CycYE8) from the imaginal discs and fat bodies were
compared. Surprisingly, I did not find any defective cell growth or proliferation when
comparing the size of CycYE8 null clones with sister twin clones or the individual cell
size of CycYE8 null and wild type (Figure 4-5 A-R). In addition, after staining for
phosphorylated histone H3 (PH3) to visualize cells undergoing mitosis, I observed no
obvious difference between wild type and CycYE8 null clones (Figure 4-5 S-U). I also did
not detect any adult morphological defects. These results are unexpected and hard to
explain considering that zygotic CycYE8 null mutants had delayed larval growth (delayed
13 hours compared with the heterozygous control animals), small sized pupae (90%
compared with the heterozygous control), and pupal lethality (Chapter 2, section 2.3.3).
One possible explanation is that both the delayed larval growth and the decreased
pupal size phenotypes are not very strong, therefore the mild difference between
CycYE8 null clones and wild-type sister twin clones is not easily appreciated. Another
possibility is that these CycYE8 null clones were formed during larval development and
the CycY proteins synthesized before the null clone formation lasted long enough
beyond the identification of any visible effect.
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Figure 4-5. CycYE8 null mutant clones do not show defective cell growth or proliferation in third
instar larvae imaginal discs and fat bodies. Third instar larvae with yellow mouth hooks (y1w* hs-FLP;
CycYE8 FRT40A/Ubi-GFP FRT40A) were dissected and stained with DAPI (blue). CycYE8 null clones are
GFP negative. Representative wing imaginal discs (A-I, S-U), eye imaginal disc (J-L), and fat bodies (MR) are shown. White dotted line circles the CycYE8 null clones in the wing imaginal disc (S-U). The
existence of CycYE8 null clones suggests that absence of CycY is not cell lethal.
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4.4 Conclusions
In this chapter, I showed that CycY does not genetically modify the hatching rate
defect associated with Eip63E81 allele, which neither supports nor weakens my
hypothesis that CycY and Eip63E form an in vivo cyclin Cdk pair. I also showed that
CycY null mutants display normal starvation induced autophagic effects during the early
third instar larval stage. Mosaic analysis of CycY null clones did not reveal any defective
cell growth or proliferation in third instar larvae imaginal discs and fat bodies compared
to wild type sister clones. Interestingly the process of glue extrusion, which is regulated
by ecdysone, is misregulated in the CycY mutant. This developmental process could be
used in the future to help elucidate the signaling pathways to which CycY belongs. Due
our failure to generate high-quality CycY antibodies and to the non-specific RNA in situ
hybridization, I was unable to determine the endogenous CycY protein or mRNA
localization. However, consistent with studies with human cells, I showed that CycY with
an N-terminal myc tag is mainly localized in the cytoplasm. Intriguingly, this version of
CycY successfully rescued the CycYE8 null mutant to the adult stage, raising the
questions of the importance of the membrane localization of CycY and of its role in Wg
signaling in vivo. Finally, in vitro kinase assays suggest that Snr1 may not be a direct
phosphorylation target of the CycY/Eip63E complex. This result suggests that Snr1 may
function as a bridge to bring CycY/Eip63E to the vicinity of the Brm complex to
phosphorylate other components and therefore regulate the Brm complex activity.
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CHAPTER 5

CONCLUSIONS AND FUTURE DIRECTIONS

5.1 CONCLUSIONS
In this dissertation, I described the characterization of a novel conserved cyclin
CG14939 (CycY) in Drosophila. I generated the first mutant animal model for this gene
as well as transgenic RNAi strains that can be used to specifically knock down the
expression of CycY in a temporally and spatially controlled manner. I provided multiple
lines of evidence showing that the Cdk partner of CycY is Eip63E (Cdk14). I also
showed that CycY is an essential gene that is required from oogenesis to adult viability.
Finally, I demonstrated the physical and genetic interaction between CycY and
components of Brm complexes from several different aspects. Here I summarize some
of the major findings and implications.

5.1.1 CycYE8 is a null mutant allele of CycY
Using P-element imprecise excision, I created a CycY null mutant allele, CycYE8,
which lacks all CycY coding sequences. Multiple lines of evidence indicate that CycY is
the only gene affected in strain CycYE8. First, the two neighboring genes, crol and
Pde1c, are expressed in homozygous CycYE8 larvae, in contrast to CycY. Second,
CycYE8 and crol04418, a lethal null allele of the neighboring gene, mutually
complemented the mutant phenotypes of each other, suggesting that crol is fully
functional in CycYE8. Third, transheterozygous mutants of CycYE8 over a deficiency
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strain that lacks CycY (Df(2L)Exel6030), display similar developmental defects to the
homozygous CycYE8 mutants. Fourth and definitively, a CycY genomic transgene or
ubiquitous expression of a CycY cDNA can substantially rescue most of the
abnormalities that I observed in homozygous CycYE8 mutants, including the delayed
larval growth, defects during metamorphosis, and adult viability. However, I have not yet
tested whether the CycYE8 oogenesis defect and embryonic lethality can be rescued
with CycY transgene, so it is formally possible that a second site mutation may partially
or fully contribute to these. A rescue experiment using the maternal and zygotic CycYE8
null mutants will be necessary for any future study of the early developmental
requirement of CycY. The CycYE8 mutant strain provides a powerful tool for further
functional characterization of CycY in Drosophila.

5.1.2 CycYiC can be used to specifically knock down the expression of CycY
In this project, I generated multiple transgenic fly strains for each of two nonoverlapping RNAi constructs, CycYiN and CycYiC. Multiple lines of evidence suggest
that CycYiC can be used to specifically knock down the expression of CycY. Expression
of CycYiC with the en-Gal4 driver led to decreased wing size in the posterior
compartment where CycY expression is reduced compared with the anterior region with
wild-type CycY expression. This decreased wing size phenotype can be partially
rescued by expression of a CycY cDNA, suggesting that the observed phenotype was
due to decreased expression of CycY and not an off-target effect. Expression of CycYiC
with the 69B-Gal4 driver induced extra wing vein tissue, which can be fully rescued by
expression of a CycY cDNA, again indicating a CycY-specific knockdown effect. A final
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piece of evidence for the specific knockdown ability of CycYiC comes from the genetic
interaction data. Using the 69B-Gal4 driver to knock down Brm resulted in no obvious
defects. However, combining Brm knockdown with either CycYiC or the removal of one
copy of wild-type CycY led to a novel wing phenotype, suggesting not only a genetic
interaction between Brm and CycY, but also the specificity of the CycY knockdown.
Combined, these results suggest that CycYiC specifically knocks down the expression of
CycY. The fly strains harboring the CycYiC transgene will be very useful in future studies
to test for tissue specific requirements of CycY and to help identify the signaling
pathways to which CycY may belong. For each new phenotype detected with CycYiC, a
test for specificity should be conducted. For example, the CycYiC phenotype should be
tested to see if it is enhanced by CycYE8 or suppressed by a CycY cDNA.

5.1.3 The Cdk partner of CycY is Eip63E/PFTK1/Cdk14
A potential Cdk partner for CycY was first identified in a large-scale yeast twohybrid screen with Drosophila proteins (Stanyon et al., 2004). The identified kinase was
Eip63E, which previously had no known cyclin partner (Rascle et al., 2003; Stowers et
al., 2000). I demonstrated that CycY and Eip63E specifically interact when expressed
with N-terminal affinity tags in Drosophila S2R+ cells. However, due to the lack of
antibodies to either CycY or Eip63E, I was unable to perform in vivo pull-down assays to
test whether they are bona fide in vivo partners. Nevertheless, several additional lines of
evidence support this conclusion. If Eip63E and CycY form a functional Cdk/cyclin
complex in vivo, we might expect their mutant phenotypes to be similar. Therefore I
performed a detailed side-by-side phenotypic characterization of CycY and Eip63E null
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mutants and showed that they are strikingly similar. Further supporting evidence that
CycY regulates Eip63E comes from studies in human cells. The human ortholog of
Eip63E is PFTK1. Two recent publications about human CycY (CCNY) in cultured cells
independently demonstrated the PFTK1/CycY interaction by co-AP assays and showed
that membrane-anchored CycY recruits cytoplasmic PFTK1 to the membrane (Davidson
et al., 2009; Jiang et al., 2009). Davidson et al further showed that Wnt co-receptor
LRP6 is a membrane-associated phosphorylation target of the CycY/PFTK1 complex
(Davidson et al., 2009).
An additional argument for the Cdk14/CycY partnership comes from examination
of sequence conservation. Cyclin proteins are present in non-metazoans but they do not
share any extensive sequence similarity to CycY. Some of the non-metazoan cyclin
proteins, however, do possess a CycY-specific cyclin box (Liu and Finley Jr, 2010). This
domain is similar to the CDK-binding domain in other cyclins but it appears to have
emerged in a common ancestor of plants and animals. The Y–type cyclin box in yeast
or plant cyclins, for example, is more similar to the same domain in human and
Drosophila CycY than to the other yeast or plant cyclin boxes, suggesting that this
domain is ancient and has been conserved independently of the other cyclins over 500
million years of evolution. A specific example of this conservation can be seen in the
yeast cyclin PCL1. This protein is the reciprocal best-matched protein for both human
and Drosophila CycY; this means that PCL1 is the yeast protein most similar to human
or Drosophila CycY, which are in turn the human and Drosophila proteins most similar
to PCL1. Essentially all of this sequence similarity resides in the CycY-specific cyclin
box. The Cdk partner for PCL1 is Pho85, which has a number of cyclin regulators and
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plays diverse roles in yeast (Huang et al., 2007). In the context of establishing the Cdk
partner for CycY, it is interesting to note that the reciprocal best-matched protein for
Pho85 in human and Drosophila is PFTK1 and Eip63E, respectively. This raises the
intriguing possibility that this particular cyclin-Cdk interaction is ancient and may have
novel properties that distinguish it from other cyclin-Cdk pairs. Taken together, these
data suggest that CycY and Cdk14 constitute a conserved cyclin-Cdk pair.

5.1.4 CycY is required from oogenesis to adult life
A thorough characterization of CycYE8 null mutant phenotypes revealed that
CycY plays an essential role during almost all developmental stages. The CycYE8
zygotic null mutant is lethal with most mutant animals arresting during pupal
development. The mutant exhibited delayed larval growth and major developmental
defects during metamorphosis, including impaired gas bubble translocation, head
eversion, leg elongation, and adult tissue growth. Heat-shock-induced expression of
CycY at different times during development resulted in variable levels of rescue, the
timing of which suggests a key function for zygotic CycY during the transition from third
instar larvae to prepupae. I further took advantage of the availability of the heat-shock
rescued CycYE8 mutant adults and found that CycY is required for adult longevity,
especially in males. Using the ovoD1 dominant female sterile technique, I revealed that
maternal CycY also plays a role during oogenesis and is required for embryogenesis;
interestingly, this role can be accomplished at least to a limited extent by zygotic
expression.
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By testing the tissue specific knockdown of CycY and genetic interaction
between CycY and Brm complex components, I was able to show a few tissue specific
requirements of CycY. Knockdown of CycY with en-Gal4 and 69B-Gal4 drivers revealed
that CycY is involved in wing growth and wing vein development. Removal of one copy
of CycY enhanced the abdominal dorsal midline fusion defect associated with Snr1
mutants, suggesting a role of CycY in the development of the integument of the adult
abdomen. The identification of the tissue- and developmental stage-specific
requirements of CycY provides a platform through which the biological functions of
CycY can be further elucidated.

5.1.5 CycY genetically and physically interacts with components of the Brm
complex and is involved in regulation of Brm complex target genes
To gain insight into the cellular functions of CycY and to identify the signaling
pathways to which CycY belongs, I began by examining the available protein interaction
data for CycY and Cdk14. Among all the identified and predicted physical interactors,
Snr1 shares similar developmental requirements and expression profiles with CycY. To
test whether CycY and Snr1 belong to a common signaling pathway, I first confirmed
the physical interaction between CycY and Snr1 by co-AP assay from cultured cells. I
further showed that CycY and two Brm complex components, Snr1 and Brm, genetically
interact during multiple developmental processes. For example, removal of one copy of
CycY enhances the adult longevity and dorsal midline fusion defects induced by
expression of truncated Snr1 in the heterozygous Snr1 null background. Knockdown of
CycY in the wing enhances the extra wing vein phenotype induced by Snr1 knockdown,
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as well as the wing phenotype induced by Brm knockdown or overexpression of a Brm
dominant negative mutant. The genetic interaction between CycY and members of the
Brm complex, combined with the physical interaction between CycY and Snr1, suggests
that CycY may promote Snr1 functions in the Brm complex to regulate gene expression
in a cell-type specific manner. The examination of gene expression of a group of Brm
complex targets, the Eig71E genes, however, suggested that CycY and Snr1 may also
regulate gene expression differentially in a temporal-specific manner. This led to a
model in which CycY promotes the activity of Snr1, which can either activate or repress
transcription of specific genes depending on the time and tissue (Fig. 3-10).
This is the first identification of a signaling pathway in which CycY may be
involved in Drosophila. It helps explain some of the developmental defects that CycY
null mutants displayed. However, whether the genetic interactions I observed are due to
direct regulation of Brm complex activity by CycY or due to a function of CycY in a
parallel signaling pathway is still unclear. My hypothesis is based on the assumption
that CycY physically interacts with Snr1. However, I was unable to test this putative
interaction in vivo due to lack of antibodies. Furthermore, I failed to show that Snr1 is a
direct phosphorylation target of CycY/Cdk14 complex in vitro. The identification of the
involvement of CycY in Wnt signaling in cultured human and Drosophila cells also
suggested another way to interpret the genetic interaction between CycY and Snr1/Brm
(see section 5.2.1). Testing for in vivo interactions between CycY and other Brm
complex components may help clarify these issues.

5.1.6 Model for CycY function
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Based on data from this study and from others, I propose the following model for
CycY functions (Figure 5-1). CycY may have different subcellular localizations that
recruit Cdk14 to the vicinity of different substrates. Cytoplasmic or nuclear CycY/Cdk14
complexes may phosphorylate Snr1 or other components of the Brm complex to
regulate genes required at many developmental stages, including metamorphosis.
Membrane-anchored CycY may recruit Cdk14 to phosphorylate membrane substrates,
such as the Wg co-receptor Arrow. The phosphorylation of Arrow activates Wg
signaling, which in turn regulates cell proliferation, differentiation, and pattern formation
in a variety of developmental contexts. Although each of the two putative CycY/Cdk14
substrates, Brm complex components and Arrow, could help explain some of the
phenotypes of CycY mutants, neither of them has been confirmed to be a bona fide in
vivo substrate. Even the partnership of CycY and Cdk14 has not been definitively
determined in vivo. Thus further studies to identify the precise in vivo Cdk binding
partner and substrates are required.
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Figure 5-1. Model for CycY function. CycY may have different subcellular
localizations that recruit Cdk14 to the vicinity of different substrates. Cytoplasmic or
nuclear CycY/Cdk14 complexes may phosphorylate Snr1 or other components of the
Brm complex to regulate genes required at many developmental stages. The regulation
of Eig71E genes, for example, may partially contribute to the regulation of
metamorphosis. CycY can also be tethered to the plasma membrane (PM) via an Nterminal myristoylation signal. CycY recruits Cdk14 to the membrane where it
phosphorylates the Wg co-receptor, Arrow, primarily during G2/M phase of the cell
cycle. The phosphorylation of Arrow activates Wg signaling, which in turn regulates cell
proliferation, differentiation, and pattern formation in a variety of developmental
contexts. The Brm complex has been directly linked with Wg signaling through inhibition
the expression of Wg targets. Other substrates and roles for CycY/Cdk14 have yet to be
identified.
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5.2 FUTURE DIRECTIONS
Data presented in this dissertation represent an initial functional characterization
of CycY. Many interesting CycY mutant defects were identified and described. The
potential Cdk interacting partner and potential downstream regulatory targets were also
revealed. However, the molecular mechanisms behind the role of CycY during these
developmental processes are still to be elucidated. The following questions must be
addressed to gain a better understanding of CycY functions.

5.2.1 Does CycY/Eip63E play a role in Wg signaling in Drosophila?
It has been reported recently that in both human and Drosophila cultured cells,
membrane-anchored CycY recruits its Cdk partner, Cdk14, to the cell membrane to
phosphorylate a membrane substrate, the Wnt/Wg co-receptor LRP6/Arrow. This was
proposed to prime subsequent phosphorylation of LRP6 by CK1γ and thereby activate
canonical Wnt signaling (Davidson et al., 2009; Jiang et al., 2009). However, this
pathway has not been tested in vivo in Drosophila. Moreover, the phenotypes of CycY
mutants are not typical of Wg pathway mutants. In Chapter 2 and Chapter 3, I showed
that CycY is required for embryogenesis, larval growth, metamorphosis, and adult
viability. Thus, it seems likely that at least some of the CycY phenotypes are due to
defects in signaling pathways that are independent of Wg signals.
Further genetic analysis will be necessary to test whether CycY/Eip63E is
involved in Wg signaling in vivo. The tools generated in this study will be useful for this
genetic analysis. For example, a well-known defect of Wg signaling pathway mutants is
disrupted segmental patterning. The Drosophila embryonic ventral epidermis is
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composed of two types of epidermal cells, denticle-secreting cells, which create short,
thick hair-like structures, and smooth cuticle-secreting cells. Denticle-secreting cells
form segmentally repeated belts separated by smooth-cuticle belts, the pattern of which
is determined by the activation of several signaling pathways during embryogenesis,
including Wg, Hedgehog, EGF, and Notch signaling pathways (Alexandre et al., 1999;
Gritzan et al., 1999). Wg signaling is active in smooth cuticle-secreting cells, while
inactive in denticle-secreting cells. Therefore, mutants of positive regulators of Wg
signaling, such as arrow, wls, and Wg, show ectopic denticles, while mutants of
negative regulators, such as bili and sgg, show ectopic smooth cuticles (Banziger et al.,
2006; Bejsovec and Wieschaus, 1993; Kategaya et al., 2009; Siegfried et al., 1992;
Wehrli et al., 2000). Analyzing the ventral cuticle patterning, therefore, is a useful way to
detect defects in Wg signaling (Alexandre, 2007). I have shown that a maternal and
zygotic null of CycYE8 is embryonic lethal. However, no further analysis has been
performed. The cuticle patterning deserves to be carefully examined in the future to see
if CycY mutants display defects associated with disrupted Wg signaling.
Another major morphological defect in mutants of Wg pathway components is the
loss of wing or wing margin. For example, blocking Wg signaling at the wing margin by
expressing a constitutively active form of Sgg causes a loss of the wing margin tissue
(Collins and Treisman, 2000). Knocking down Wg or wls by dsRNA expressed under
en-Gal4 control induces the loss of wing margin specifically in the posterior
compartment of the wing (Boutros and Ahringer, 2008). Knockdown of CycY by enGal4/RNAi, however, led to decreased wing size in the posterior region without
generating a wing margin defect. This suggests that CycY has functions beyond Wg
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signaling, even if it does regulate Wg signaling in some tissues. Further testing for
genetic interactions between CycY and Wg signaling mutants should help establish
whether and to what extent CycY plays a role in Wg signaling.
I have shown that CycY genetically interacts with the Brm complex components,
Snr1 and Brm. Interestingly, the Brm complex has been found to inhibit the expression
of Wg targets (Collins and Treisman, 2000). This situation makes the interpretation of
the genetic interactions between CycY, the Brm complex, and potential Wg pathway
components difficult. The genetic interaction between CycY and the Brm complex, for
example, could be explained by the action of CycY on the Brm complex or on the Wg
pathway, or both. To distinguish these possibilities, the epistatic relationship between
CycY, the Brm complex, and Wg targets should be investigated. If CycY functions in Wg
signaling to regulate Wg target expression, it should be upstream of the Wg pathway
transcription factor, β-catenin/Arm. If CycY functions through the Brm complex to
indirectly regulate Wg target genes, it should be downstream of Arm. One can test the
expression of Arm protein and Arm target genes, such as dll by utilizing a dll-LacZ fly
strain, in CycY mutant to determine the epistatic relationship between them.

5.2.2 What is the significance of the myristoylation signal and presumptive
membrane localization to CycY function?
Human CycY has been reported to have two isoforms, one with and one without
the N-terminal myristoylation signal, which is required to anchor CycY to the cell
membrane (Jiang et al., 2009; Li et al., 2009). The subcellular localization of
endogenous Drosophila CycY has not been tested either in vitro or in vivo, although the
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myristoylation signal does exist. Whether there is a non-membrane anchored isoform of
Drosophila CycY has not been determined. To identify the existence of other isoforms of
CycY, it will be useful to perform a Northern blot with a probe that recognizes the 3’ end
of the CycY transcript. To test the subcellular localization of CycY in vivo, I have
suggested in Chapter 4 (section 4.3.4) generation of transgenic flies with a CycY
genomic transgene, into which a C-terminal GFP or myc tag should be inserted. The
reason that a C-terminal tag must be used is that N-terminal tags block the
myristoylation signal and the membrane localization in human CCNY. To test
localization in vitro, similarly, CycY cDNA should be cloned into a cell culture expression
vector with a C-terminal tag, for example pMK33-CTAP (Finley lab # 840).
The N-terminal myristoylation signal of CycY has been shown to be crucial for
recruiting Cdk14 to the membrane to phosphorylate LRP6 and activate Wnt signaling
(Davidson et al., 2009). Is the membrane localization essential for all or part of the CycY
functions in Drosophila? At this point, we do not know the subcellular localization of
endogenous CycY, but consistent with data from human cells, an N-terminally tagged
CycY localizes primarily to the cytoplasm. Interestingly, this form of CycY (myc-CycY)
can successfully rescue the CycYE8 null mutant into the adult stage. This would seem to
suggest that membrane localization and arrow phosphorylation are not necessary for
CycY function in vivo. However, it is possible that a small fraction of myc-CycY spends
some time attached to the membrane to recruit Cdk14 and phosphorylate arrow. It is
also possible that the sgg kinase is sufficient to phosphorylate arrow in the absence of
membrane-anchored CycY. To distinguish between these possibilities, I suggest
generating transgenic flies that harbor genes to express either truncated CycY, which
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lacks the N-terminal myristoylation signal, or a mutated CycY, CycYM2A, that should not
localize to the membrane, and to test how well these flies rescue the CycYE8 null
mutants. Such transgenic flies could also be used in genetic interaction assays with Wg
pathway mutants to gain further insight into the relationship between CycY, membrane
localization, and the Wg pathway.

5.2.3 Is CycY involved in the chromatin modification mediated by the Brm
complex?
In this project, I identified genetic interactions suggesting that CycY and
components of the Brm chromatin-remodeling complex function together to regulate
multiple developmental processes. However, the molecular mechanisms that account
for these interactions are still unknown. The physical interaction between CycY and
Snr1 prompted me to hypothesize that CycY, together with its Cdk partner Cdk14, may
phosphorylate Snr1 or other components of the Brm complex to regulate the activity of
ATP-dependent chromatin remodeling. Several experiments could be used to test this
hypothesis. First, one could test whether CycY interacts with other components of the
Brm complex by Y2H or co-AP assays from fly cells. Ideally any interactions detected
should be confirmed in vivo by pull-down assays; however, this will require antibodies
against CycY and Brm complex components. Second, it would be helpful in
understanding the function of the CycY-Snr1 interaction if one could refine the physical
interaction between them. A mutagenic PCR approach could be used to identify a CycY
mutant unable to interact with Snr1, but still able to interact with Eip63E. This mutant
form of CycY could then be used to test how well it mimics wild type CycY. Third, it
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would be useful to establish an in vitro assay system to test the influence of CycY on
transcription of Brm complex targets. For example, stg transcription is directly regulated
by the Brm complex in Drosophila S2 cells. Several questions should be addressed. For
instance, how is the transcription of stg regulated in the absence of CycY? Does the
Brm complex still bind to the stg promoter in the absence of CycY? These questions
can be answered by doing RT-qPCR of stg and ChIP with Brm Ab.

5.2.4 What other signaling pathways is CycY/Cdk14 complex involved in?
The work described in this dissertation and from another group suggested that
CycY may be involved in Brm-mediated chromatin remodeling (Chapter 3) and Wg
signaling (Davidson et al., 2009). Considering the limited number of cellular kinases and
the huge number of phosphorylation events in cells (de la Fuente van Bentem et al.,
2008), I hypothesis that CycY may be involved in other signaling pathways by
phosphorylating other substrates. I base this hypothesis in part on the fact that CycY is
required for a broad range of developmental processes that appears to exceed the
range of processes that requires Wg and Brm complex. This hypothesis could be tested
in several ways. One could identify other CycY interaction partners by TAP purification
and LC-MS/MS by using Drosophila cell lines or transgenic flies that stably express Cterminally TAP-tagged CycY. In addition, it would be very informative if one could
identify in vivo CycY-dependant phosphorylation targets on a proteome-wide scale by
quantitative MS (Smolka et al., 2005).

5.2.5 Implications for understanding human diseases
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It is intriguing that CycY has been connected with several intestine-related
human diseases. Recently, CCNY was identified as a potential susceptibility factor for
inflammatory bowel disease (IBD), a complicated genetic disorder affecting the
intestinal mucosa. A single nucleotide polymorphism (SNP) located in an intron of
CCNY was found to be strongly associated with the two IBD subphenotypes, Crohn’s
disease and ulcerative colitis (Franke et al., 2008; Weersma et al., 2009). Another study
found that human CycY is significantly upregulated in metastatic colorectal cancer cells
(Ying-Tao et al., 2005). Davidson et al recently found that CycY binds to and activates
Cdk14 to phosphorylate Wg/Wnt co-receptor LRP6/Arrow to activate Wg/Wnt signaling
(Davidson et al., 2009). Interestingly, adenomatous polyposis coli (APC), a component
of Wnt signaling pathway, is a tumor suppressor gene, which encodes a cytoplasmic
protein that can bind to and promote the degradation of β-catenin. APC mutation is a
common initiating factor in most human colorectal tumors (Kinzler and Vogelstein, 1996).
Although CycY has been implicated in these human diseases, it is still unclear how
CycY is involved. The generation of CycY null and tissue-specific knockdown animal
models described in this dissertation provides valuable tools that may help us to further
understand CycY’s cellular functions and potential roles in these human diseases. For
example, we know that CycY is highly conserved between Drosophila and human, but
we do not know whether they are functionally interchangeable. To test this, one could
generate transgenic flies that harbor human CCNY to see whether CycYE8 null mutant
phenotypes can be rescued. One SNP has been identified in an intron of CCNY in
patients with IBD. However, the molecular consequence of this mutation has not been
determined. Does this have any impact on the transcription or translation of CCNY?
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Once this has been determined, further testing the behavior of CycY null mutant flies
with CCNY mutant transgenes may shed some light on the mechanism of the
inflammatory bowel disease.

This study initiated an interesting discussion about the function of a novel
conserved cyclin, CycY. The more I read, work, write, and think about it, the stronger I
feel that there is much to be elucidated about CycY functions in the future.
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APPENDICES

Appendix A. Fly strains used in the study described in Chapter 2.
Finely Stock center &
lab # numbers

Alias or genotypes

References

352

Bloomington 11374

crol04418

(D'Avino and
Thummel, 1998)

286

Bloomington 4513

Eip63E81

(Stowers et al., 2000)

9

Bloomington 3687

Df(3L)GN50 (Eip63EGN50)

(Stowers et al., 2000)

232

Bloomington 7574

Df(3L)Exel6095 (Eip63EDf6095)

-

606

Bloomington 7575

Df(3L)Exel6096 (Eip63EDf6096)

-

103

Bloomington 3664

P{Δ2-3}

(Robertson et al.,
1988)

422

Bloomington 2121

ovoD1 neoFRT40A

(Chou et al., 1993)

162

Bloomington 5138

Tubulin-Gal4

-

197

Bloomington 7513

Df(2L)Exel6030 (CycYDf6030)

this study

208

Harvard Exelixis
d03228

d03228

this study

355

Bloomington 8403

FRT40A

-

358

Bloomington 1929

hs-FLP

-

12

Bloomington 4533

w; Sco/CyO Act5C-GFP

-

41

-

w; CyO/Sp; TM3 Ser/Sb

VanBerkum’s lab

692

-

w; CycYE8/CyO; TM3 Ser/Sb

this study

693

-

w; CycYE8/CyO, Act5C-GFP

this study

702

-

w; CycYE8 FRT40A/CyO

this study
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Appendix B. Plasmids used or constructed in the study described in Chapter 2.
Plasmids
Finely lab #
289

Plasmids Alias

Source or References

pCaspeR2

(Thummel et al., 1988)

977
339
1006
966

pCaspeR2-CycY
pCaspeR-hs
pCaspeR-hs-CycY
pMT-Gal4

812

pAS1

897
986
985
991
1000
961
1016
903
893
904
894
895
896
898
899
900
901
902
905

pAS1-CycY
pAS1-CycY S389A
pAS1-CycY S388/389A
pAS1-Cyc39 S389E
pAS1-Cyc39 S388E
pAS1-Eip63E

pAS1-β-tubulin
pAS1-GFP
pAS1-Cdk2
pAS1-Cdk4
pAS1-Cdk5
pAS1-koko
pAS1-CycD
pAS1-CycE
pAS1-CycK
pAS1-Dap
pAS1-p35

This study
(Thummel et al., 1988)
This study
(Klueg et al., 2002)
(A. Soans, and R.L.F.,
unpublished)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

pUAST-NTAP
pDL4
pDL4-CycY
pDL4-CycY S388/389A
pDL4-CycY S389A
pDL4-CycY S389E
pDL4-CycY S388E

(Veraksa et al., 2005)
This study
This study
This study
This study
This study
This study

841
844
928
983
984
992
999

pAS1-Eip63E (B1, G243A)
pAS1-Eip63E(B1, K234M)
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933
934
936
937
924
925
926
927
923
938
931
930
929
932
939

pDL4-Eip63E
pDL4-Eip63E G243A
pDL4-Eip63E I249L
pDL4-Eip63E (B1 K234M)
pDL4-Cdc2rk
pDL4-Cdk2
pDL4-Cdk4
pDL4-Cdk5
pDL4-β-tubulin
pDL4-GFP
pDL4-CycK
pDL4-CycD
pDL4-koko
pDL4-Dap
pDL4-p35

This study
This study
This study
This study
This study
This study
This study
S. Guest and H. Zhang
This study
This study
This study
This study
This study
This study
This study

910

pDL2

This study

914
919
911
912
913
915
916
917
918
920
921
922

pDL2-CycY
pDL2-Eip63E (A1)
pDL2-Cdc2rk
pDL2-Cdk2
pDL2-Cdk4
pDL2-Koko
pDL2-Cyclin D
pDL2-Cyclin J
pDL2-Cyclin K
pDL2-Side
pDL2-tinman
pDL2-tintin

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

969
975
979
980

pCeMM-NTAP (GS)
pDL5
pDL5-CycY
pDL5-Snr1

(Burckstummer et al., 2006)
This study
This study
This study
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Appendix C. Transgenic fly strains generated for the study described in Chapter
2.
Finley
lab #

Alias

Genotypes

Plasmids for P-element
transformation

Used in this
study?

636

2T1

UAS-CycY

pAS1-CycY

No

637

2T11

w; UAS-CycY/CyO; TM3 Ser/Sb

pAS1-CycY

No

638

2T35

w; CyO/Sp; UAS-CycY/TM3 Ser

pAS1-CycY

No

639

2T44

w; CyO/Sp; UAS-CycY/TM3 Ser

pAS1-CycY

Yes

640

2T46

w; CyO/Sp; UAS-CycY/TM3 Ser

pAS1-CycY

No

642

2T44H

w; CyO/Sp; UAS-CycY/UAS-CycY

pAS1-CycY

Yes

643

2T46H

w; CyO/Sp; UAS-CycY/UAS-CycY

pAS1-CycY

No

655

3T1

P{CycY}; CyO/Sp; TM3 Ser/Sb

pCaspeR2-CycY

No

656

3T2

P{CycY}; CyO/Sp; TM3 Ser/Sb

pCaspeR2-CycY

No

657

3T11

w; P{CycY}/CyO; TM3 Ser/Sb

pCaspeR2-CycY

No

658

3T12

w; P{CycY}/CyO; TM3 Ser/Sb

pCaspeR2-CycY

No

659

3T13

w; P{CycY}/CyO; TM3 Ser/Sb

pCaspeR2-CycY

No

660

3T21

w; CyO/Sp; P{CycY}/TM3 Ser

pCaspeR2-CycY

Yes

661

3T22

w; CyO/Sp; P{CycY}/TM3 Ser

pCaspeR2-CycY

No

662

3T27

w; CyO/Sp; P{CycY}/TM3 Ser

pCaspeR2-CycY

Yes

663

4T1

hs-CyY; CyO/Sp; TM3 Ser/Sb

pCaspeR-hs-CycY

No

664

4T11

w; hs-CycY/CyO; TM3 Ser/Sb

pCaspeR-hs-CycY

No

665

4T12

w; hs-CycY/CyO; TM3 Ser/Sb

pCaspeR-hs-CycY

No

666

4T13

w; hs-CycY/CyO; TM3 Ser/Sb

pCaspeR-hs-CycY

No

667

4T21

w; CyO/Sp; hs-CycY/TM3 Ser

pCaspeR-hs-CycY

No

668

4T22 (G6.1)

w; CyO/Sp; hs-CycY/TM3 Ser

pCaspeR-hs-CycY

Yes

669

4T23

w; CyO/Sp; hs-CycY/TM3 Ser

pCaspeR-hs-CycY

No

E8

699

E8;G6.1/G6.1

w; CycY /CyO; hs-CycY/hs-CycY

pCaspeR-hs-CycY

Yes

700

E8;G6.1/Ser

w; CycYE8/CyO; hs-CycY/TM3 Ser

pCaspeR-hs-CycY

Yes

670

5T1-1

UAS-Eip63E; CyO/Sp; TM3 Ser/Sb

pAS1-Eip63E

No

671

5T1-2

UAS-Eip63E; CyO/Sp; TM3 Ser/Sb

pAS1-Eip63E

No

672

5T11

w; UAS-Eip63E/CyO; TM3 Ser/Sb

pAS1-Eip63E

No

673

5T12

w; UAS-Eip63E/CyO; TM3 Ser/Sb

pAS1-Eip63E

No

674

5T21

w; CyO/Sp; UAS-Eip63E/TM3 Ser

pAS1-Eip63E

No

675

5T22

w; CyO/Sp; UAS-Eip63E/TM3 Ser

pAS1-Eip63E

No

676

5T23

w; CyO/Sp; UAS-Eip63E/TM3 Ser

pAS1-Eip63E

No

677

5T24

w; CyO/Sp; UAS-Eip63E/TM3 Ser

pAS1-Eip63E

No
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678

6T1

UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

679

6T2

UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

680

6T3

UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

681

6T4

UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

682

6T11

w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

683

6T12

w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

684

6T13

w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

685

6T14

w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

686

6T15

w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb

pAS1-Eip63E (G243A)

No

687

6T21

w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser

pAS1-Eip63E (G243A)

No

688

6T22

w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser

pAS1-Eip63E (G243A)

No

689

6T23

w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser

pAS1-Eip63E (G243A)

No

690

6T24

w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser

pAS1-Eip63E (G243A)

No

691

6T25

w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser

pAS1-Eip63E (G243A)

No
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Appendix D. Primer pairs used to characterize the deletion after P-element mobilization.
Primer pairs

Region to be amplified

DL20/DL17

Span the whole P-element inserted region

DL44/DL17

The right end of the P-element

DL45/DL20

The left end of the P-element

DL83/DL17

CycY gene region

DL78/DL58

CycY gene region

DL77/DL58

CycY gene region

DL77/DL21

CycY gene region

DL78/DL17

CycY gene region

DL83/DL57

CycY gene region

DL72/DL84

Crol gene region

DL74/DL82

Crol gene region

DL56/DL81

Crol gene region

DL73/DL80

Crol gene region

DL55/DL79

Crol gene region

DL96/DL97

Crol gene region

DL96/DL98

Crol gene region

DL98/DL106

Crol gene region

DL107/DL106

Crol gene region

DL107/DL104

Crol gene region

DL93/DL95

Pde1c gene region

DL94/DL95

Pde1c gene region

DL75/DL59

Pde1c gene region

DL72/DL57

Crol and CycY gene region

DL72/DL58

Crol and CycY gene region

DL20/DL58

Crol and CycY gene region

DL99/DL101

Intergene between CycY and Pde1c

DL100/DL103

Intergene between CycY and Pde1c

DL76/DL21

Intergene between CycY and Pde1c

DL72/DL59

Crol, CycY, and Pde1c gene region

DL20/DL59

Crol, CycY, and Pde1c gene region

DL98/DL99

Crol, CycY, and Pde1c gene region

DL94/DL98

Crol, CycY, and Pde1c gene region
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Appendix E. Sequences of primers used in the study described in Chapter 2.
Primers Finley lab #

Primers Alias

Sequences

469

DL17

5’ TACTCCCGGTGGCAATAG

648

DL20

5' GTGCGATTGCGTTGTTCTTA

649

DL21

5' CGTAGGGAAATTCGAGGTGG

664

DL42

5' CAAGGCGGTTTATCTGATCG

522

DL43

5' AATGATTCGCAGTGGAAGGCT

523

DL44

5' CACCCAAGGCTCTGCTCCCACAAT

524

DL45

5' CGACACTCAGAATACTATTCC

525

DL46

5' AATTTGCGAGTACGCAAAGC

669

DL55

5’ TTTGCCTTACATTGTCTCTC

670

DL56

5’ ATGACAAGGGACACGAAAAT

671

DL57

5’ CCAATTGCCAAACGAAAGAT

672

DL58

5’ ACCCAATAATCCCGATTTGG

673

DL59

5' AGAGGCATTGCAGGATATG

686

DL72

5' CATCCCATCATATCCGACC

687

DL73

5' GTAACACGAATCCCCTAACC

688

DL74

5’ CCGCTGCTAATTGATGATTG

689

DL75

5’ CTCGGCATCTGAAAACAGG

690

DL76

5’ GCTTTGAGCGTTCAAGTTTG

691

DL77

5’ GAGCACGACTCTAACTTCTTC

692

DL78

5’ CCAGGTAGACTAGCGTGATG

693

DL79

5’ CCTGTACTCGCTTGTCTCTC

694

DL80

5’ GATCATTCTTGTTTCTGGACC

695

DL81

5’ AAACCAGGACCTATGCAAAC
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696

DL82

5’ GGATCTGGACACAAGAATGC

697

DL83

5’ AATCGATTTGTGCCTGAAGC

698

DL84

5’ CCGCGTCTCATTCAGTTTTC

707

DL93

5’ TCACCTGTTTTCAGATGCCGAG

708

DL94

5’ GGGCCAAGCACAAATACAAACG

709

DL95

5’ GATCGACGCGTCTGTCGTTCC

710

DL96

5’ AATCGCACGCACACACACACATG

711

DL97

5’ ACAAGGCGGTTTATCTGATCGG

712

DL98

5’ TGGTGAACGGCGAACAGAGC

713

DL99

5’ TCAAGAAAGGAACGACAGACG

808

RA19

5’ TACTATTCCTTTCACTCGCACTTATTG

714

DL100

5’ GGGACAAAAGTGAGAGCAG

715

DL101

5’ CTGCTCTCACTTTTGTCCC

716

DL102

5’ GCGGATGTCTACTAGTAGCC

717

DL103

5’ GGCTACTAGTAGACATCCGC

718

DL104

5’ GTAATTGGAGTAAGTGCAGGTG

719

DL105

5’ CACCTGCACTTACTCCAATTAC

720

DL106

5’ CGATCAGATAAACCGCCTTG

721

DL107

5’ TTGAACTTCCTAAGTGTGGC

722

DL108

5’ AGGAGAATGGCACCCAAC

891

5’ RT-F

5' TTGACTGTATCGCCGGAATTC

892

3’ RT-R

5' CCGGAATTAGCTTGGCTGCAG
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Appendix F. CycY and Eip63E null mutant pupae are smaller than wild-type pupae. A
collection of 30 to 40 pupae of CycYE8/+ (A), CycYE8 (B), CycYE8/+; P{CycY} (C), CycYE8;
P{CycY} (D), Eip63EGN50/+ and Eip63E81/+ (E), Eip63EGN50/Eip63E81 (F), CycYE8/+ and
Df(2L)Exel6030/+ (G), CycYE8/Df(2L)Exel6030 (H), CycYE8/+; P{CycY} and Df(2L)Exel6030/+;
P{CycY} (I), CycYE8/Df(2L)Exel6030; P{CycY} (J) were photographed and the relative pupal
length on the image was measured. Images A-F were taken at the same magnification and
images G-J were taken at the same magnification.
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Appendix G. Fly strains used in the study described in chapter 3
Finely Stock center &
lab # numbers

Alias or genotypes

References

210

Bloomington 1104

GMR-Gal4

(Freeman, 1996)

284

Bloomington 6356

en-Gal4

(Brand and Perrimon, 1993;
Sigrist and Lehner, 1997)

446

Bloomington 1774

69B-Gal4

(Brand and Perrimon, 1993)

161

Bloomington 1973

e22c-Gal4

(Zraly et al., 2003)

290

Bloomington 4414

Act5C-Gal4

-

424

-

UAS-Snr1-2, Snr1R3

(Zraly et al., 2003)

448

-

UAS-BrmK804R

(Elfring et al., 1998)

434

-

y1w* hs-FLP; Ubi-GFP
FRT40A

Dr. Dongbin Xu

407

VDRC 60008

UAS-dicer2

(Lee et al., 2004)

482

VDRC 12644

UAS-Snr1i

(Terriente-Felix and de
Celis, 2009)

484

VDRC 37720

UAS-Brmi

(Terriente-Felix and de
Celis, 2009)

692

-

CycYE8

(Liu and Finley Jr, 2010)

702

-

CycYE8 FRT40A

(Liu and Finley Jr, 2010)

642

-

UAS-CycY

(Liu and Finley Jr, 2010)

668

-

hs-CycY

(Liu and Finley Jr, 2010)
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Appendix H. Plasmids used or constructed for the study described in chapter 3
Plasmids Finely lab #

Plasmids Alias

Source or References

955

pWIZ

(Lee and Carthew, 2003)

952

pWIZ-CycYiN

This study

953

pWIZ-CycYiC

This study

766

pTLJ03

(Parrish et al., 2004)

943

pTLJ03-Eip63E A1

This study

944

pTLJ03-Eip63E A1 I249L

This study

945

pTLJ03-Eip63E B1

This study

946

pTLJ03-Eip63E B1 I249L

This study

947

pTLJ03-Eip63E(B1, K234M)

This study

948

pTLJ03-Snr1

This study

949

pTLJ03-Snr1(T102/198A)

This study

950

pTLJ03-Snr1(T102A)

This study

978

pTLJ03-CycY

This study

981

pTLJ03-CycY S388/389A

This study

982

pTLJ03-CycY S389A

This study

990

pTLJ03-CycY S389E

This study

998

pTLJ03-CycY S388E

This study

378

pET-28a(+)

-

1011

pET28a-Eip63E

This study

1012

pET28a-Snr1

This study

1017

pET28a-CycY

This study

1029

pET28a-nCycY

This study

1007

pMal-c2

-

1009

pMalc2-Eip63E

This study

1010

pMalc2-Snr1

This study

1030

pMalc2-nCycY

This study

1033

pMalc2-Snr1 T102/198A

This study

1034

pMalc2-Snr1 T102A

This study

1035

pMalc2-Snr1 T198A

This study
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Appendix I. Transgenic fly strains generated for the study described in chapter 3
Finley
lab #

Alias

Genotypes

Plasmids for P-element
transformation

Used in
this study?

644

3R2

CycYi

pWIZ-CycYiC

No

645

3R22

w; CycYiC2/CyO; Ser/Sb

pWIZ-CycYiC

Yes

646

3R22H

w; CycYiC2; Ser/Sb

pWIZ-CycYiC

Yes

647

3R23

w; CycYi/CyO; Ser/Sb

pWIZ-CycYiC

No

648

3R51

w; Sp/CyO; Ser/CycYi

pWIZ-CycYiC

No

649

3R52

w; Sp/CyO; Ser/CycYiC1

pWIZ-CycYiC

Yes

650

3R53

w; Sp/CyO; Ser/CycYi

pWIZ-CycYiC

No

651

3R54

w; Sp/CyO; Ser/CycYi

pWIZ-CycYiC

No

652

3R21B1

w; CycYi/CyO Act5C-GFP; Ser/Sb

pWIZ-CycYiC

Yes

653

3R22B1

w; CycYi/CyO Act5C-GFP; Ser/Sb

pWIZ-CycYiC

Yes

654

3R23B1

w; CycYi/CyO Act5C-GFP; Ser/Sb

pWIZ-CycYiC

Yes

752

2R2

CycYi

pWIZ-CycYiN

Yes

753

2R21

w; CyO/CycYiN1; Ser/Sb

pWIZ-CycYiN

Yes

754

2R22

w; CyO/CycYi; Ser/Sb

pWIZ-CycYiN

Yes

755

2R51

w; CyO/Sp; CycYiN2/Ser

pWIZ-CycYiN

Yes

756

2R52

w; CyO/Sp; CycYi/Ser

pWIZ-CycYiN

Yes
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Appendix J. Wing imaginal discs upon knockdown of CycY do not show
abnormal proportion of apoptotic cells. Wing imaginal discs (en-Gal4/+; UASCycYiC1/UAS-GFP) were stained with GFP (Green, A), TUNEL (Red, B), and DAPI
(Blue, C).
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Appendix K. Fly strains used in the study described in Chapter 4
Finley
lab #

Stock center &
numbers

Alias or genotypes

References or sources

434

-

y1w* hs-FLP; Ubi-GFP FRT40A

Dr. Dongbin Xu

435

-

y1w* ey-FLP; Ubi-GFP FRT40A

Dr. Dongbin Xu

442

-

y1w*;Sp/CyO [y+];TM2/TM6B Tb

Dr. Lei Zhang

711

-

y1w*; CyO [y+]/Sp; TM6B Tb/Sb

this study

704

-

y1w*; FRT40A/CyO [y+]; TM6B Tb/Sb

this study

705

-

y1w*; CycYE8/CyO [y+]; TM6B Tb/Sb

this study

777

-

y1w*; CycYE8/CyO [y+]; TM6B
Tb/Eip63E81

this study

778

-

y1w*; CycYDf6030/CyO [y+]; TM6B
Tb/Eip63EDf6096

this study

779

-

y1w*; CycYDf6030/CyO [y+]; TM6B
Tb/Eip63EDf6095

this study

437

Bloomington 5885

Sgs3-GFP

(Biyasheva et al.,
2001)

706

-

y1w*; CyO [y+]/Sp; sgs3-GFP/TM6B
Tb

this study

710

-

y1w*; CycYE8/CyO [y+]; sgs3GFP/TM6B Tb

this study

535

-

w*; Atg1∆3D/TM6B

Thomas P. Neufeld’s
lab

717

-

y1w*; CycYE8/CyO [y+]; Atg1∆3D/TM6B
Tb

this study

534

-

y1w*; TOR∆6B/CyO

Thomas P. Neufeld’s
lab

718

-

y1w*; TOR∆6B/CyO [y+]; CycYiC1/TM6B
Tb

this study (also see
Chapter 3 for details
bout CycYiC1)

719

-

y1w*; TOR∆6B/CyO [y+]; TubGal4/TM6B Tb

this study
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The Drosophila gene CG14939 encodes a member of a highly conserved family
of cyclins, the Y type cyclins, which have not been functionally characterized in any
organism. Here I report the generation and phenotypic characterization of a null mutant
of CG14939, which we rename Cyclin Y (CycY). I show that the null mutant, CycYE8, is
homozygous lethal with most mutant animals arresting during pupal development. The
mutant exhibits delayed larval growth and major developmental defects during
metamorphosis. Heat shock-induced expression of CycY at different times during
development resulted in variable levels of rescue, the timing of which suggests a key
function for zygotic CycY during the transition from third instar larvae to prepupae. CycY
also plays an essential role during embryogenesis since zygotic null embryos from null
mothers fail to hatch into first instar larvae. Furthermore I show that CycY is required for
adult viability, especially in males. I provide evidence that the CycY protein (CycY)
interacts with Eip63E, a Cyclin-dependent kinase (Cdk) for which no cyclin partner had
previously been identified. Like CycY, the Eip63E gene has essential functions during
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embryogenesis, larval development, and metamorphosis. My data suggest that
CycY/Eip63E form a cyclin/Cdk complex that is essential for several developmental
processes.
To gain insight into the cellular functions of CycY and to identify signaling
pathways to which it belongs, I used RNA interference (RNAi) to knock down CycY
expression in specific tissues. I show that CycY is required for wing growth and wing
vein development. I also show that CycY genetically interacts with Snr1 and Brm, two
components of the Brm ATP-dependent chromatin remodeling complex, and that CycY
can physically interact with Snr1. Furthermore, I show that downstream targets of the
Brm complex are misregulated in CycY mutants. Taken together, these data suggest
that CycY may be involved in gene regulation by modulating Brm complex activity.
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